A molecular investigation of the otrB locus of Streptomyces rimosus by MacGregor-Pryde, Susan Elizabeth
 
 
 
 
 
Liuhto, Kari Tapani (1996) The entrepreneurial and management 
cultural transformation in independent Estonia. PhD thesis. 
 
 
 
http://theses.gla.ac.uk/2075/ 
 
 
 
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
 
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
A molecular investigation of the otrB locus of Streptomyces 
rimosus. 
A thesis submitted for the degree of 
Doctor of Philosophy at the University of Glasgow. 
by 
Susan Elizabeth MacGregor-Pryde 
Division of Molecular Genetics, 
Institute of Biomedical and Life Sciences, 
Church Street, 
The University, 
Glasgow, 
G11 5JS. 
November, 1995. 
Dedicated to Mum, Dad, Gordon, Lynne and my Husband lain 
without your love and support this thesis would not have been 
written. 
The research reported in this thesis is my own original work 
except where otherwise stated and has not been submitted for 
any other degree. 
Susan Elizabeth MacGregor-Pryde, November, 1995. 
Contents 
List of figures and Tables 
(i) (x 
-(x) Abbreviations 
Acknowledgements ( xiii) 
Summary (xi " -) - (``') 
Chapter 1 Introduction 
1.1 General Introduction ...................................................................................... 
1 
1.2 Developments in Streptomycete molecular biology ......................... 
3 
1.3 Evolution of secondary metabolism ........................................................ 
4 
1.4 Regulation of secondary metabolism in 
Streptomyces ............................................................................................................ 
7 
1.4.1 BId mutants ........................................................................................ 
8 
1.4.2 A-factor ............................................................................................... 
11 
1.4.3 afsB locus and absA! B genes. 
1.4.4 ppGpp ..................................................................................................... 
13 
1.4.5 "Two-component" regulatory systems ................................ 15 1.5 Catabolite Regulation .................................................................................... 16 1.6 Polyketide Biosynthesis ............................................................................... 18 1.6.1 Introduction ........................................................................................ 18 1 . 6.2 Biosynthesis ....................................................................................... 19 1.6.3 Polyketide synthases (PKS) ......................................................... 20 1.6.4 The Acyl Carrier Protein (ACP) .................. .............................. 21 1.6.5 Organisation of polyketide genes ............................................. 25 1.6.6 Organisation of the Oxytetracycline (OTC) 
biosynthetic gene cluster ........................................................................ 28 1.7 Antibiotic resistance .................................................................................... 32 1.7.1 Introduction ........................................................................................ 32 1.7.2 Organisation of resistance genes ............................................. 33 1.7.3 Modification of the produced antibiotic ................................ 34 1.7.4 Modification of a cellular component(s) ............................... 34 1.7.5 Induction of an alternative component that is 
insensitive to the antibiotic .................................................................. 35 1.7.6 Export/ Efflux of the produced antibiotic from 
the cell ............................................................................................................. 1.8 Transcriptional and translational control of 
35 
Streptomyces genes ............................................................................................... 38 1.9 Expression of Streptomyces production genes ................................ 42 1.10 Prospects for genetic engineering in 
streptomycetes ........................................................................................................ 43 1.11 Scope of present work ................................................................................ 44 
Chapter 2 Materials and Methods 
2.1 Bacterial strains and vectors .................................................................... 46 2.2 Microbiological techniques and standard media ................................ 47 2.2.1 Standard media for the growth of E. coli ............................... 47 
1 
2.2.2 Standard media for the growth of 
Streptomyces ................................................................................................ 
48 
2.2.3 Sterilisation ..................................................................................... 
49 
2.2.4 Preparation of Streptomyces spore 
suspensions .................................................................................................... 
49 
2.2.5 E. coli growth conditions .............................................................. 
50 
2.2.6 Growth of Streptomyces mycelium ........................................ 
51 
2.2.7 Quantification of oxytetracycline in culture 
supernatants .................................................................................................. 
51 
2.2.8 Antibiotics and indicators ......................................................... 
51 
2.2.9 Preservation of Streptomyces and E. coli 
strains .............................................................................................................. 
52 
2.2.10 Transfection of E. coli cells with 
bacteriophage M 13 ...................................................................................... 
53 
2.2.1 1 Introduction of plasmid DNA into 
Streptomyces ................................................................................................ 
54 
2.2.12 Mating between Streptomyces species .............................. 55 2.3 Nucleic acid isolation and manipulation ............................................... 56 2.3.1 Isolation of plasmid DNA from E. coli species ................... 56 2.3.2 Isolation of total RNA .................................................................. 58 2.3.3 Quantification of nucleic acid .................................................. 60 2.3.4 Precipation of nucleic acids using ethanol or 
isopropanol ..................................................................................................... 61 2.3.5 Digestion of DNA with restriction 
endonucleases ............................................................................................... 61 2.3.6 Ligation of DNA fragments .......................................................... 61 2.3.7 Removal of 5' phosphate from linear DNA ............................. 62 2.3.8 Filling recessed 3'-Termini ........................................................ 62 2.3.9 Addition of DNA linkers to blunt-ended DNA ....................... 62 2.3.10 Removal of protein from nucleic acid 
solutions using organic solvents ......................................................... 63 2.3.11 Preparation of radiolabelled probes .................................... 63 2.3.11.1 Random primed labelling method .......................... 63 2.3.11.2 5'-End labelling of oligonucleotides .................... 64 2.3.11.3 Sephadex G50 column 
chromatography ................................................................................ 65 2.3.12 Agarose gel electrophoresis .................................... . 65 ... ............ 2.3.12.1 Mini gels .................................................... .. 65 .. ................... 2.3.12.2 Large gels ................................................. . 66 .. .................... 2.3.12.3 Photography of resolved nucleic 
acids .................................................................................................... 2.3.13 Denaturing polyacrylamide gel 
66 
electrophoresis ......................................................................................... 66 2.3.14 Recovery of DNA from agarose gels ...................................... 67 2.3.14.1 GENECLEANTM 
.......................................................... 68 .......... 2.3.14.2 Co-Star® Spin-XTM tubes 68 ............................................. 
11 
2.3.15 Southern analysis ........................................................................ 
69 
2.3.15.1 Capillary transfer ......................................................... 
69 
2.3.15.2 Aqueous prehybridisation and 
hybridisation ..................................................................................... 
69 
2.3.15.3 (a) Hybridisation using random 
probes .................................................................................................... 
69 
2.3.15.3 (b) Conditions for aqueous 
hybridisation with oligonucleotides ...................................... 
70 
2.3.16 Preparation of single-stranded DNA 
template ............................................................................................................. 
71 
72 2.3.17 DNA sequencing ................................................................................ 
2.3.18 Primer extension mapping of 5' transcript 
ends ...................................................................................................................... 
73 
74 2.3.19 Autoradiography .............................................................................. 2.4 Protein isolation and manipulation ........................................................ 
74 
2.4.1 Preparation of crude extracts .................................................... 
74 
2.4.2 Denaturing polyacrylamide gel electrophoresis 
of proteins ...................................................................................................... 
74 
2.4.3 immunoblotting of proteins (Western 
blotting) .......................................................................................................... 
75 
Chapter 3 The otrB gene 
3.1 Introduction ...................................................................................................... 
77 
3.1.2 Aims of the project ............................................................ 
78 
3.2 Computer-assisted analysis ..................................................................... 
80 
3.2.1 Analysis of open reading frames .............................................. 
81 
3.2.2 Sequencing strategy for the otrB gene ................................... 82 3.2.3 Translational start and stop codons ....................................... 95 3.2.4 Amino acid comparison of the otrB gene 
product ............................................................................................................. 
95 
3.2.5 Transcriptional analysis of the otrB gene ............................ 99 3.3 Discussion ......................................................................................................... 101 3.4 Future work ........................................................................................................ 103 
Chapter 4 The OtrB protein 
4.1 introduction ................................................................ 104 ....................................... 4.2 Results ................................................................................................................. 106 4.2.1 Amino acid sequence for otrB .................................................... 106 4.2.2 Hydropathy profiles ........................................................................ 106 4.2.3 Comparison to other transport proteins ................................ 108 4.2.4 Residue conservation ..................................................................... 113 4.2.5 Identification of motifs for proton transport .................... 113 4.2.6 Dotplot analysis ............................................................................... 119 4.3 The Antiport system ...................................................................................... 119 4.3.1 Conservation of transmernbrane charged 
residues ........................................................................................................... 122 
m 
4.4 Membrane topology .......................................................................................... 
123 
4.5 Discussion ........................................................................................................... 
124 
4.6 Future work ........................................................................................................ 
128 
Chapter 5 The otrR gene 
5.1 Introduction ....................................................................................................... 
129 
5.1.2 Aims of the project ........................................................................ 
130 
5.2 Computer assisted analysis of the otrR gene ..................................... 
131 
5.2.1 Frame analysis of the otrR gene (potential 
protein coding regions) ............................................................................. 
131 
5.2.2 Sequencing strategy for the otrR gene ................................... 131 5.2.3 Data base analysis of the otrR gene product ....................... 133 5.2.4 Dotplot analysis of the otrR gene ........................................... 140 5.3 Transcriptional analysis of the otrR gene ........................................... 140 5.4: Characteristics of the otrR gene and upstream 
region ............................................................................................................................ 142 5.5 Discussion ........................................................................................................... 149 5.6 Future work ........................................................................................................ 151 
Chapter 6 Physiological investigations 
6.1 Introduction 
........................ ........................................................................... Is 
3 
6.1.2 Experimental aims ........................................................................... 155 6.2 Results 
................................................................................................................. 155 6.2.1 The influence of phosphate concentration on 
oxytetracycline production ..................................................................... 15 5 6.2.2 Transposon mutagenesis of the 
oxytetracycline gene cluster ................................................................. 162 6.2.3 Analysis of a haemoglobin gene containing 
plasmid and its influence on oxytetracycline 
production ....................................................................................................... 170 6.2.4 Comparison of oxytetracycline production to 
isolate RNA for transcriptional studies ........................................... 174 6.3 Discussion ........................................................................................................... 178 
Chapter 7 Future work 
7.1 The otrB gene and putative membrane protein ................................... 180 7.1.1 Transcriptional studies ................................................................ 180 7.1.2 Studies of the otrB protein ......................................................... 180 7.2 The otrR gene product .................................................................................. 181 7.2.1 Transcriptional studies ................................................................ 181 7.2.2 Studies with the putative 
otrR protein .................................................................................... 181 7.3 Physiological investigations 
...................................................................... 182 7.3.1 The effect of phosphate on oxytetracycline 
production ....................................................................................................... 182 7.3.2 Transposon mutagenesis studies .............................................. 182 
iv 
7.3.3 The VHb gene ...................................................................................... 
183 
References .................................................................................................................. 
184 
V 
List of Figures and Tables 
Chapter 1 
Figure 1.1- Diagrammatic representation of the S. coelicolor 
Lifecycle .......................................................................................... 
2 
Figure 1.2- Schematic diagram of proposed expression 
and/or activation dependence relationships for the 
production of act in S. coelicolor ................................................. 
8 
Table 1.1- A summary of Streptomyces genes containing TTA 
codons ............................................................................................ 10 
Figure 1.3- The afsB locus ............................................................ 13 
Table 1.2- Phosphate control sequences existing in 
E. coli and streptomycete species ................................................ 17 
Figure 1.4- A schematic representation of the biosynthesis 
of fattyacids and polyketides ...................................................... 22 
Figure 1.5- Schematic diagrams indicating the organisation 
of the polyketide synthases ....................................................... 26 
Figure 1.6- The oxytetracycline pathway ................................... 30 
Figure 1.7- A restriction map of the oxytetracycline genes....... 31 
Figure 1.8- The location of genes within the otcD and otcY 
regions of the oxytetracycline cluster .......................................... 32 
Table 1.3- Enzymes inactivating autogenous antibiotics 
in producing species ........................................................................ 36 
Table 1.4- Resistance to autogeneous antibiotics 
resulting from the methylation of ribosomal RNA 
in producing organisms ................................................................. 36 
vi 
Table 1.5- Resistance to autogenous antibiotics exerted 
at the level of non-ribosomal target sites .................................... 
37 
Figure 1.9- G+C content of streptomycete promoter regions.. 42 
Table 1.6- Pharmacological functions of antibiotics ................. 
44 
Chapter 2 
Table 2.1- Bacterial strains .......................................................... 
46 
Table 2.2- Plasmids ...................................................................... 
47 
Chapter 3 
Figure 3.1- Restriction map of the right-hand 
end of the oxytetracycline gene cluster .................................... 
79 
Figure 3.2- Summary of the sequencing strategy for the 
otrB gene and upstream region ................................................. 
84 
Figure 3.3- The complete annotated sequence of the otrB 
gene ............................................................................................... 85-89 
Figure 3.4- CODONPREFERENCE indicating the open-reading 
frame of the otrB gene ................................................................ 90 
Figure 3.4- BESTFIT analysis of the otrB gene sequence 
in comparison to the tet347 sequence ........................................ 91-94 
Figure 3.6- DOTPLOTS of the comparisons between OtrB, 
tcmA, ActII-orf2 and ActVa-orfl .................................................. 96-97 
Figure 3.7- Primer extension analysis of the otrB gene......... 98 
Figure 3.8- Transcriptional sequence data of the 
deduced otrB gene product ...................................................... 100 
Chapter 4 
Vii 
Figure 4.1- A restriction map of the right-hand 
end of the oxytetracycline cluster ............................................. 105 
Figure 4.2- Hydropathy plots of the otrB protein and 
other members of the class III transporter family .................. 107 
Figure 4.3- PILEUP amino acid sequence comparisons of 
members of the class III transporter family ............................ 109-1 11 
Figure 4.4- OtrB protein complete amino acid sequence.... 112 
Figure 4.5- Comparison between TetA and OtrB protein 
sequences ................................................................................. 
114 
Figure 4.6- DOTPLOT analysis of the OtrB protein against the 
QuacA and Tht15 proteins ................................................... 
120-121 
Figure 4.7- Membrane topology of the Mmr export protein.. 123 
Figure 4.8- The evolutionary tree of the four 
classes of electrochemical transporters ................................... 125 
Chapter 5 
Figure 5.1- Restriction map of the right hand 
end of the oxytetracycline cluster ............................................ 130 
Figure 5.2 CODONPREFERENCE analysis of the otrR gene..... 132 
Figure 5.3- The complete annotated sequence of the 
otrR gene ..................................................................................... 134-135 
Figure 5.4 DOTPLOT analysis of the OtrR protein against 
Actll-orf 1, MarR and TcmR ......................................................... 137-139 
Figure 5.5- Primer extension analysis of the otrR gene......... 144 
viii 
Figure 5.6- A comparison of presumptive 
helix-turn-helix motifs .............................................................. 
145 
Figure 5.7- The otrB/otrR intergenic region ........................... 
14 7 
Figure 5.8- The tcmR and ActII-orfl intergenic regions........ 148 
Chapter 6 
Table 6.1 - Results of xylE expression in different gene regions 
of the otc cluster ....................................................................... 
156 
Figure 6.1- The effect of phosphate on oxytetracycline 
production ................................................................................ 
158 
Table 6.2- Observed zones of inhibition of oxytetracycline 
producing pGLW101 on E. coli MC1061 seeded plates ......... 160 
Figure 6.2- Biomass of S. rimosus 4018 at different 
phosphate concentrations ........................................................ 
161 
Figure 6.3- The pUC 1169 transposon ..................................... 163 
Figure 6.4 -A schematic diagram of pUCl 169 mutagenesis 
strategy for pGLW 101 ............................................................. 164 
Table 6.3(a)- Colony pigmentation and OTC production 
of pG LW IOl mutants .............................................................. 165 
Table 6.3(b)- Cross-feeding studies between 
selected pUC 1169/pGLW 101 mutants ................................. 165 
Figure 6.5- Restriction digests of pUC1169/pGLW101 
transposon mutants ................................................................ 167 
Figure 6.6- Restriction digests of pUC 1169/pGLW 101 
transposon mutants ............................................................... 168 
Figure 6.7- The effect of the VHb gene on OTC 
ix 
production ............................................................................... 
172-173 
Figure 6.8- A protein gel of 4018/pDS 118 and 
401 8/pDS903 cell extracts .................................................... 175 
Figure 6.9- A western blot of the protein gel in 
Figure 6.8 probed with VHb antibody ................................... 176 
Figure 6.10 - The comparison of OTC production 
in 4018 on minimal and production media ....................... 177 
Figure 6.11 - OTC production in a Pfizer 
production strain of S. rimosus .............................................. 177 
X 
Abbreviations 
A- Absorbance 
ATP - adenosine S'-triphosphate 
ACP - Acyl carrier protein 
ATC - anhydrotetracycline 
bp(s) - base pair(s) 
cpm - counts per minute 
CoA - co enzyme A 
dNTP - dinucleoside S'-triphosphate 
dATP - deoxyadenosine 5'-triphosphate 
dCTP - deoxycytidine 5'-triphosphate 
dGTP - deoxyguanidine 5'-triphosphate 
dTTP - deoxy thymidine 5'-triphosphate 
DNA - deoxynucleic acid 
dsDNA- double-stranded deoxynucleic acid 
DNase - deoxyribonuclease 
EF-Tu - elongation factor Tu 
EF-G - elongation factor G 
FAS - fatty acid synthase 
g- gravity 
g- gram 
hr(s) - hour(s) 
HPLC - high performance liquid chromatography 
K- thousand 
Kb(s) - kilobase(s) 
Kd(s) - kilodalton(s) 
min(s) - minute(s) 
mM - millimolar 
ml(s) - millilitre(s) 
pM - micro molar 
pl - micro litre 
pCi - micro currie 
nt(s) - nucleotide(s) 
ng(s) - nanogram(s) 
O. D. - optical density 
ORF - open reading frame 
xi 
OTC - oxytetracyc line 
PC - phosphate control 
pho boxes - phosphate recognition boxes 
ppG pp - (ol, pý. 3( ou eL-CSIO LcJ: & 
PKS - polyketide synthases 
PCR - polymerase chain reaction 
RNA - ribonucleic acid 
mRNA - messenger ribonucleic acid 
rRNA - ribosomal ribonucleic acid 
tRNA - transfer ribonucleic acid 
rpm - revolutions per minute 
SDS - sodium deodecyl sulphate 
Tm - melting temperature 
UV - ultraviolet 
v/v - volume to volume ratio 
w/v - weight to volume ratio 
x-gal - 5-bromo-4chloro-3 indoyl-ß-D-galactoside 
xii 
Acknowledgements 
Firstly, I would like to thank all the people in the 
Streptomyces group past and present for their friendship and 
scientific advice "when the going got tough". Special mention must 
go to Kenny McDowall, Alison, Kenny Linton, Richard, Anne, Paul, 
Colin, and Shelia. 
A big thank-you goes to Marion (for all the birthday cards, 
cakes and parties) and for keeping the shelves and me stocked with 
Streptomyces media and cultures respectively. A thank-you to Doris 
and all her "girls" for the laughter and supplies of sterile labware 
and media. A thank-you to everyone at Pfizer (Sandwich) in the IPD, 
for making me welcome and allowing me to monopolise the -70 and 
glassware for a few weeks. 
To lain Hunter, my supervisor, a sincere thank-you for all the 
hard work involved in the drafting of this thesis. 
This work was supported by an SERC (CASE) studentship in 
collaboration with Pfizer. 
? Gill 
Summary 
The industrial and commercial importance of antibiotic- 
producing Streptomyces species has generated abundant data on 
the clusters of genes which encode the production of antibiotics. 
This information is also being used in strategies towards the 
development of novel antibiotic structures. The gene cluster- 
encoding production of oxytetracycline (OTC) by Streptom ces 
rimosus (the commercial producer) has been studied in this 
laboratory. 
The topic of this thesis was the region of the otc cluster 
including and upstream of the OTC-resistance gene otrB, which has 
been shown previously to be responsible for reduced accumulation 
of the antibiotic. 
The otrB gene was sequenced. The sequence revealed some 
discrepancies with previously-published data on tet347 (Reynes et 
al., 1988; Journal of General Microbiology 134: 585-598), a OTC- 
resistant determinant from another strain of S. rimosus. The deduced 
gene product of the otrB showed considerable identity with efflux 
proteins from other Gram-negative and Gram-positive bacteria. 
These proteins contain conserved functional motifs, and OtrB was 
analysed in this context. The transcriptional start of otrB was 
identified. 
Upstream of otrB, a divergent open reading frame was 
deduced, which showed some similarity to repressor proteins 
associated with antibiotic resistance in other species. For this reason, 
the gene was named otrR. The transcriptional start point of otrR was 
identified, and the intergeneic region between otrB and otrR was 
characterised. A comparison of OtrR with known streptomycete 
repressors was investigated and the data discussed in relation to 
relevant publications on organisation and regulation of the 
exporter/ repressor pairs, and to the recently characterised cry stal 
structure of the homodimeric Tet repressor from enteric bacteria 
(Hinrichs eta)., 1994; Science 2 64: 418-420). 
xiv 
Several short investigations were undertaken into the 
physiology of antibiotic production. (1) A transcriptional fusion 
vector (pIJ2 843) using catechol oxygenase as a reporter was used to 
monitor the response of transcription of various regions of the otc 
cluster (cloned from a high-producing strain) to changes in external 
phosphate concentration. These data were compared in relation to 
antibiotic production by the wild-type strain. (2) A transposon 
mutagenesis strategy was used to attempt to generate novel 
mutations within the otc cluster. (3) The presence of genetically- 
engineered haemoglobin cloned into S. rlmosus production strains 
was investigated. The relationship between expression of the 
recombinant protein, antibiotic production and the aeration of the 
S. rirnosus cultures is discussed 
xv 
Chapter 1: Introduction 
Chapter 1 Introduction 
1.1 General Introduction 
Streptomyces are a group of Gram-positive, soil-living micro- 
organisms that belong to the genus Actinomycetes. These mico- 
organisms have shown a long history of producing compounds that 
are beneficial to mankind. In nature, they degrade waste materials 
and play an integral part in the recycling of material within the soil. 
They produce glucose isomerase for the food and beverage 
industries, and produce a wealth of extracellular enzymes such as 
proteases, amylases, and xylanases. Streptomyces produce a 
plethora of well-known drugs such as daunorubicin (an anti-cancer 
drug), avermectin (an anti-nematode compound), and FK506 (an 
immunosupressant compound) (Cohen, 1977 and Burg, 1982). 
However, Streptomyces are mainly recognised for production of 
many of our most effective antibiotics such as streptomycin, the 
tetracyclines and erythromycin. 
Streptomyces are one of only a few bacterial species that exist 
as multicellular organisms. They exhibit a complex life-cycle of 
physiological differentiation that involves the progression from 
dormant spores, through vegetative mycelium, to aerial mycelium 
and then again to the spore stages (Figure 1.1). Secondary 
metabolites are those metabolites produced in a phase subsequent 
to growth, and have no known function in growth (although they 
may have a survival function) (Hopwood and Khosla, 1992). Lack of 
detailed knowledge about the switch from primary to secondary 
metabolism has proved a major hurdle in using logical approaches 
to improve the productivity of actinomycete fermentations. This has 
fuelled a desire for an understanding of antibiotic biosynthesis, 
combined with research into the biochemistry of antibiotic 
precursor production and the physiological switches within the 
organism that enable this production to occur. Improved 
understanding of Streptomyces physiology and antibiotic 
production at the genetic level is the goal of most research groups 
involved with these organisms. 
Antibiotics are metabolites made by step-wise biosynthesis. 
Each simple metabolite requires some 10-30 genes merely to 
determine its structure, as well as resistance genes for self protection 
1 
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and regulatory genes to control the activity of the structural genes, 
particularly in response to specific ecological needs or stimuli. 
(More complex metabolites require many more genes). Expression of 
many regulatory genes often coincides with the transition between 
active, vegetative growth and sporulation. Moreover, a single 
Streptomycete species can produce more than one antibiotic, each 
needing its own set of structural, regulatory and resistance genes 
(Hopwood, 1989). 
An understanding of the molecular mechanisms governing 
antibiotic biosynthesis will indicate potential areas of improvement 
in antibiotic fermentations. Detailed genetic analysis of antibiotic 
clusters and their regulation considered along with physiological 
studies may make it possible to isolate or generate new strains 
producing novel antibiotics or improve the efficiency of current 
production strains of Streptomyces; creating more efficient 
antibiotic production factories which will be increasingly important 
in today's industrial world. 
Grey pigmentation, 
maturation and release of Germination 
spores o and outgrowth 
Free-- Substrate mycelium ýhiE 
spore Rounding up 
of immature 
spores b/d A Growth of aerial 
b/dB hyphae with 
b/dD fibrous sheath 
whiF? b/d F 
bidG 
,9 b/d H1, 
I! lý 
Aerial 
hypha 
whi0 whit Wall Initiation 
thickening / 
and rounding off of coiling 
at junctions of 
spore whil whIH compartments 
ý(whiC) 
Sporulat ion Completion 
septotion , ýý of coU1ng 
FIGURE 1.1: Diagramatic representation of the Streptomyces 
coelicolor life cycle showing the requirements for bid and whi genes 
during various stages of development. From Chater and Merrick, 
1979. 
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1.2 Developments in Streptomycete molecular 
biology 
In the early 1970s many studies on Streptomyces were 
confined to a single strain, Streptomyces coelicolor A3(2). At this 
point a variety of other groups produced genetic linkage neaps of 
other Streptomyces species, most notably the linkage map of 
Streptomyces rimosus (Hopwood and Friend, 1971), a known 
antibiotic-producing strain. At this time interest in Streptomycete 
biology was further fuelled by the discovery that Streptorllyces DNA 
consisted of a high G and C content of 73 % (on average) which 
differed substantially from that of E. co1i (51%) and B. subtilis (40%) 
(Enquist and Bradley, 1971). 
By the late 1970s it had been proved that conjugation was 
widespread among Actinomycetes and that if a selectable marker 
could be introduced into the system a potential strategy could exist 
for detecting recombinants and so lead to applications for strain 
improvement (Cohen et al., 1977). A group of researchers at the 
John Innes Institute at Norwich, led by David Hopwood, then began 
the pioneering work of Streptomyces molecular biology by 
developing protoplasting and regeneration techniques, using 
polyethylene glycol (PEG). This protocol enabled the transformation 
of Streptomyces species (Bibb et al, 1978), and lead to the first gene 
being cloned from a Streptomycete: the gene conferring 
methylenomycin resistance in Streptomyces coelicolor (Bibb et al., 
1980). 
Gene cloning allowed biologists to perform experiments with 
Streptomyces that were previously impossible and by the mid to late 
1980's a variety of entire antibiotic clusters had been cloned by 
several groups. In the 1990's due to massive progress in molecular 
biology whole antibiotic clusters have now been sequenced, 
structural genes over expressed and protein structures examined. 
3 
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1.3 Evolution of secondary metabolism. 
Secondary metabolites are those metabolites produced in a 
phase subsequent to growth, and have no known function in growth 
(although they may have a survival function). They are produced by 
certain taxonomic groups of micro-organisms, have unusual 
chemical structure, and are formed as mixtures of closely-related 
members of a chemical family (Nisbet, 1993). There is a great deal 
of debate about the evolution of secondary metabolism, and a great 
deal of speculation as to the role of secondary metabolism and its 
origins. 
Two main theories are contested in this area: 
1) A belief that secondary metabolism evolved as a beneficial 
advantage for micro-organisms for survival in competitive 
ecosystems. 
2) A belief that secondary metabolism was a central part of 
cellular metabolism and played roles in pre- or early enzyme 
reactions as effectors or as co-factors to stabilise preferred active 
conformations, that is non-peptide forerunners of enzymes (Davies, 
1990). 
With the ever expanding field of biochemistry allowing us to 
understand metabolite structures and their relationships to each 
other, it may now be possible to comprehend the existence of 
secondary metabolism and its functions in nature. 
Arguments for theory one appear to be the more widely-held 
views of most Streptomycete biologists. They believe that secondary 
metabolism exists to protect the host organism during stages in its 
life cycle when its metabolic nutrients can be scavenged by other 
microoganisms within the vicinity. In Streptomycetes, the 
observations that the association between the two "specialised" 
properties of Streptomyces (production of antibiotics and the onset 
of aerial mycelium formation and sporulation) does not appear to be 
a chance one, because the genetic control mechanisms for the two 
processes show important cross-correlations (Hopwood, 1986 and 
4 
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Davies, 1986). This suggests that pleotrophic switching is common 
in Streptomyces and the early "shunt" hypothesis, that secondary 
metabolism is regarded as an overflow process to regulate 
overproduction of the products from primary metabolic processes, is 
untrue. Other evidence is based on several important observations: 
a) Currently there are no proven exceptions to the rule that 
genes controlling successive steps in antibiotic production are 
clustered. Antibiotic gene clusters contain not only genes necessary, 
for the production of the antibiotic but also genes involved in 
regulatory roles (activators or repressors) and resistance genes to 
protect the producing organism against its product. Clustering in 
this manner of functionally-related genes on a chromosome implies 
that at least part of their evolution has occurred as a unit. 
Additionally these clusters contain very little DNA that is not 
involved in biosynthesis or regulation of antibiotic production 
(Stone and Williams, 1992). 
b) It has been proved that secondary metabolites are 
produced in nature and are not an artefact of fermentation 
conditions in laboratories or industrial processes- by implication in 
competition between various microbes indicating antagonistic 
properties in nature (Cavalier-Smith, 1992) 
c) In general secondary metabolism is observed among 
organisms that do not possess an immune system per se. Therefore 
it is proposed to act as an alternative defence mechanism. 
d) Phylogenetic evidence suggests that the majority of 
secondary metabolites appear to be of recent rather than of 
primordial origin (although some may date back to the early 
evolutionary stages). 
The basis of the evidence for these views was summarised by 
Vining (1992), stating that the genes coding for secondary 
metabolism could not have evolved and been conserved for man`, 
tens, hundreds and sometimes thousands of millions of years 
without conferring a considerable selective advantage to their hosts. 
5 
Chapter 1 Introduction 
Functional similarities may also exist between chemical 
signalling mechanisms used to integrate the cellular activities in 
modern highly differentiated animals and those still present in 
microorganisms where the essential components originated (Roth et 
a], 1986). 
Recent advances in Streptomycete molecular biology have 
allowed cloning, DNA sequencing and protein analysis of a 
multitude of primary and secondary metabolic enzymes. Sequence 
analysis of these enzymes has indicated that secondary metabolism 
appears to have arisen by modification of primary metabolic 
reactions (Vining, 1992). Also, amino acid sequence comparisons 
have indicated that although primary and secondary metabolic 
enzymes from the same family originate from the same ancestry, 
secondary metabolic enzymes in a particular organism may be more 
closely-related to primary metabolic enzymes from another 
organism. This suggests that gene transfer between organisms has 
played a substantial role in the evolution of secondary metabolism. 
A smaller field of scientists believe that theory one does not 
answer all of the scientific questions posed, for example secondary 
metabolite production associated with some organisms (e. g. 
Norcardioforms) which do not form aerial mycelium. This gives rise 
to the alternative hypothesis that, in the unbalanced nutrient state 
when mycelial growth slows down, the secondary metabolite system 
prevents the detrimental accumulation of unwanted intermediates 
thus detoxifying these intermediary metabolites (Hunter and 
Baumberg, 1989). Davies (1990) also proposed that antibiotics may 
have composed part of the "primordial soup". 
However with the unresolved arguments between 
phylogeneticists on cladistic analysis of the archaic antibiotic 
producers, this theory may never be fully proven. 
Currently it would be unrealistic not to believe that both 
theories have a place in evolutionary history to explain all the 
possible permutations. The wealth of information currently being 
generated using PCR based methods of more primitive DNA 
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sequences may allow for all the arguments to be resolved in the 
future. 
1.4 Regulation of secondary metabolism in 
Streptomyces 
The regulatory mechanisms of secondary metabolism in 
Streptomyces cannot be distinguished from studies into the genetics 
of differentiation in the species owing to the fact that the two are 
physically-linked in the time scale of the Streptomyces life cycle. A 
subclass of genetic mutants were identified by their failure to 
produce secondary metabolites and also appeared to be 
characterised by defects in their ability to differentiate normally. 
Biosynthetic activity in streptomycetes seems to be regulated 
by at least two types of control. Firstly signals generated by the 
nature and concentration of specific nutrients (mainly carbon, 
nitrogen or phosphorus compounds) are involved in regulation of 
secondary metabolism, as are "master genes" that are implicated in 
both morphological differentiation and secondary metabolism. 
Secondary metabolism is regulated by a wide variety of small 
molecular weight substances and regulatory proteins. (A summary 
of the systems discussed is shown in Figure 1.2). Many of the studies 
on regulatory factors have been characterised using the model 
system of Streptomyces coelicolor A3(2). Streptomyces griseus 
mutants have also been studied to produce results complementary 
to those in Streptomyces coelicolor because of two particular 
attributes: 
1. Its ability to sporulate in submerged culture (Beppu, 1992). 
2. Its use of an extracellular autoregulator A-factor as part of 
the mechanism activating secondary metabolism (Horinouchi and 
Beppu, 1994). 
The genes controlling different metabolic steps, in particular 
biosynthetic clusters, in streptomycetes may be typically located in 
clusters which also include regulatory genes specific for that 
pathway. This type of control can be termed local regulation. At a 
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second level the regulation of pathways for several secondary 
metabolites may be linked by particular regulatory genes. Finally at 
the third level of regulation both the production of mycelium and 
antibiotics may be regulated by particular genes. 
1.4.1 B1 d mutants 
Bld mutants are those which lack aerial mycelium formation 
in Streptomyces. Early experiments indicated that the bld mutants of 
Streptomyces coelicolor were nearly all deficient in secondary 
metabolism production although not always completely. The 
majority of the mutants isolated can be suppresed phenotypically to 
produce aerial mycelium and spores by changing the composition of 
the growth medium. There are twelve classes of bld mutants. The 
five most extensively studied were induced by classical mutagenesis, 
(bldA, B, C, D and H). Other mutations remain to be fully 
characterised by transcriptional fusion experiments. 
afsB 
clusi 
actll/orf4 
actl etc. 
actinorhodin 
FIGURE 1.2: Schematic of proposed expression and /or 
activation dependence relationships for the production of 
actinhorodin in Streptomyces coelicolor. The shaded box indicates a 
"black box" of (as yet) undetermined processes. The fine lines 
indicate hypothesised dependence and the solid line indicates 
proved dependence. Adapted from Champness et al., 1992. 
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The study of how these mutants respond to different media 
conditions has indicated that the regulatory mechanisms of 
individual biosynthetic pathways for secondary metabolism differ, 
despite elements common to their regulation, in the way that they 
respond to a profusion of physiological conditions that can be 
experienced by the organisms (Chater, 1992). For example bid. A 
mutants will grow on low phosphate medium (Guthrie and Chater, 
1990), bldB mutants produce a blue pigment when incubated for a 
long time and secondary metabolism is restored to bldH mutants 
when mannitol replaces glucose as carbon source in minimal 
medium (Brown et al., 1992). 
None of the bld mutants can produce secondary metabolites 
under natural conditions. Several hypothesis may explain this: 
a) Genes essential for aerial mycelium formation but not 
secondary metabolite production are also essential for growth and 
cannot be identified by non-conditional mutation. 
b) The genes are functionally redundant and would require a 
double mutation to reflect the mutant phenotype. 
c) Maybe there is a mechanism of positive feedback regulation 
of secondary metabolism by formation of aerial mycelium. 
Initially four of the genes for bld mutations were cloned 
(A, B, C, and D, Merrick, 1976 and Champness, 1988). However only 
the function of b1dA has been clarified. The gene product of bld. A 
encodes for the only tRNA that recognises the rare leucine codon 
UUA. The UUA codons elucidated to date are found exclusively in 
pathway-specific, regulatory, and resistance genes associated with 
the biosynthesis of secondary metabolites (Table 1.1) . 
The bldA gene coding for the UUA codon can be deleted 
indicating that no genes essential genes involved in vegetative 
growth contain this codon or the organisms would not survive. 
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GENE DESCRIPTION ORGANISM NUMBER OF TTA 
Resistance genes 
hygromycin 
carbomycin 
streptomycin 
Export genes 
Actinhorodin 
Regulatory genes 
streptomycin 
actinhorodin 
bialophos 
S hygroscopicus (hyg) 
S. grise us (aphE) 
S. thermotolerans 
(carB) 
S. coelicolor actIl-ORF2 
S. griseus (strR) 
S. coelicolor actll-ORF4 
S. hygroscopic us 
(brpA) 
CODONS IN GENE 
I 
1 
2 
1 
1 
1 
1 
Differentiation 
genes 
bid gene 
bid gene 
S. griseus 
S. coelicolor 
1 
1 
Table 1.1: A summary of Streptomyces genes containing 
TTA codons (adapted from Leskiw et al., 1991). 
There are two main theories about the function of the UUA 
codon in Streptomyces 
a) It is an important regulator, in some circumstances. 
b) It is an inefficiently-translated codon that has been 
eliminated from genes for essential pathways during the 
evolutionary process or maintained in genes whose expression needs 
to be efficently regulated. Genes containing the TTA codon are 
remarkably conserved in S. coelicolor and S. griseus eluding to some 
adaptive benefit. Evolution of the TTA codon is based on the theory 
of codon loss and codon capture (Osawa et al., 1990). As mutational 
drift towards high G+C content occurs within an organism this 
reduces the frequency of TTA codons. During this process the TTA 
codon becomes selected against in highly expressed vegetative genes 
(due to their limiting effect on translation). Therefore, the TTA 
10 
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codon prevails in only those genes specific for low or zero growth 
rates, for example in antibiotic production genes. 
1.4.2 A-factor 
A-factor (2-(6`-methylheptanoyl)-3-R-hydroxymethyl-4 
butanolide) triggers both aerial mycelium formation and 
streptomycin biosynthesis. Originally discovered by Khokhlov et a]. 
(1967,1982), as a diffusable extracellular molecule, A-factor 
exhibits its regulatory role by binding to a specific receptor protein 
that, without A-factor, acts as a repressor-type regulator for 
morphological and physiological differentiation. 
A low concentration of A-factor is needed for effects on 
Streptomyces. Therefore it has been deemed a "microbial hormone". 
A-factor deficient mutants of Streptomyces griesus lose the ability to 
produce streptomycin and form spores (Hara and Beppu, 1982). In 
Streptomyces griesus, A-factor expresses its regulatory function by 
binding to A-factor binding protein leading to a depression of a 
gene(s) that is important for secondary metabolism and sporulation 
(Miyake et al., 1990). In the signal message leading to streptomycin 
production, the A-factor signal is transferred from the A-factor 
receptor to the upstream activation sequence of a regulatory gene 
strR, via an A-factor dependent protein that serves as a transcription 
factor for strR. The strR protein thus activates the transcription of 
the other streptomycin production genes (Horinouchi and Beppu, 
1994). 
It is believed that the timing of streptomycin production is 
determined by the intracellular concentration of A-factor, as excess 
A-factor in the production medium does not increase the production 
of streptomycin whereas additional A-factor added at the time of 
culture inoculation does (Beppu, 1992). Transcriptional studies 
have also shown that only the promoter of strR is directly controlled 
by A-factor (Vujaklija et al., 1991). 
In Streptomyces coelicolor and Streptomyces griesus, A-factor 
is made by the afsA gene which is chromosomally encoded (Athough 
the exact chromosomal location for afsA has not yet been 
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established, Horinouchi and Beppu, 1994). (A-factor in Streptomyces 
coelicolor is discussed more fully in section 1.4-3). 
1.4.3 afsB locus and a bsA/B genes. 
Mutations in the afsB locus have pleotrophic effects in 
Streptomyces coelicolor, including the loss of the ability to make 
actinorhodin and undecylprodigiosin. The deduced regulatory 
cascade of the cluster also controls the production of A-factor. 
Initially the locus was thought to comprise of only two genes that 
made up a two-component regulatory system. However recent 
studies have indicated a much more complex system exists. Figure 
1.3 shows the regulatory pathway as proposed by Vogtli et a]. 
(1994). 
It has been shown that afsK suppresses the action of afsR. The 
afsR gene product functions by phosphorylation as a membrane- 
bound kinase and as a positive regulator for actinorhodin 
production. Recently characterised, afsR-2, shows substantial 
similarity to protein sequences of prokaryotic sigma factors. 
Unfortunately it lacks the most important conserved domain 2 of 
these factors and is likely not to function as a true sigma factor 
(Vogtli et a1., 1994). 
The afsB gene cluster therefore (from the investigation of one 
specific controlling factor) has provided the identification of a 
complex regulatory network which controls antibiotic production in 
Streptomyces coelicolor - currently one of the many regulatory 
clusters being defined extensively in Streptomyces. 
Mutants of S. coelicolor deficient in absA and absB fail to 
produce any of the four S. coelicolor antibiotics, but sporulate 
normally. The abs mutants are metabolically and biosynthetically 
competent to synthesise antibiotics, but the block to antibiotic 
synthesis occurs ultimately at the transcriptional level of the 
biosynthetic genes (Champness et al., 1992). 
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FIGURE 1.3 : The afsB locus. 
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The chromosomal location of these genes has been mapped in 
Streptomyces coelicolor. However the relationships of the afsB locus 
and absA and B regulatory genes and their products in the overall 
regulation of secondary metabolism are still unclear (Figure 1.2). 
1.4.4 ppGpp 
In several streptomycete species the stringent response has 
been implicated as an initiating signal in the transition between 
primary and secondary metabolism (vegetative growth and the 
stationary growth phase) (Ochi, 1988). ppGpp or guanosine 5' 
diphosphate 3'-diphosphate is a positive regulator of a stationary 
phase-specific sigma factor in E. coli encoded by the rpoS gene. The 
rpoS gene product is also a positive regulator of many genes 
selectively expressed as cells enter stationary phase. The rpoS gene 
is also known as katF, because of its regulatory effects on katE which 
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encodes a stationary phase-specific catalase. In E. co11 the regulation 
of ppGpp is mediated by starvation of amino acids. Starvation of 
amino acids causes increased levels of ppGpp which in turn activates 
a stationary-phase specific sigma factor. Increased concentration of 
ppGpp depends on the products of two genes, reLA and spoT. In 
conditions of amino acid starvation, the reLA protein is activated by 
uncharged tRNA, leading to an increase in ppGpp synthesis. In 
carbon source limitation the spoT gene is activated and degradation 
of ppGpp is blocked by a ppGpp 3' pyrophosphohydrolase (encoded 
by the spoT gene), leading to increased ppGpp concentrations. This 
activation may provide the point of entry for the changes in gene 
expression accompanying stationary phase development (Gentry et 
al., 1993). 
In streptomycete species, Ochi (1988), observed that 
nutritional shift down (transition between vegetative growth and 
stationary phase) coincided with increased ppGpp synthesis and 
increased antibiotic production. However, although this correlation 
is observed in numerous streptomycete species it is not present in 
all species tested (Vining, 1987). For Streptomyces clavuligerus, 
(which produces several antibiotics) when the possible role of 
ppGpp in the initiation of secondary metabolism was investigated, 
results did not rule out a possible stimulating effect of ppGpp on 
antibiotic production, but there appears to be no compulsory 
relationship between this activity and the stringent response 
(Bascaran et al., 1991). Observations that the structure and function 
of ribosomes change dramatically during the Streptomyces life-cycle 
(Quiros et al., 1989), suggest that an extensive range of major 
changes within the streptomycete cell form a hierarchical command 
system for regulating the switches for various antibiotic genes. 
Therefore, ppGpp is only a small link in the regulatory organisation 
of streptomycete antibiotic production. 
Recent studies have futher characterised the stringent 
response in S. coelicolor. The stringent response in S. coelicolor can 
be induced either by nutritional shiftdown or by the addition of 
serine hydroxamate (SHX; a competitive inhibitor of seryl-tRNA 
synthesis), and is characterised by ppGpp synthesis and a rapid 
decrease in the level of transcription of rRNA genes (Strauch et a], 
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1991). Although the role of ppGpp in mediating the growth rate 
control of gene expression remains controversial, there is a 
reasonably good correlation in S. coelicolor between ppGpp synthesis 
and the transcription of antibiotic pathway-specific regulatory genes 
(Tanako and Bibb, 1994). However, ppGpp synthesis alone does not 
appear sufficent to initiate secondary metabolism in S. coelicolor. 
1.4.5 "Two-component" regulatory systems 
Bacteria respond to fluctuations in the concentrations of 
various solutes in their environment by modulating the expression 
of specific sets of genes. In prokaryotic evolution, the two 
component regulatory system has been continually adapted for 
sensing specific changes in the environment and transducing that 
information usually to the transcriptional apparatus of the cell. One 
component of each system is thought to act as an environmental 
sensor (sensor component) that transmits a signal to the second 
component (regulatory component), which effects the response. 
Bacterial systems include genes in E. coli responding to osmolarity 
(envZ/ompR), nitrogen limitation (ntrB/ ntrC) and phosphate 
limitation (phoR/phoB). 
In Streptomyces hygroscopicus the gene brpA involved in 
bialaphos production is believed to act as the regulatory component 
that controls at least 27 proteins implicated in the biosynthesis of 
bialaphos. 
The gene cluster containing brpA has three upstream regions 
that are transcriptionally coupled to the brpA gene and are 
cotranscribed from unidentified promoter(s) under the positive 
control of the brpA gene product. The brpA gene product was shown 
by SI analysis to be transcribed from three promoters. All three 
transcripts were present during exponential growth and increased 
just before the stationary phase. The nucleotide sequence of brpA 
contained a possible helix-turn-helix motif at its C-terminus, similar 
to those found in the receiver component of two-component 
transcriptional activator proteins (Holt et al., 1992). 
In two-component systems, the sensor component has a 
membrane-spanning N-terminal region and is able to auto 
15 
Chapter 1 Introduction 
phosphorylate at a conserved site in the C-terminus in response to 
specific external signals. In the bialaphos cluster there is no such 
sensor component which could modulate the expression of brp. A. 
The N-terminus of brpB was shown to contain three hydrophobic 
regions that may be transmembrane domains or protein-protein 
hydrophobic interactions allowing some form of transcriptional 
activation of the brpA gene. The sequence of the C-terminus of the 
protein is consistent with it being a member of a sub-family of 
transcriptional activator proteins. ORF's 1 and 2 encode an N-acetyl 
hydrolase and a thioesterase respectively and ORF3 encodes a 
hydrophobic gene product which showed characteristic traits of 
integral membrane proteins which transport solutes. 
Since the described two-component regulatory system in 
bialaphos production appears to have different characteristics and 
may be a different activation mechanism than that of classical 
examples, it may not be suprising that as yet many specific systems 
have not yet been identified in Streptomyces species. The 
complexity of transciptional systems in Streptomyces allowing for 
multiple antibiotics to be produced by one microorganism may also 
contribute to the laborious task of identifying these systems in many 
streptomycetes. 
1.5 Catabolite Regulation 
Expression of genes encoding enzymes involved in antibiotic 
and other secondary metabolite biosynthesis are down-regulated by 
easily utilisable carbon, phosphate and nitrogen sources. Phosphate 
control of antibiotic production appears to act at the transcriptional 
level by a mechanism similar to that involved in control of 
phosphatases and other phosphate-regulated enzymes (Liras et al., 
1990). A phosphate control (PC) sequence, similar to the phosphate 
control (pho boxes) of many bacterial genes has been isolated from 
the phosphate-regulated promoter that controls biosynthesis of the 
antibiotic candicidin (Liras et al., 1990). From computer analysis of 
several antibiotic biosynthetic gene regions it appears that several 
streptomycete species contain PC sequences. PC sequences function 
as phoB binding sites in E. coli and other microoganisms. This is 
important as phoB is the response regulator of the pho regulon. 
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The phoB protein is essential for the expression of phoA - indeed 
the pho regulon is defined as the set of genes whose expression is 
dependent on phoB. PhoB is homologous to a family of response 
regulators such as OmpR and VirG (Stock et al., 1989). 
MICRO GENE PROTEIN SEQUENCE 
ORGANISM 
phoB PhoB Consensus 
regulator For E. col i 
E. coli phoR PhoR CTGTCATA 
regulator A 
T 
T 
phoA Alkaline 
phosphatase 
S. griseus pabS PABA CTGTCATG 
synthase AT 
S. lividans ORFXb Unknown CTTGCACC 
product TC 
S. griseus sph=aphD Streptomyci CTGTGCCG 
phosphotran AC 
sferase 
5'-3' 
ýiÖ 
lb mol9y 
95a 
AACTGTCA 95"" 
T 
TC 
89 
ACTGCGCG 66 
ACGTCACG 66 
ATCTGGCA 72 
T 
Table 1.2: Phosphate control sequences existing in E. coli and 
streptomycete species. a= phoA and phoR form an operon with a 
common promoter and pho box. All the E. coli sequences show slight 
differences with respect to the consensus. 
b= ORFX is expressed from the P143 promoter region of the tipA 
gene but in the opposite orientation. The nucleotides in bold type 
are conserved with respect to the E. coli consensus pho box. 
(Adapted from Liras eta]., 1990). 
Biosynthesis of many antibiotics is repressed by 
concentrations above 1 mM of phosphate. Inorganic phosphate 
concentrations greater than 3-5mM are frequently inhibitory for the 
production of plant, fungal and bacterial secondary metabolites in 
liquid culture, although growth of antibiotic production strains is 
stimulated by increasing phosphate concentrations up to 300pti1 
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(Liras et al., 1977). If abundant nutrients are available (for example 
the addition of glucose, phosphate or ammonium) in a Streptomyces 
culture already producing an antibiotic, suppression of antibiotic 
production followed by a burst of growth is observed. Conversel}', a 
limited supply of these nutrients produces a rapid onset of 
secondary metabolite production. It has been shown in Streptomyyces 
griesus that addition of phosphate stimulates the production of RNA 
(mainly ribosomal) within the cells (Martin et aL, 1988). It is 
therefore believed that phosphate stimulates expression of genes 
involved in the biosynthesis of macromolecules and house-keeping 
genes but inhibits antibiotic biosynthetic genes. 
The PC region in candicidin production is characterised by a 
114 base pair phosphate-regulated promoter which contains a PC 
sequence homologous to those in E. coli (Martin at al., 1989, Table 
1.2). Northern analysis revealed that transcriptional regulation of 
this region is governed by phosphate concentration. These pho 
boxes observed in streptomycetes were observed to have about 66- 
72% homology with the consensus for the E. coli pho box. However, 
in Streptomyces rimosus an observed pho box was shown to have 
only 33-44% homology to the E. coli consensus sequence. This is 
maybe not so suprising since the sequence obtained from S. rimosus 
was that of a production strain that had been highly mutated 
through strain improvement programmes (McDowall, 1991). 
The observation by McDowall, that Streptomyces rimosus 
contained putative pho boxes led to some of the investigations 
presented in this thesis (Chapter 6). It was decided to investigate the 
link between oxytetracycline production in Streptomyces rimosus 
and the amount of phosphate present in the culture media. 
Investigations were also undertaken to investigate the possible link 
between phosphate concentrations and expression of various genes 
within the otc gene cluster. 
1.6 Polyketide Biosynthesis 
1.6.1 Introduction 
Polyketides are natural products made by micro-organisms 
and plants from simple fatty acids (Herbert, 1981). Tetracycline 
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antibiotics such as oxytetracycline and chlorotetracycline and 
macrolide antibiotics such as erythromycin belong to the polyketide 
family of antibiotics . The common biosynthesis of this family of 
antibiotics induces keto groups (which may be modified) at 
alternating carbons along the backbone giving rise to the name 
"polyketide". There are three types of polyketide biosynthetic 
enzymes: 
Types I and II are found in bacteria and fungi. They consist of 
complexes of multifunctional or monofunctional proteins, 
respectively, that are believed to act as covalently-bound substrates 
attached by thioesters to an acyl carrier protein (ACP) domain or a 
separate ACP. 
Type III - are found in plants. They differ from types I and II 
because they lack a functional ACP and act directly on the co- 
enzyme A. 
Interest in the biosynthesis of such natural products has 
heightened recently because of the advances in the genetic 
understanding of polyketide metabolism and the exciting prospect 
of manufacturing new polyketide-derived drugs with recombinant 
microorganisms. However, detailed genetic analysis of produced 
compounds reveals unexpected complexity leaving main areas of 
debate. 
Polyketide biosynthesis in Streptomyces and, other bacteria 
involves the formation of poly-ß-keto intermediates "\ fatty acids 
and their processing by reduction, dehydration and cyclisation 
before the release of a diffusable compound from the assembly 
complex. 
1.6.2 Biosynthesis 
In 1953, Birch and Donovan showed that polyketides were 
formed by way of poly-ß-ketone intermediates based on the results 
of the incorporation of isotopically-labelled acetate and malonate 
into the fungal 6-methyl-salicylic acid. The knowledge of fatty acid 
biosynthesis emerging at the same time showed that the two 
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processes were very similar with only one principal difference: the 
frequent lack of reduction of the R-ketoacyl intermediates in the 
polyketide pathways. Polyketide biosynthesis follows several steps 
(Figure 1.4); 
a) Condensation of acyl unit with an malonyl unit (extender) 
to eliminate one C02. 
b) Chain grows by two hydroxyl residues and two carbon 
residues and is then reduced and oxidised. 
c) This cycle is followed until the molecule reaches its final 
length, it then detaches from the PKS and is cyclised. 
There are two major differences between fatty acid 
biosynthesis and polyketide biosynthesis. Firstly polyketides can use 
different extender and starter units compared to fatty acid 
biosynthesis which uses the same components. Secondly, polyketides 
can omit some stages of the pathway due to the absence of distinct 
proteins for functions such as ketoreduction whereas in fatty acid 
biosynthesis this is not possible as similar functions are performed 
by a set of multifunctional proteins or, as in the case of E. coli, 
multiprotein complexes. 
1.6.3 Polyketide synthases (PKS) 
The PKS's of many Streptomycete species have become 
particularly interesting to molecular biologists as the huge potential 
diversity built into the primary structures of polyketides is 
determined by the genetic "programming" of the PKS's that catalyse 
chain building. Unlike simple fatty acid synthesis the PKS'S require a 
complex control of a hierarchy of biochemical choices. 
(i) Substrate 
(ii) Reaction sequence. 
(iii) Stereochemistry. 
(iv) Chain length. 
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The PKS needs to be highly programmed. For example, in 
monensin A production, the PKS makes 37 choices during chain 
assembly: a choice of 13 building units in a specific order, a choice 
of 4 possibilities for the chemistry after each of the 12 steps in chain 
building and the correct choice of stereochemistry at 12 positions 
(Hopwood and Sherman, 1992). The challenge to understand all of 
these processes will involve the combination of biochemistry, 
chemistry and molecular biology. Ultimately, it is believed that 
genetically-engineered PKS genes can produce new metabolites that 
may have new or improved pharmacological activity. 
The carbon skeleton of the polyketide is characterised by the 
sequential condensation of fatty acids like acetate, propionate and 
butyrate which is catalysed by the PKS. PKS's can utilise different 
starter and extender units and can process intermediates in a strictly 
programed manner by selective reduction and dehydration to leave 
different functional groups (keto, enol, hydroxyl and alkyl) at 
particular points in the carbon chain. It is this feature of PKS's that 
allows for the structural diversity found in the polyketides. The 
unique feature of the PKS's is their ability to choose different starter 
units for biosynthesis, for example acetyl-CoA is the starter for 
tetracenomycin production but propinyl-CoA and malonamyl-CoA 
are the starters for daunorubicin and oxytetracycline production 
respectively. As yet, how this substrate specificity is determined 
remains to be elucidated. In both fatty acid biosynthesis and 
polyketide biosynthesis, the growing carbon chain is intermittently 
attached to an ß-ketoacyl carrier protein (ACP), via a 
phosphopantetheine "arm". The ACP in Streptomyces species has 
also been the subject of intense study as the transacylation step 
between it and the ß-ketoacyl synthase active site could perhaps 
play a part in the programming, by ensuring that only correctly 
modified intermediates are transferred between active sites during 
polyketide production. 
1.6.4 The Acyl Carrier Protein (ACP) 
To date for fatty acid synthesis and polyketide biosynthesis, the 
amino acid sequences of all of the ACP's show substantial similarity 
at the amino acid level in domains or subunits between or within 
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Figure 1.4: A schematic representation of the biosynthesis of 
fatty acids and polyketides. The circle labelled FAS or PKS represents 
the fatty acid synthases or polyketide synthases. These complexes 
carry two thiol groups, one ß-ketoacyl synthase (0) and the other on 
the acyl carrier protein (0). Also labelled are the different functions 
required for each step; acetyl transferase (AT), acyl transferase 
reaction (TR, which is not ambiguously assigned to a specific 
component of the complex), malonyl transferase (MT), ß-ketoacyl 
synthase (KS), ketoreductase (KR), dehydratase (DH), enoyl 
reductase (ER), palmityl transferase (PT), or thioesterase (TE) 
involved in the release of palmityl transferase CoA (X=CoA) or free 
palmitic acid (x=OH) respectively. From Hopwood and Sherman, 
1990. 
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these groups. The highest degree of identity is around the 4' 
phosphopantenylation site of the domains and subunits, 
characterised by a highly-conserved serine residue, the putative site 
of pantenylation. The ACP together with the co-enzyme A is the 
substrate for the transferase reaction and acetyl CoA-ACP complex is 
the substrate for the ketosynthase that catalyses the condensation 
reaction in the growing polyketide chain. 
Genetic replacement of the ACP in Streptomyces coelicolor 
A3(2) by Khosla et al., (1993) with homologues fron granaticin, 
oxytetracycline and tetracenomycin producers produced a 
functional PKS. Products showed similarity to actinorhodin or shunt 
products of actinorhodin biosynthesis similar to those produced by 
mutants defective in actinorhodin production. Quantitative 
differences observed in the products obtained may be explained by 
the differences in upstream ribosome binding sites of the hybrid 
ACP/PKS constructs. This indicated that ACP concentration maybe a 
limiting factor in polyketide biosynthesis. The overproduction of 
daunorubicin in a null-production mutant was carried out by Grimm 
et al., 1994. They confirmed that introduction of the 
tetracenomycin-C ACP on a high copy plasmid into this mutant led 
to the restoration of daunorubicin production and caused a 2-30 
fold increase in production. This suggests that the concentration of 
ACP affects the amount of antibiotic produced. 
Considerable interest has developed in the possibility of 
generating novel polyketides through rational design of PKS's or 
through the construction of combinational libraries of genetically 
engineered PKS (McDaniel eta], 1994). 
A strategy has been determined for the rational design of 
novel aromatic polyketides (McDaniel et al., 1994). 
a) Chain length- PKS chain length is dictated by the minimal 
PKS. The minimal PKS consists of three genes i) Ketosynthase (KS) 
(which carries a putative acyltransferase domain) ii) Chain length 
factor (CLF) iii) An acyl carrier protein (ACP). Several properties 
about the minimal PKS have been established. Some ketosynthase 
and chain length factor combinations from different combinations 
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of Streptomyces species are not functional. Biosynthesis of a 
polyketide chain of a specified chain length can be guaranteed if i) 
and ii) are from the same gene cluster (for example 16 carbon atoms 
for the act ketosynthase and chain length factor). The production of 
"simple" metabolites need only the "minimal" PKS whereas, to 
produce more complex reduced compounds the additional activities 
of a ketoreductase (KR), an aromatase (ARO) and a cyclase (CYC) are 
required. 
b) Ketoreduction - the most extensively studied so far is the 
actinhorodin KR, which is compatible with the minimal PKS and can 
reduce the C-9 carbonyl residue to an hydroxyl residue (and the C-7 
carbonyl residue to an hydroxyl residue in unusual circumstances) 
of any nascent polyketide backbone studied so far. 
c) Cyclisation of the first ring- the minimal PKS alone can 
control formation of the first ring. The cyclisation of other rings may 
be controlled by specific PKS proteins namely the cyclases. 
d) First ring aromatization- the first ring in unreduced 
polyketides aromatizes non-catalytically, whereas an aromatizing 
subunit is required for reduced polyketides. 
e) Second ring cyclization- in reduced polyketides an 
appropriate cyclase is required to instigate this function. 
f) Additional cyclizations- the KS, CLF, ACP, ARO and CYC 
subunits of the PKS together catalyse the formation of intermediate 
structures with a defined chain length, reduction pattern and the 
first two cyclizations, although, the biosynthesis of naturally- 
occuring polyketides require the involvement of downstream 
cyclases and other modifying enzymes to produce a biologically. -- 
active product. 
The work of Khosla et al., has indicated that the construction 
of hybrid polyketides may be a useful approach in further studies 
to determine the molecular basis of polyketide biosynthesis. The 
work also shows the need to reduce the complexity of the produced 
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products from genetic manipulation in order to allow detailed 
biochemical explanations of polyketide biosynthesis to be achieved. 
1.6.5 Organisation of polyketide genes 
Polyketide synthases (PKS) consist of alternatively used active 
sites that are contained either in a group of separate proteins 
encoded by a cluster of genes -Type II bacterial PKSs or a single 
protein- Typel fungal, bacterial or eukaryotic PKSs. 
In Streptomyces species the PKS genes are organised in a 
cluster (Figure 1.5a), containing genes for acyltransferase, 
ketosynthase, dehydrogenase, cyclase. ACP, thioesterase and chain 
length factor functions. The PKS genes account for side chain 
variability, chirality of one or more carbon atoms (by varying the 
reductive cycle of ketoreduction, dehydration, and enoyl reduction 
on the ß-keto group formed after each condensation), and the total 
length of the polyketide chain. These factors in turn determine the 
potential diversity of polyketide products (Hopwood and Sherman, 
1990). 
In fungal/mammalian systems and the macrolide producers of 
erythromycin, avermectin and rapamycin, the PKS genes produce 
large multifunctional proteins (Figure 1.5b). Each multifunctional 
protein contains a complete set of PKS genes. In erythromycin, each 
of the six repeated mutifunctional motifs is similar but clearly 
distinct from each other. Each repeated motif was found to contain 
ACP, acyltransferase, ß-keto synthase, ketoreductase and 
dehydratase activities. Each motif of the multifunctional unit carries 
out one set of reactions and then the growing polyketide chain is 
passed to the next motif to undergo the next chain-forming cycle. 
Recent studies into the function of the PKS genes in 
Streptomyces species have revealed and confirmed associations 
between Type I and II PKS functions and type II bacterial and plant 
fatty acid synthases (FAS) (Bedford et al., 1995 and Revill et al., 
1995). 
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Figure 1.5: Schematic diagrams indicating the organisation 
of the Polyketide Synthases (PKS) in a) act= actinorhodin production 
cluster, gra=granatacin production cluster, tcm=tetracenomycin 
production cluster, fren= frenolicin production cluster, gris= 
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In the third ORF (ACP) the type II cluster in Streptornvices 
resembles type II fatty acid synthases (FAS) from other bacteria and 
plants. This region has a characteristic C-H-S-X-G motif centred on a 
potential 4-phosphopantetheine-binding serine (believed to be 
involved in substrate attachment). Replacement of a serine residue 
conserved in ACP's across the species with an alternative amino 
acid has shown that it is essential for the function of the PKS (Khosla 
et al., 1992). 
The purified ACP from S. glaucescens was recently found to behave 
analougously to other ACPs from other bacteria and plants. 
(Summers et al., 1995). The close similarity of the organisation of 
the S. glaucescens fabD, H, C, and B genes to that of the E. co1i FAS- 
encoding genes (Fab H, fabD, fabG, acpP and fabF) suggests that 
S. glaucescens PKS genes are similar to those enzymes in fatty acid 
biosynthesis. This may also suggest a relationship between fatty acid 
metabolism and polyketide biosynthesis. This link has been further 
established by Revill eta] (1995), finding that the S. coelicolor A3(2) 
malonyltransferase gene (fabD) lies 2.8 Mega bases away from the 
act cluster and adjacent to an open reading frame whose gene 
product resembles ketoacylsynthase III of E. co1i FAS, suggesting that 
the malonytransferase may be shared between the act FAS and PKS 
gene clusters. 
Futher recent evidence by Bedford et a]. (1995), reveals that 
the fungal PKS for 6-MSAS production can be expressed in 
S. coelicolor CH999 (a strain deleted for the act aromatic gene cluster 
and linked with the expression plasmid pRM5). This may indicate 
that the differences between the type I and type II PKS gene 
organisation may not be relevant in the production of novel 
aromatic polyketides. However, fundamental differences in the 
mechanisms by which aromatic and macrolide PKSs control product 
structure may mean that rational design of novel aromatic 
compounds may not be as straight-forward as initially anticipated 
(McDaniel eta]., 1995). 
Clearly the relationship between the PKS subfamilies is only 
just beginning to be completely investigated and further research 
will only enhance understanding of this relationship. 
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1.6.6 Organisation of the Oxytetracycline (OTC) biosynthetic 
gene cluster 
The industrially-important antibiotic, oxytetracycline, is 
produced by Streptomyces rimosus. Initial studies by Rhodes et a1. 
(1981) characterised the oxytetracycline production chromosomal 
gene locus by utilising the same mutagenesis and genetic techniques 
as used to characterise the Streptomyces coelicolor A3(2) 
chromosome. There was significant similarity between the two 
chromosomes. However interest in Streptomyces rimosus was 
heightened because it was of its industrial importance. The pathway 
for oxytetracycline biosynthesis was then partially characterised 
both genetically and biochemically by Rhodes et al. (1981; Figure 
1.6). They produced blocked mutants in the pathway by NTG and 
UV mutagenesis and classified these mutants by cosynthesis tests 
and feeding intermediates of the OTC pathway to blocked mutant 
strains. These techniques defined the organisation of 6 mutants in 
oxytetracycline biosynthesis. Two of the blocked mutants were 
assigned to specific steps in the conversion of anhydrotetracycline 
(ATC) to OTC and the other four mutants were blocked before ATC. 
The order of the otcX otcY and otcZ was not determined but otcD 
was found to be blocked in the conversion of 4-amino-ATC to ATC. 
The mutants mapped to diametrically opposite clusters on the 
Streptomyces rimosus linkage map with at least one resistance gene 
within the "early" cluster. 
OTC resistance clones were then isolated by screening a gene 
library made in an OTC-sensitive host, Streptomyces rimosus 
M1 5883S (Rhodes et al., 1984). Two unrelated clones were isolated, 
as observed by restriction analysis and DNA/DNA hybridisation. 
This suggested that there were two resistance genes and possibly two 
mechanisms of antibiotic resistance as had been already observed by 
other workers in the field. 
The two oxytetracycline resistance genes were cloned and 
named tetA and tetB (Ohnuki et aL, 1985). These were shown to be 
inducible in Streptom}ves griseus and Streptomyces rimosus. The 
tetA (otrA) and tetB (otrB) genes were found to -encode tetracycline 
resistance determinants responsible for the resistance to 
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translational arrest and the reduced accumulation of tetrac, "cline 
respectively. (Discussed further in 1.6.3 and chapter 3 respectively). 
A transformation system for a production strain of Streptom yces 
rimosus was developed and found suitable for the construction of 
genomic DNA libraries (Butler et al., 1989). The two OTC resistance 
genes were found to map physically within 24 kilobases of each 
other on the genome. All of the mutants generated by Rhodes et al. 
were complemented with DNA physically linked to the resistance 
genes. It was hypothesised that the biosynthetic genes for OTC 
biosynthesis might all be linked within a cluster. This hypothesis was 
confirmed by Binnie et al. (1989). 
Purified anhydrotetracycline oxygenase enzyme was 
sequenced and used to probe the S. rimosus genome. This confirmed 
that the otcC gene mapped to the early cluster and led to the 
hypothesis that the genes for oxytetracycline biosynthesis were 
contained in one cluster. Futhermore, transformants of 
Streptomyces lividans and Streptomyces al bus containing a 34 
kilobase EcoRI (Figure 1.7) fragment of DNA flanked by the two 
resistance genes otrA and otrB produced oxytetracycline. The 
heterologous expression of OTC by both Streptomyces lividans and 
Streptomyces albus confirmed that the structural genes required for 
OTC had been isolated intact. 
The organisation of the otc cluster is shown in Figure 1.7. 
Along with the positions of otc-negative classes of mutant (Butler et 
al., 1989) the two positions of the flanking resistance genes otrA and 
otrB are shown in this figure. The otrA, otcZ and otcC gene regions 
were extensively characterised by Doyle et a]. (1991) and McDowall 
(1991). 
The otcD and otcY gene regions have been extensively 
characterised recently to confirm the location of many of the 
oxytetracycline PKS genes summarised in Figure 1. g. 
(Thamchaipenet, (1994) and Linton, unpublished results). As yet not 
all of the genes needed to produce oxytetracycline have been 
located within the cluster in Figure 1. ý. It may be possible that 
some genes may be located to the left or right sides of otrA and 
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Figure 1.6: The oxytetracycline pathway and assignment of 
blocked mutants (data of Rhodes et al., 1981). 
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Figure 1.7: A restriction map of the oxytetracycline gene 
cluster. Hatched boxes denote the location of the otr resistance 
genes. Blocked boxes show the minimum DNA segments that can 
complement the OTC-negative classes of mutants (Butler et eil., 
1989). Stippled boxes display homology to act DNA (Butler et al., 
1989) in DNA/DNA hybridisation experiments. The open box 
denotes the position of the otcC gene located by "reverse genetics" 
(Binnie et el., 1989). pPFZ163 confers the ability to produce OTC 
when introduced into S. lividans and S. albus (Binnie et al., 1989). 
Abbreviations: B, BannHI; Bg, Bg1II; E, EcoRl; H, Hind111; K, Kpnl; P, 
PstI; R, EcoRV; S, Sacl; Sp, SphI. Modified from Butler et al. (1989). 
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otrB, respectively. The otrB gene region and upstream region to the 
©RFII actl homologous region were investigated during this thesis 
(Chapters 3,4 and 5) as it was necessary to fill in the gap in 
sequence information between the otcY locus and the otrB gene. 
otcD 
otrB 
otcY 
4cef 
-ý. 1- bg 
a h 
Figure 1.8: The location of genes within the otcD and otcY 
regions of the oxytetracycline cluster. (not to scale). a=otcD/orf3, 
b=otcD/orf2, c=otcD/orfl, d=otcY/orfl-, e=otcY/orf2, f=otcY/orf3, 
g= otcY/orf4- an undefined 14 kilodalton region., h=otcY/orf5, i= 
otcY/orf6, j= orf2/ act! homologue, k= orf l/ actl homologue, 1= 
region studied in this thesis. 
1.7 Antibiotic resistance 
1.7.1 Introduction 
All organisms that produce antibiotics must be able to protect 
themselves against self-destruction from the antibiotic that they 
produce. Until recently, studies on antibiotic resistance in 
tetracyclines was limited to antibiotic efflux (Salyers et al, 1990). 
Since then, four main mechanisms of self protection have 
been identified in other antibiotic producing organisms: 
a) Modification of the antibiotic (the active form is only 
detected once outside the cell) 
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b) Modification of the cellular component that the antibiotic 
acts on to render it unsuceptible to attack by the produced 
antibiotic. 
c) Induction of an alternative cellular component which is 
insensitive to the antibiotic. 
d) Export/efflux of the antibiotic. 
The choice of resistance mechanism by a producer of an 
antibiotic is determined by several factors including the biosynthetic 
route of the antibiotic, as some are synthesised as active molecules 
and others as inactive derivatives that will be activated once outside 
the cell (Cundliffe, 1992). 
1.7.2 Organisation of resistance genes 
Resistance genes are closely-related to the structural genes for 
antibiotic biosynthesis. This observation may be explained in terms 
of lateral transfer of biosynthetic ability between bacterial species 
(Hopwood 1986, Davies 1986). If a set of biosynthetic genes 
transferred without a resistance gene, then the organism receiving 
the new genes would die as soon as it started to produce the 
antibiotic. Consequently, in evolutionary terms, only the organisms 
that received resistance genes would survive thereby ensuring the 
linkage or close association of the antibiotic biosynthetic genes with 
resistance genes. 
Antibiotic resistance genes may also be found within 
organisms that do not produce antibiotics, which provides evidence 
that this may be an advantageous defence mechanism in organisms. 
Plasmid borne resistance genes also support the theory that transfer 
of these genes can occur and therefore must offer some selective 
advantage (for example the methylenomycin resistance gene on 
plasmid SCP1). Existence of resistance genes discounts theories that 
there is no evidence for antibiotic production in nature in natural 
habitats and that antibiotic production is an artefact of " unnatural" 
fermentation conditions in laboratories and production plants. 
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1.7.3 Modification of the produced antibiotic. 
Some antibiotics of the aminoglycoside and macrolide 
families are secreted from the producing organism in an inactive 
form. Streptomyces griseus produces and secretes 6- 
phosphorostreptomycin (SPH(6)) (an enzyme), which is 
dephosphorylated and thereby activated outside the mycelium by a 
specific enzyme also produced by the organism. 
SPH(6) can also utilise streptomycin as a substrate, therefore 
it can metabolise any streptomycin that may come in contact with 
the mycelium, although this is highly unlikely. Some strains of 
Streptomyces have more than one of these antibiotic inactivating 
enzymes present as shown in Table 1.3. The reason for this is 
somewhat unclear and remains to be elucidated. 
1.7.4 Modification of a cellular component(s) 
One of the most documented modifications of cellular 
components of antibiotic producers is at the ribosome. Ribosomal 
modification is wide-spread among streptomycetes which produce 
antibiotics that inhibit protein synthesis by binding directly to 
ribosomes. However, not all Streptomyces strains whose antibiotics 
act by this mechanism modify their ribosomes e. g. streptomycin, as 
discussed above. Two methods of ribosomal modification have been 
described in Streptomyces. 
Many Streptomyces species ensure insensitivity of their 
ribosomes to their produced antibiotic by methylating a specific 
nucleotide within one of the RNA components of the ribosome. 
Streptomyces strains that use this resistance mechanism can be 
identified by the use of a fractionated, coupled transcription- 
translation system as described by Calcutt and Cundliffe in 1989. (A 
selection of Streptomyces strains identified in this manner are 
indicated in Table 1.4). 
In many tetracycline-producing bacteria another mechanism 
of ribosomal modification involves the protection of ribosomes by 
soluble cytoplasmic proteins. In Streptomyces rimosus one of the 
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two resistance genes, otrA, is thought to exhibit resistance by the 
above mechanism. The otrA gene encodes a polypeptide of 72 kDa 
(Ohunki et al., 1985), which confers resistance by tetracycline in an 
in vitro assay. The otrA gene product has a high degree of sequence 
similarity with the TetM and TetO proteins associated with Gram- 
positive resistance transposons. The OtrA, TetM and TetO gene 
products show sequence identity with known elongation factors EF- 
Tu and EF-G (Doyle et al., 1991 and Salyers et al., 1990). However 
purified TetM although proven to have GTPase activity does not 
substitute for EF-Tu in Bacillus subtilis or E. coli species (Burdett, 
1991). It may be that these gene products function in a manner 
similar to EF-Tu or EF-G but this aspect will require futher 
biochemical evidence. 
1.7.5 Induction of an alternative component that is 
insensitive to the antibiotic. 
Certain other cellular components may also be the targets for 
antibiotics. In order to combat this a number of Streptomyces 
species may modify or duplicate the targets of the antibiotic. 
Streptomyces sphaeroides synthesises novobiocin, a coumarin 
antibiotic that acts on the ß-subunit of DNA gyrase. Two gyrB genes 
are present in S. sphaeroides, whereas other bacteria posses only 
one (Triara and Cundliffe, 1989). When S. sphaeroides is grown in 
the absence of antibiotic, only a novobiocin-sensitive DNA gyrase 
activity is detected. However, when novobiocin is added to the 
medium, drug-resistant DNA gyrase appears. In most cases in 
Streptomyces the exact mechanism of resistance has not been 
elucidated. However, other Streptomyces strains exhibiting this trait 
are identified in Table 1.5 with their resistant target. 
1.7.6 Export/ Efflux of the produced antibiotic from 
the cell. 
The way in which antibiotics cross cellular membranes to 
enter cells has been widely studied. However, mechanisms by which 
they are exported from cells have been given much less attention. As 
antibiotics may enter bacterial cells by diffusion or by utilisation of 
another cellular uptake system, it was postulated that antibiotics 
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SPECIES 
S. griseus 
S. fradiae 
S. hygroscopicus 
S. vinace us 
S. hydroscoicus 
S. antibioticus 
ANTIBIOTIC 
Streptomycin 
Neomycin 
Hygromycin B 
Viomycin 
Bialaphos 
Oleandomycin 
ENZYME(S) 
SPH(6), SPH(3) 
APH(3), AAC(3) 
HPH 
VPH 
DAPT (PAT) 
MGT 
Table 1.3 Enzymes inactivating autogenous 
antibiotics in the producing species. SPH(3) 3"- 
phosphotransferase, APH(3) aminoglycoside 3'-phosphotrans fe rase, 
AAC(3) aminoglycoside N-acetyltransferase, HPH hygromycin 
phosphotransferase, VPH viomycin phosphotransferase, DAPT(PAT) 
demethylphosphinothricin (or phosphinothricin)acetyltransferase, 
MGT macrolide glycosyltransferase. Table abbreviated from 
Cundliffe, 1992. 
ORGANISM ANTIBIOTIC RESISTANCE SITE OF RNA 
GENE METHYLATION 
a 
S. azureus 
S. fradiae 
S. 
kanamyceticus 
Saccharopolysp- 
ora erythraea 
Thiostrepton 
Tylosin 
Kanamycin 
Erythromycin 
tsr 23S, A-1067 
t1rA 23S, A-2058 
kan 16S, G-1405 
ermE 23S, A-2058 
Table 1.4: Resistance to autogenous antibiotics 
resulting from the methylation of ribosomal RNA in 
producing organisms. Equivalent site within Escherichia coli 
rRNA. Table modified from Cundliffe, 1992. 
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ORGANISM 
S. sphaeroides 
S. cinnamonmeus 
S. arenae 
ANTIBIOTIC 
Novobiocin 
Kirrothricin 
Pentalenolactone 
RESISTANT TARGET 
DNA gyrase 
EF-Tu 
GPDH 
Table 1.5: Resistance to autogenous antibiotics 
exerted at the level of non-ribosomal target sites. EF-Tu 
protein synthesis elongation factor, GPDH glyceraldehyde-3- 
phosphate dehydrogenase. Table modified from Cundliffe, 1992. 
could be exported from cells in a similar manner. Two main 
mechanisms of antibiotic efflux have been described in recent years 
in relation to Streptomyces species. 
a) Efflux mediated by electrochemical gradients- 
Streptomycetes may utilise electrochemical gradients (for example 
protonmotive forces) and act as drug efflux pumps. This may 
involve accessory proteins and will be fully discussed in Chapters 3 
and 4. 
b) Efflux mediated by ATP hydrolysis- Recently several 
streptomycete species have been shown to have resistance genes 
that revealed significant homology to the ATP-binding domains of 
the ABC (ATP binding cassette) super family of transport-related 
proteins. 
ABC transporters are involved, typically in membrane 
transport and are widespread in both prokaryotic and eukaroytic 
organisms. The family contains a diverse group of transporters 
including the periplasmic permeases of enteric bacteria, the 
haemolysin exporter of E. coli (HlyB), the eukaryotic cystic fibrosis 
transductance regulator, CTRF, and the P-glycoprotein, a multiple 
drug resistance pump in mammalian tumour cells (Mdr). 
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ABC transporters are thought to typically comprise of four 
distinct membrane domains, two hydrophilic domains to bind and 
hydrolyse ATP and two integral domains to bind and translocate the 
substrate (Hyde et al., 1990). The ABC transporter may be formed 
either by a single polypeptide or by multiple proteins containing the 
membrane bound and the ATP binding components in a 2: 2 
stoichiometry. As with most antibiotic efflux systems, the exact 
mechanisms determining substate recognition and the component(s) 
of the transport for this specificity have not been fully 
characterised. For Gram-positive bacterial uptake systems there is 
evidence to suggest that both the periplasmic binding-proteins and 
the membrane-associated components are involved in substrate 
specificity (Higgins, 1992). However, in most of the systems studied 
there is no evidence to support a role of the ATP-binding proteins as 
a determinant for substrate specificity (Buschman and Gross, 1991). 
Examples of Streptomyces ABC transporters include the T1rC protein 
product from Streptomyces fradiae (Rostek et al, 1991) and the 
DrrAB protein product from Streptomyces peucetius (Guilfoile and 
Hutchinson, 1991). 
1.8 Transcriptional and translational control of 
Streptomyces genes. 
Streptomyces are Gram-positive organisms with very G+C rich 
DNA (about 73%). They are unusual amongst bacterial species 
because they are differentiating multicellular organisms. Their 
complex life cycle coupled with their ability to produce many 
different antibiotic structures, has led much research to characterise 
the complex transcriptional and translational machinery utilised by 
these organisms. 
Genes encoding ribosomal RNA (rRNA) factors in 
Streptomyces species have been characterised by several groups (5S, 
16S AND 23S-RNA; Bayliss and Bibb, 1988). However, sequence data 
of rRNA species in Streptomyces has not been well characterised 
until recently. 2D-gel electrophoresis has revealed that most of the 
ribosomal proteins are synthesised throughout the streptomycete 
life cycle (Blanco et al., 1994). In E. coli the stringent response co- 
ordinates the down regulation of rRNA and ribosomal protein 
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promoters in response to starvation. In streptomycetes the stringent 
response coincides with the transition phase to secondary 
metabolite production. Two rRNA's were observed in Streptomyces 
lividans to decrease in abundance in this manner (Blanco et al., 
1994). The organisation of rRNA operons in several Streptomyces 
species has been determined. The 6 rRNA operons rrnA to rrnF are 
located in the gene order 16S-23S-5S rDNA. This is significantly 
different to the organisation of E. co1i (and most other bacteria) 
where the spacer region between the 16S and 23S rRNA genes 
contains a tRNA (Sedlemeir et al., 1994). 
The high G+C content of Streptomyces also results in a biased 
codon usage suggesting a corresponding bias in relative transfer 
RNA (tRNA) abundance. In Gram-positive Bacillus subtilis (an 
organism that undergoes a large amount of morphological changes- 
from bacterium to spore) 69 tRNA genes are found in only nine 
transcription units with up to 21 genes in a single cluster (Green and 
Vold, 1993). In the nine tRNA gene regions only two regions have no 
association with rDNA (coded by rRNA). In Gram-negative E. coli 
species, 78 of the tRNA genes are in 40 transcription units with no 
more than seven genes in a cluster and each of seven tRNA operons 
are associated with one rRNA gene (Morgan et al., 1980). In 
Streptomyces lividans it was observed that six tRNA genes occur 
singly, and the others are in small clusters never containing more 
than five genes. In Streptomyces it was also observed that no 
tRNA`s occurred in the interspace regions of several rRNA operons 
(Pernodet et al., 1989, Plohl et al., 1991 and Suzuki and Yamada, 
1988). Nearly all of the S. lividans sequences reveal highly-conserved 
nucleotides of prokaryotic tRNAs. However, the ability of S. lividans 
to recognise rare tRNA codons that do not exist in E. coli and 
B. subtilis indicates that Streptomyces promoters, even for a related 
group of genes, exhibit a greater variability (Sedlmeier et al., 1994). 
Additionally, no tRNA genes are closely linked to any of the rRNA 
operons, a feature that is so far unique in actinomycetes. The 
scattering of genes of RNA polymerase subunits, EF-Tus, rRNAs and 
tRNAs is also a striking feature of the S. coelicolor chromosome (Van- 
Wezel et al., 1995). 
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Transfer RNA's, as this data suggests, may play a crucial role 
in the regulation of expression of genes involved in the 
differentiation process in Streptomyces. In E. coli and B. subtilis the 
tRNA genes are expressed from promoters with typical sigma 70 
consensus sequences. In Streptomycetes there are least seven 
different sigma factors that have an active role in the transcriptional 
regulation of gene expression (Buttner, 1989). The sigma7° family 
can be divided into three groups. Group 1 consist of the primary 
sigma facors responsible for RNA synthesis. This group includes 
HrdB from S. coelicolor, which is known to be essential (Brown et al., 
1992). Group 2 contains the closely related but non essential sigma 
factors and includes rpoD (from S. aureofaciens), HrdA, HrdC and 
HrdD (from S. coelicolor). Group 3 contains alternative sigma factors 
responsible for transcription of specific regulons and contains WhiG 
from from S. coelicolor (that appears to be a limiting factor in 
sporulation, Ta and Chater, 1993; Lonetto et al., 1992). 
Holoenzymes containing alternative sigma factors have 
different specificities and thus can be used to transcribe from 
different sets of promoters. Consequently, the ability of 
Streptomyces species to utilise different sigma factors allows the 
control of expression of discrete genes. The sequences capable of 
transcriptional initiation in Streptomyces have been shown 
predominately to be incapable of function in E. coli. Only 29 of the 
139 tabulated streptomycete promoter sequences were found to be 
of the E. coli sigma70-like promoters (Hopwood et al., 1986). A class 
of A+T rich, transcriptionally-active sequences were isolated from 
Streptomyces lividans, and shown to be functionally active in E. coli 
(Jaurin and Cohen, 1985). Although the Streptomyces-E. coli-type 
promoters (SEP) may not have the in vivo activity in streptomycetes, 
they have been considered as part of the E. coli sigma70-like 
promoters, in previous sequence analysis (Strohl, 1992). 
In the detailed analysis of promoters that are recognised by 
the E. coli RNA polymerase (Rpol), two hexamers, found 
approximately at -10 and -35 upstream of the transcriptional start 
site, have been identified as the sites of recognition for Rpol's 
containing the vegetative sigma70 like sigma-factors (Helman and 
Chamberlain, 1988; Hawley and McClure, 1983; Harley and 
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Reynolds, 1987). Mutational studies on the sigma-factors have 
confirmed that nucleotides within these hexamers are the point of 
contact for RNA polymerase (Garella et al., 1989; Siegele et al., 1989; 
Zuber et al., 1989). 
The distance between the hexamers has been shown to be of 
particular importance. In E. coli, the hexamers are predominantly 
found 16-18 bases apart (>92%), 57% of which are spacers of 1 
nucleotides. Streptomycete promoters of this type have an average 
spacer of 17.3 nucleotides (Strohl, 1992). 
The Rpol holoenzyme is in contact with only one face of the 
DNA and so different spacer distances modify the strength of the 
interaction. Mutational studies on spacer distance, both for the E. co1i 
and streptomycete promoters, have confirmed the relationship 
between spacer distance and functional strength (Strohl and 
references cited therein, 1992). The E. co1i amp C gene has a linear 
correlation between ß-lactamase production and ampicillin 
resistance. When E. co1i sigma70-like streptomycete promoters were 
fused to the E. co1i ampC gene, the insertion of a single nucleotide 
into the 16-nucleotide spacer region produced a 16-fold and a 30- 
fold increase in transcription for E. coli and S. lividans respectively 
(Jaurin and Cohen, 1985). 
In certain streptomycete promoters, spacer distance would 
appear to be significantly more important than the nucleotide 
sequence of the hexamers. The mutagenesis by Westpheling on the 
gal-P1 promoter sequence has identified that it was not the E. coli 
sigma70-like hexameric sequence 23 nucleotides upstream of the 
putative -10 hexamer, but a hexamer of GGGGGG, 17 nucleotides 
upstream that was the -35 hexamer that was important for the 
transcription of gal-PI (Strohl, 1992). 
Given the stringency of the spacer distance, and the 
differences from the E. coli sigma70-promoters, consensus sequences 
for the -35 and -10 hexamers of 28 streptomycete promoters have 
been determined, requiring spacers of 16-18 nucleotides (Strohl, 
1992). 
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-35 REGION 
12345 
% 86 90 100 69 66 
TTGAC 
T 
-10 REGION 
6123456 
62 59 86 41 69 72 100 
(Pu) TAg (Pu) (Pu) 
Figure 1.9: G+C content of streptomycete promoter regions and 
percentage occurrence (From Strohl, 1992). 
The G+C content of streptomycete DNA ranges between 69 
and 78% (Goodfellow and Cross, 1984), and the coding regions 
average 70.1% (Seno and Baltz, 1989). The G+C content of the E. coii- 
like promoters, taken as twenty nucleotides on either side of the 
mid-point between the -10 and -35 hexamers, has been shown to be 
consistently lower (43% mol) than unrelated streptomycete 
promoters such as ermE (62-65%) (Bibb et al., 1985). Those 
promoters which have been shown to function in E. coli, have the 
lowest G+C content. 
1.9 Expression of Streptomyces production genes 
In recent years, knowledge about the genetics of secondary 
metabolism in Streptomyces has grown exponentially. However, 
control of expression and regulation of production genes is still an 
enigma. Relationships of closely-linked genes in the production 
clusters have been obtained from studies of mutations within these 
clusters. These mutations affect antibiotic production as well as 
other characteristics that are known to be developmentally- 
regulated. Therefore it is believed that not all control of antibiotic 
production is mediated by genes within the production cluster, as 
detailed in section 1.5. 
The organisation of genes within the production clusters 
seems to involve both possible orientations, mixing of genes for 
early and late enzymatic functions, and both mono- and 
polycistronic transcription units (Distler et al., 1987). 
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A number of Streptomycete species have divergent promoters 
and complex regulatory sequences in the intergenic region. In 
S. coelicolor, the actII-ORF1 and the actll-ORF 2/3 gene products are 
expressed from a pair of overlapping divergent E. coli sigma70-like 
vegetative promoters (Caballero et al., 1991). The methylenomycin 
resistance gene mmr and the protein J12, which is as yet of 
unknown function, are derived from the SCPI plasmid. Their 
promoters, although not overlapping have -35 hexamers within 11 
bases of each other, and the two genes share the regulatory control 
sequences in the intergenic region (Neal and Chater, 1991). InS. 
glaucescens, tcmA and tcmR are also divergently transcribed from 
overlapping vegetative promoters (Guilfoile and Hutchinson, 1992). 
tcmA appears to have a single transcriptional start and tcrR to have 
two start sites, the weaker constitutive promoter, originating from 
within the tcmA translated region and the stronger inducible 
promoter in the intergenic region. 
1.10 Prospects for genetic engineering in 
streptomycetes 
Prospects for improving antibiotic production in the future 
will be long-term aims. Companies already have concentrated and 
will concentrate on a great variety of traditional strain selection, 
molecular and transcriptional approaches to achieve success. 
Originally, natural product screening was employed by 
companies to randomly screen for new secondary metabolites. This 
is now being replaced by sophisticated, target-directed mode of 
action screens (Nisbet, 1992). In conjunction with this new 
approach, a knowledge of ecology and an appreciation of 
biodiversity is used to direct microbial isolation programmes in 
order to uncover new regulatory molecules. By those systems, many 
antibiotics initially discovered by traditional screening have 
subsequently been shown to posses highly potent activity in 
mammalian systems (Table 1.6). 
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Antibiotic 
Vancomycin 
Erythromycin 
Ivermectin 
Cyclosporin 
Mevilonin 
Antibiotic Activity Pharmacological 
Gram +ve bacteria 
Gram +ve bacteria 
Antihelminthic 
Antifungal 
Antifungal 
Function 
Hypotensive agent 
Motilin agonist 
GABA agonist 
Inhibitor of 
interleukin 2 
Cholesterol lowering 
Table 1.6: Pharmacological functions of antibiotics (from Nisbet, 
1992). 
The progression of Streptomycete molecular biology through 
gene cloning, cloning of antibiotic production gene clusters and 
analysis of regulatory factors affecting antibiotic production has 
allowed ideas to be developed on the best genes to be genetically 
manipulated (Chater, 1990). To understand one change made by 
genetic manipulation it may be necessary to be able to understand 
all the changes in the organism as a whole not just in one specific 
area. Limitations in evaluating the benefits of recombinant DNA 
techniques in the antibiotics industry have been improved by the 
cloning of numerous antibiotic biosynthetic genes. Great progress 
has been made in analysis of polyketide gene clusters (as already 
discussed in section 1.6). Manipulation of the DNA sequence or 
specificity of these processes to produce novel secondary 
metabolites is an obvious area of current research. The key to 
success is to develop an understanding of the complex genetics of 
the various bacterial polyketide synthases. A set of guidelines have 
been recently proposed for engineering polyketides in a predictive 
manner. (McDaniel et al., 1995). Therefore, the future should hold 
some interesting developments in this field. 
l. ll Scope of present work 
As the knowledge of the OTC cluster was incomplete, as 
indicated in Figure 1.8, the work presented in this thesis was 
initiated to fully characterise the otrB gene and upstream region 
(the gap between the otrB gene and the PKS genes). It was intended 
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to produce a greater understanding of the export of oxytetracycline 
from the S. rimosus cells, and the regulation of this export to be able 
to control these genes efficently when future hybrid strains are 
generated by genetic engineering. The aims of the work presented 
here therefore, were two-fold: 
a) To characterise the otrB gene and upstream region in the 
oxytetracycline production gene cluster by sequence and 
transcriptional analysis. 
b) To analyse some of the other regulatory factors involved in 
oxytetracycline production to understand more clearly how to 
enhance oxytetracycline production. 
45 
Chapter 2: Materials and Methods 
Chapter 2 Materials and methods 
Introduction 
This chapter contains the general procedures used in the 
experiments which were the basis of this thesis. The chapter is 
divided into four main sections; (2.1) bacterial strains and vectors, 
(2.2) microbiological techniques and standard media, (2.3) nucleic 
acid isolation and manipulation and (2.4) protein isolation and 
analysis. 
Many of the methods detailed in this thesis have be used or 
adapted from two main sources: 
a) Sambrook et al., 1989. 
b) Hopwood et al., 1985. 
2.1 Bacterial strains and vectors. 
The bacterial strains, plasmids and bacteriophages used in 
this study are listed in Tables 2.1 , 2.2 and 2.3 respectively. 
TABLE 2.1 Bacterial strains 
STRAIN GENOTYPE REFERENCE/SOURCE 
Escherichia coli strains 
TG I supE, hsd 5, thi, Gibson (1984) 
( lac-proAB ), F 
[ traD36, proAB+, 
laclq, lacZ Ml S ]. 
Streptomyces lividans strains 
TK24 str6 Hopwood et al . (1985 ) 
TK54 his2, leu2, spcl. Hopwood et al. (1985) 
TK64 pro2, str6. Hopwood eta] . (1985) 
Streptomyces rimosus strains 
M4018 OTC R Rhodes et al . (1981) 
M15883 OTC R Binnie et al . (1989) 
Ml 5883S OTC S non-producing oxytetracycline 
strain. 
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TABLE 2.2 Plasmids 
pUC18/pUC19 
pMT660 
pIJ940 
pIJ916 
pDS118 
pDS903 
4018/pDS 118 
4018/pDS903 
Yanisch-Peron eta]. (1985). 
Birch and Cullum. (1985). 
Lydiate eta . (1985). 
Lydiate et aL (1985 ). 
Hughes and Galazzo., (1992). 
Hughes and Galazzo., (1992). 
This work. 
This work. 
TABLE 2.3 Bacteriophages 
M13mp18/19 Messing. 1983. 
2.2 Microbiological techniques and standard media. 
Chemicals of good quality were used in the preparation of the 
growth media and solutions; AnalaR grade when available. The 
sources of many of the chemicals varied during the course of this 
work. The most common suppliers were BDH Chemicals Ltd, Poole, 
Dorset; Difco Laboratories , Detroit Michigan USA and Sigma 
Chemical Co. Ltd, Poole, Dorset. 
2.2.1 Standard media for the growth of E. coli. 
L-Broth: I Og tryptone, 5g yeast extract, 5g NaCl, 1g glucose , 
20mg thymine, made up to 1 litre in distilled water and adjusted to 
pH 7.0 with NaOH. 
Lagar: As L-Broth without glucose and the addition of 15g. L-1 
agar. 
2YT-Broth: lOg bacto-tryptone, 10g yeast extract, 5g NaCI 
made up to I litre in distilled water. 
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Minimal Agar: 2g K2HPO4,2g KH2PO4,4g (NH4) 2SO4, 
0.25M trisodium citrate, 0.1g MgSO4.7H2O, 17.5g agar made up to 1 
litre in distilled water. 
Minimal Medium Supplements: glucose and thiamine 
were added to give concentrations of 2mg. ml-1 and 20pg. ml-1, 
respectively. 
Davis and Mingioli (D&M) Salts (X4): 28g K2HPO4,8g 
KH2PO4,16g (NH4) 2SO4 Ig trisodium citrate , 0.4g MgSO2. i H2O, 
made up to 1 litre with distilled water. 
2.2.2 Standard media for the growth of Streptomyces 
Emersons agar: purchased as a powder and prepared as 
directed by the manufacturer (Difco). 
R2 Medium: R2A- 44g agar, 0.5g K2SO4,8.2g MgC12.6H2O, 
5.9g CaC12.2H20,20g glucose, 6g proline, 0.2g casamino acids, 4m1 
trace elements solution (Hopwood et al., 1985), made up to 1 litre in 
distilled water. R2B- 11.5g MOPS, 10g yeast extract , 203g sucrose, 
adjusted to pH 7.4 with NaOH, made up to 1 litre in distilled water. 
Equal volumes (100 mis) of R2A (melted and cooled to 55°C) and 
R2B plus lml of 1% (w/v) KH2PO4 were combined prior to use. 
R9 Medium: R9A- 44g agar, 0.5g K2SO4,8.2g MgCl2.6H2O, 
4.7g CaC12.2H20,4g NaNO3, Ig KCI, 0.4g MgSO4,20g glucose, 0.8g 
casanino acids, 4ml trace elements solution (Hopwood et al 1985a), 
2ml FeSO4 (1% [w/v] solution), made up to 1 litre in distilled water. 
R9B- 11.5g MOPS, 10g yeast extract, 410g sucrose, adjusted to pH 
7.4 with NaOH, made up to 1 litre with distilled water. Equal 
volumes (100 mis) of R9A (melted and cooled to 55°C) and R9B 
were mixed with Iml of 1% (w/v) KH2PO4 prior to use. 
Soya Mannitol Agar (SM): 20g mannitol, 20g soya bean 
flour, 16g agar, made up to 1 litre using tap water. 
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Tryptone Soya Broth (TSB): 30g of Oxoid tryptone soya 
broth powder made up to 1 litre in distilled water. 
Trusoya Medium 1 (TS1): soya flour, starch, vegetable oil, 
inorganic salts and MOPS (pH7.5). The exact composition of this 
medium cannot be revealed as it is commercially used by Pfizer for 
strain improvement. 
Rimosus Minimal Medium (TSM6): glucose, inorganic 
salts, MOPS and phosphate solution ( added after autoclaving ). The 
exact composition of this medium cannot be revealed as it is 
commercially used by Pfizer for strain improvement. 
Yeast extract-Malt extract (YEME): 3g Difco yeast extract, 
5g Difco bacto peptone, 3g Oxoid malt extract, lOg glucose, 340g 
sucrose, made up to 1 litre in distilled water. 
2.2.3 Sterilisation 
All growth media were sterilised by heating to 120°C for 15 
minutes in an autoclave. Supplements and buffer solutions were 
heated to 108°C and CaC12 to114°C for 10 minutes. Heat-libile 
solutions, such as amino acids, were sterilised by filtration through 
Nalgene 0.22pm pore membranes. 
2.2.4 Preparation of Streptomyces spore suspensions 
Concentrated spore suspensions were required for inoculating 
liquid cultures of S. lividans and S. rimosus. The protocol described 
by Hopwood et al. (1985) was followed with minor modifications. 
Proceedure: S. lividans and S. rimosus strains used during 
this work sporulated exceptionally well on Soya Mannitol (SM) agar. 
A boiling tube containing a slant of SM agar (produced by pouring 
ca. 15m1 of molten agar into the tube and allowing it to solidify with 
the tube held at 50 from the horizontal ) was inoculated with 150P1 
of a spore or mycelial fragment suspension and incubated at 300C . 
49 
Chapter 2 Materials and methods 
After 4-7 days the surface of the culture was covered in a dark grey 
mass of spores. The slant was then sealed using parafilm and frozen 
at -200C. Spores could then be harvested immediately or stored at 
-20°C indefinitely. The spores were then harvested by adding 5m1 of 
20% (v/v) glycerol to the frozen slant with a 10ml glass pipette. 
When the surface had been scraped clean of spores, the spore 
suspension was decanted into a sterile universal. The slant was 
rinsed with an additional 5ml of 20% (v/v) glycerol to remove any 
spores remaining from the first wash. The spore suspension (ca 
10ml) thus produced was dark grey in colour. Contaminating agar 
or mycelial fragments were removed by a single passage through a 
cotton wool filter, as described in Hopwood et al. (1985). The 
filtered spore suspension was then aliquoted and frozen at -200C. 
Aliquots were thawed and thoroughly mixed using a vortex prior to 
use. The titre of the spore suspension was determined after storage 
at -20°C overnight by spreading out serial dilutions onto plates 
containing Emersons agar. Titres remained stable for several 
months. Solid growth media other than SM agar were conducive to 
sporulation. R2 agar was used sometimes for S. lividans strains and 
R9 was used occasionally for S. rimosus strains. 
2.2.5 E. coli growth conditions. 
Liquid cultures of E. co1i strains from which plasmids were to 
be isolated were grown in L-broth with the appropriate antibiotic 
selection (usually ampicillin at 50pg. m1-1). The volume of broth 
inoculated depended on the quantity of plasmid required. 
Routinely, 5ml and 200m1 cultures were used for large-and small- 
scale plasmid preparations respectively (see section 2.3.1). For the 
preparation of competent cells E coli TGI was grown on 2YT. To 
maximise aeration of the culture, the volume of the Ehrlenmeyer 
flask was at least five times that of the broth. All cultures were 
incubated at 37°C in an orbital shaker at ca. 250 rpm. 
E. coli strains were also propagated on L-agar or Minimal 
Medium agar plates (containing supplements) with the appropriate 
selection. Plates contained ca. 25ml of agar and were incubated at 
37°C overnight. 
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2.2.6 Growth of Streptomyces mycelium. 
Ehrlenmeyer flasks were used for growing liquid cultures of 
Streptomyces. YEME broth was used for growing Streptomyces 
lividans strains and TSB broth used for growing Streptomyces 
rimosus strains. Cultures required for the formation of S. lividans or 
S. rimosus protoplasts also contained 0.5% (w/v) glycine and 5mM 
MgC12. The formation of the protoplasts required 30 to 50m1 of 
broth, while 200m1 of broth or multiples thereof were used for 
plasmid isolation. Routinely, 100p1 of a dense spore suspension 
(105-106 spores ) were used to inoculate 50m1 of broth. The flask 
volume was at least five times the volume of the broth to facilitate 
good aeration when incubated in an orbital shaker ( 300C at ca. 250 
rpm). 
2.2.7 Quantification of oxytetracycline in culture 
supernatants 
Samples of liquid cultures (lml) were extracted into 9ml of 
HC1 (pH 1.7) for 30 minutes and then filtered through Whatman 
No. 1 papers, for removal of extra debris the supernatants were also 
spun at 14k rpm for 5 minutes in an Eppendorf centrifuge. I ml 
samples were then sent to the Pfizer Process Development 
Laboratories at Sandwich and quantified by isocratic, ion-paired, 
reverse-phase high performance liquid chromatography (hplc) using 
a C-18p Bondapak column (Waters, Millipore House, Harrow, 
Middlesex, UK. ) with a mobile phase of acetonitrile/water (3: 7) 
containing O. Sg L-1 of 1-hexanesulphonic acid, adjusted to pH 1.7 
with sulphuric acid. 
2.2.8 Antibiotics and indicators. 
The antibiotic concentrations used throughout for both liquid 
and plate selection were as follows : 
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DRUG SELECTIVE 
CONCENTRATION 
Ampicillin 50pg. ml-1 
Thiostrepton 25pg. m1-' 
Streptomycin 50pg. ml -1 
Viomycin 30pg. ml -1 
Spectinomycin 50pg. ml-1 
2 Materials and methods 
STOCK STORAGE 
SOLUTION TEMP 
20mg. ml-1 -200C 
10mg. ml-1 40C 
30mg. ml-1 -20°C 
30mg. m1-1 40C 
50mg. ml-1 40C 
X-gal (5-bromo-4-chloro-3-indolyl-ß-galactosidase) was used 
in conjunction with IPTG to identify E. coli strains TG1 containing 
pUC or Ml3mp vectors with inserts in their multiple cloning sites. X- 
gal was stored at a concentration of 20mg. ml-1 in 
dimethylformamide (DMF) at -20°C while IPTG was stored at a 
concentration of 24mg. m1-1 in dH2O at -200C. X-gal and IPTG were 
added to L-agar plates to a final concentration of 20pg. m1-1 and 
50pg. m1-1, respectively. 
2.2.9 Preservation of Streptomyces and E. coli 
strains 
Streptomyces spp. were preserved by freezing agar slants 
covered in spores at -20°C. The Streptomyces spp. used in this work 
remain viable indefinitely under these conditions. Small slants made 
in 5ml bijou bottles were used for the long term storage of strains. 
However, few spores could be harvested from these slopes and it was 
therefore necessary to inoculate large slants (c. a. 15ml) in order to 
generate sufficient spores for most purposes. E. coli strains were 
stored in glycerol, an 800pl aliquot of an overnight culture nixed 
with an equal volume of 40% (v/v) glycerol, 2% peptone (w/v) and 
frozen at -700C. 
The strains were revived by scraping the surface of the frozen 
suspension with a sterile toothpick and either inoculating liquid 
broth or streaking onto agar and isolating a single colony. 
52 
Chapter 2 
2.2.10 Transfection 
bacteriophage M13 
Materials and methods 
of E. coli cells with 
A modified version of the protocol developed by Hanahan 
(1983) was used to prepare competent cells of E. coli TG I for 
transfection with the replicative form of M 13. 
Reagents: l OmM 2-N-ßmorpholino]ethanesulphonic acid 
(MES) buffer (pH 6.3), 10mM RbCl, 45mM MnC12.4H20,10mM 
CaC12.2H20, DTT/KAc: 2.25mM dithiothreitol, 40mM potassium 
acetate (pH 6.0). TFB: (For 1 litre) 10ml 1M MES (pH 6.3), 8-91g 
MnC12.4H20,1.47g CaC12.2H20,7.46g KCI, 0.8g Hexamminecobalt 
chloride made up to 1 litre with distilled water. 
Preparation of competent cells: An overnight culture of 
E. coli TG I grown in 2YT broth was diluted 1 in 100 into 30mis of 
fresh YT. The culture was grown until the OD600 was between 0.45 
and 0.55. The culture was then transferred to a 50ml polypropylene 
centrifuge tube (pre-rinsed with sterile distilled dH2O and pre- 
chilled on ice) and incubated on ice for 20 minutes. The were 
harvested by centrifugation (4000g, 4°C for 10 minutes), 
resuspended very gently in 2.5m1 of pre-chilled TFB and incubated 
on ice for 15 minutes. The cells were then treated with 1001u1 of 
dimethylsulphoxide (DMSO) and incubated on ice for 5 minutes. 
This was followed by the addition of 100pl DTT/KAc and 
incubation on ice for a futher 5 minutes. The cells were then ready 
to use after adding a second aliquot of DMSO and incubating on ice 
for 5 minutes. 
Transfection of E. coli with bacteriophage M13mp: 
200pl aliquots of the competent cells were added to plasmid DNA 
(1-100ng) in a volume less than 10p1, mixed gently by inverting the 
microfuge tube and incubated on ice for up to 1 hour. The cells 
were heat-shocked (2 minutes at 42°C) and returned to ice for a 
futher 15 minutes. After this step, 200pl of fresh exponential TG I 
culture was added to the transfected cells, followed by 1OpI of IPTG 
(24nig. ml-1) and 50p1 X-gal (20mg. ml-1). The cells were then mixed 
and added to 2.5m1 of molten water-agar (0.6% w/v, pre-cooled to 
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45°C), which were poured onto thoroughly dried minimal medium 
plates containing D&M salts, vitamin BI (5pg. ml-1) and glucose 
(2mg. ml-1) supplements. 
2.2.11 
Strep tomyces 
Introduction of plasmid DNA into 
Plasmids were introduced into Streptomyces spp. by genetic 
transformation using the polyethelyene-glycol-mediated protocol 
described by Hunter (1985). 
Reagents: Trace element solution: Per litre, 40mg ZnC12, 
200mg FeC13.6H20,10mg CuC12. H20,10mg MnC12.4H20,10mg 
Na2B407.1OH20 and 10mg (NH4)6Mo7024.4H20. Medium P; 
5.73g N-tris[Hydroxymethyl]methyl-2-aminoethanesulphonic acid 
(TES), 103g sucrose, 2.93g MgC12.7H2O, 0.5g K2S04,3.68g 
CaC12.2H2O, 2ml trace element solution. Adjust to pH 7.4 with NaOH 
and made up to 1 litre in distilled water. Lysozyme solution: 10% 
(w/v) sucrose, 25mM TES buffer (pH 7.2) , 2.5mM K2SO4,2ml trace 
elements (Hopwood et al., 1985a), 2.5mM MgC12,2.5mM CaC12. 
KH2PO4 (0.005% [w/v]) and lyzozyme (0.3mg. ml-1) were added 
immediately prior to use. PEG solution; 1g of polyethylene glycol 
1540 (supplied by BDH) was melted in a microwave (600W) for 10 
seconds on the reheat setting and then mixed with 3ml of medium P. 
Preparation of protoplasts: 30m1 cultures were grown in 
the appropriate medium at 30°C. The optimal time to harvest the 
mycelium in order to recover the most competent protoplasts was 
species dependent i. e. S. lividans mycelium was harvested after 65hr 
and S. rimosus after 48hr, respectively. The mycelium was pelleted at 
12000g for 10 minutes and washed twice in 10.3% (w/v) sucrose. 
The pellet then resuspended in 4m1 of lysozyme solution and 
incubated at 37°C for 15-30 minutes. The formation of protoplasts 
was monitored using a microscope, the reaction terminated by 
adding 5ml of medium P and the protoplasts triurated twice. The 
protoplasts were then filtered through cotton wool (Hopwood et al., 
1985), pelleted using a centrifuge (12000g for 10 minutes) and 
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washed twice in medium P, dispensed into 200ul aliquots and 
frozen at -70°C. 
Transformation of transformed protoplasts: The 
method used to prepare the regeneration medium for the 
protoplasts was standardised. The medium was stored in two parts, 
RA and RB; the former solid and the latter liquid. Both parts were 
placed in a steam bath until the RA portion had melted. The two 
components (100mis of each) were allowed to cool to 50°C before 
they were combined and I ml of 1% (w/v) KH2PO4 added. The 
complete regeneration medium was mixed by swirling and then 
poured into petri dishes (diameter 9cm). On average 8 plates were 
obtained from 200m1 of medium. The plates were dried in a laminar 
flow hood to minimise air-borne contamination by leaving the lids 
half open for 45 minutes. They were then rotated 180° and their 
relative positions reversed so that those at the front of the hood 
were placed at the back. After a futher 45 minutes, the plates were 
removed and left overnight at 30°C. The next day, any plates which 
showed any signs of contaminating growth were discarded and the 
rest used for regeneration of protoplasts. 
The only drug used in this work for plasmid selection in 
Streptomyces was thiostrepton (obtained from E. R. Squibb, New 
Jersey, USA). It was dissolved in DMSO to make a 1% (w/v) stock 
solution. Transformed protoplasts were selected after 16-22 hrs of 
non-selective growth at 30°C by overlaying the plates with 1. ml of a 
220pg. ml-1 thiostrepton solution in 10.3% (w/v) sucrose solution. 
S. lividans protoplasts were regenerated on R2 agar plates 
and R9 plates were used for S. rimosus. 
2.2.12 Mating between Streptomyces species 
The protocol used was based on the technique described in 
Hopwood et a] (1985). This method was used to mate and analyse 
Streptomyces spp. 
Making the cross: Spore suspensions of the Streptomyces 
spp to be crossed were made as already described (see section 
2.2.4). The Streptomyces spp were then mixed together on the 
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surface of an agar slant ( R2 or SM media were used routinely). 
One inoculating loop of spore suspension from each strain was 
mixed at the bottom of the slant and then spread uniformly over the 
surface of the slant. The slants were then incubated at 30°C for 3-4 
days, or until ample sporulation had occurred. The spores were then 
harvested (see section 2.2.4). 
Analysing the cross: The spore suspension obtained after 
crossing was analysed by plating onto selective agar plates, 
containing the appropriate antibiotic selections. Serial dilutions 
were carried out on the original suspension, allowing the frequency 
of recombination to be calculated. 
Calculation of recombination frequency: The 
recombination frequency was effectively calculated by plating out 
dilutions of the spore suspensions derived from a cross on the two 
media selective for one of the parental genotypes and on one or 
more media selective for recombinants. Frequencies were expressed 
as a fraction obtained by dividing the average colony count, on 
media selecting recombinants, by the sum of the two counts on the 
two media selecting for parental strains. 
2.3 Nucleic acid isolation and manipulation 
2.3.1 Isolation of plasmid DNA from E. coli species 
Protocols based on the alkaline lysis method ( Birnboim and 
Doly, 1979 ) were used for the isolation of plasmid from small (5m1) 
or large (50-200m1) culture volumes of both Streptomyces spp. and 
E. coli. 
Reagents: Birnboim Doly 1 (BD1); 50mM glucose, 25mM 
Tris-HCl (pH 8.0), 1OmM EDTA. Lysozyme was added immediately 
before use to a final concentration of 1-4mg. ml-1. Birnboim doly 
I 1(BDI 1) ; 0.2M NaOH, 1%(w/v) SDS which was stored in a plastic 
container. Birnboim Doty 111(BD 111); SM KOAc (pH 4.8); 
prepared by mixing equal volumes of 3M CH3COOK and CH3000H. 
Phenol; The phenol was redistilled, buffered against 0.5M Tris. HC1 
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(pH 8.0) and contained 0.1% (w/v) 8-hydroxyquinoline. 
Phenol. Chloroform; 50 parts phenol, 49 parts chloroform, 1 part 
isoamyl alcohol. DNAase-free RNAase; Pancreatic RNAase 
(RNAase A) was dissolved at a concentration of 10mg. ml-1 in dH2O, 
heated to 100°C for 15 minutes and allowed to cool slowly to room 
temperature. The RNAase was then aliquoted and stored at -20°C. 
Large-scale plasmid preparations: 200m1 cultures of 
stationary phase cells were harvested using a centrifuge (12000g, 5 
minutes at 4°C). The pellet was resuspended in 4m1 of Birnboim- 
Doly 1 solution. At this stage, Streptomyces preparations were 
treated with lysozyme. The amount of lysozyme that resulted in the 
optimum recovery of plasmid was determined for each strain. 
S. lividans and S. rimosus strains were incubated at 370C for 
20minutes with 1 mg. ml-1 and 4mg. m1-1 lysozyme solutions, 
respectively. E. coli cultures were incubated on ice for 5 minutes. 
Then 8ml of BirnboimDoly 11 solution was added and the solution 
left on ice for 5-10 minutes before 6ml of ice-cold Birnboim-Doly 11 
solution was added. The suspension was mixed gently and left on ice 
for 15-30 minutes. The cell debris and most of the chromosomal 
DNA was removed by centrifugation (392000g, 5 minutes at 4°C). 
The remaining nucleic acid pellet was washed with 70% (v/v) 
ethanol. The plasmid DNA was futher purified by equilibrium 
density centrifugation on a caesium chloride ethidium bromide 
(CsCI. EtBr) gradient. The nucleic acid pellet was redissolved in 1 ml 
of dH2O and 4.5g of CsCI dissolved in 3.5 ml of dH2O. The DNA and 
CsCI solutions were combined with 250pl of EtBr (10mg. ml-1), 
creating a solution with a density of 1.58g. ml-1. The nucleic acid- 
CsCl solution was spun in a Beckman Ti70 angled rotor at 289,000g 
for 16hrs at 200C. Two bands were visible in the gradients after 
centrifugation, a lower supercoiled plasmid band and an upper 
chromosomal and relaxed plasmid DNA band. The lower band was 
removed using aI ml syringe and the EtBr removed by repeated 
extractions with water-saturated butanol. After dilution with 3 
volumes of dH2O, 9 volumes of absolute alcohol was added. The 
precipitate was pelleted by centrifugation (27000g, 40C 30 
minutes). The resulting plasmid pellet was washed twice with 70% 
(v/v) ethanol and dried in vacuo before being redissolved in I ml 
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dH2O. This proceedure yielded very large amounts of pure plasmid 
DNA (up to 1 mg from E. coli and 1 OOpg from Streptomyces cultures) 
suitable for all in vitro manipulations. 
Small scale-plasmid preparations: This protocol was 
used for isolation of plasmids from both Streptomyces spp and 
E. coli, without modification. Routinely, plasmids were isolated from 
1.5m1 of E. coli cultures and 3. Oml of Streptomyces cultures or 
2cm2 patches of mycelial growth on the agar plates. The cells were 
pelleted by centrifugation in a 1.5m1 microfuge tube (12000g for 
30s) and resuspended in 1 OOp1 of BD 1, containing lysozyme at a 
concentration of 1 mg. ml-1, using a vortex mixer. This was followed 
by the addition of 200pl of BD 11 and repeated inversion of the 
microfuge tube to mix thoroughly the suspension. Immediately 
afterwards, 15Opl of prechilled BD 111 was added to the viscous 
bacterial lysate, mixed gently on the vortex mixer and placed on ice 
for 5-10 minutes. The cell debris and most of the chromosomal 
material was harvested by centrifugation (12000g, 4°C for 10 
minutes) in a microfuge. The supernate was transferred to a fresh 
tube and extracted with half volumes of phenol/chloroform and 
chloroform. The nucleic acid was then precipitated by the addition 
of 2 volumes of ethanol and allowed to stand at room temperature 
for 3-5 minutes. The precipitate was harvested by centrifugation in 
a microfuge (12000g, 4°C for at least 15 minutes). The resulting 
pellet was rinsed twice with 70% (v/v) ethanol before it was allowed 
to dry by leaving the tube open on the bench. The nucleic acid was 
then resuspended in 5Opul dH2O containing DNAase-free RNAase 
(20pg. ml-1). The typical yield of high-copy-number plasmids such 
as pUC from E. coli and pIJ486 from Streptomyces was 2-Spg of 
plasmid. Plasmid prepared in this way could be used for most in 
vitro manipulations. 
2.3.2 Isolation of total RNA 
This proceedure is based on that of Kirby et al. (1976) with 
extensive modifications by Covey and Smith (see Hopwood et al, 
1985). RNAase is a very persistent enzyme and precautions were 
taken against contamination of equipment and solutions. Prior to 
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use, all glassware was incubated overnight at 3000C. Distilled water 
was treated with DEPC (0.1% [v/v] of total volume) overnight and 
heated to 1210C for 15 minutes in an autoclave. All solutions were 
prepared from DEPC-treated water and chemicals reserved for RNA 
work. 
Reagents: Phenol; The phenol was redistilled, buffered 
against 0.5M Tris. HC1 (pH8.0) and contained 0.1% 8- 
hydroxyquinoline. Phenol. Chloroform; 50 parts phenol, 49 parts 
chloroform, 1 part isoamyl alcohol. Kirby mixture; lg tri- 
isopropylnapthalene sulphonate, 6g 4-amino salycilate (Na salt), 
50mM Tris. HC1 (pH 8.3), 6ml phenol, made up to 100ml in distilled 
water. 
Proceedure: RNA was isolated always from 50ml liquid 
cultures grown in 250m1 Ehrlenmeyer flasks. When the culture 
reached the appropriate stage of growth, the contents were 
immediately decanted into a 50m1 flask containing 20ml of dH2O, 
which had been frozen at -200C, rapidly lowering the temperature 
to c. a. 00C. As much of the chilled culture as possible, including any 
residual ice, was then transferred to an unused polypropylene 
centrifuge tube. The mycelium were then harvested using a 
centrifuge in a prechilled rotor. The pellet was then resuspended in 
5ml Kirby mix (prechilled on ice) containing 12g of 0.45mm 
diameter glass beads and agitated thoroughly on a vortex mixer for 
1-2 minutes. 5m1 of phenol/chloroform (stored at room 
temperature) were then added and the mixture agitated for a 
further 1-2 minutes. The homogenate was then spun in the 
centrifuge (9000g, 40C for 10 minutes) to separate the phases. The 
aqueous phase was removed, using a baked pasteur pipette, to a 
fresh centrifuge tube containing 5m1 of phenol/chloroform and 
mixed for 1 minute on the vortex mixer. The phases were then 
separated as before. At this stage, the nucleic acid solution could be 
stored at -70oC without any degradation being detectable. To 
remove DNA from the preparation, the RNA could be pelleted by 
caesium chloride centrifugation and/or it could be treated with 
RNAase-free DNAase. 
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Pelleting the RNA through a dense caesium chloride 
cushion: Homogenate (ca. 3.5ml) from the Kirby lysis was layered 
carefully on top of a 5.7M CSc1-0.1 M EDTA cushion (l . Sml, 
density 
1.707g. ml-1) in an ultracentrifuge tube (Srnl, Beckman 
polyallomerTM ). The RNA was then pelleted by centrifugation 
(3 5000rpm, 20°C for 16hrs) using a Beckman SW50.1 rotor. After 
centrifugation, the supernatant was removed using a baked pasteur 
pipette. The tube was then inverted to drain away the remaining 
fluid. Using a fresh scapel blade to cut the centrifuge tube, the 
bottom was isolated in the form of a small cup. The pellet was 
dissolved in 400p1 of dH2O and extracted with half volumes 
phenol. chloroform and chloroform. The RNA was precipitated by 
the addition of 1/50 volume of 5M NaCI and two volumes of 
absolute ethanol, and harvested by centrifugation in a microfuge 
(I 2000g 40C for 10 minutes). The RNA pellet was washed twice with 
70% (v/v) ethanol, dried in the open microfuge tube at room 
temperature and dissolved in 100-200pl of dH2O. The RNA 
concentration was estimated spectrophotometrically, reprecipitated 
and stored at -70°C. 
2.3.3 Quantification of nucleic acid 
The concentration and the purity of nucleic acid was 
determined by spectrophotometry; an A260 of 1 is equivalent to 
40pg. ml-1 RNA and 50pg. ml-1 double stranded DNA. Pure 
preparations of RNA and DNA have an A260/A280 of 1.8 and 2.0 
respectively. Contaminating protein or phenol lowers significantly 
these values. 
For quantitative Si nuclease protection experiments, 25-30ig 
of RNA that had been purified by CsC1 density centrifugation was 
resuspended in DEPC-treated dH2O. Optical density measurements 
were used to quantify the amount of RNA in 5/ßl aliquots which had 
been diluted to I nil. The measurements were repeated until three 
consecutive absorbance values agreed to within -/+ 0.002 
(approximately 0.1 erg). 
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2.3.4 Precipation of nucleic acids using ethanol or 
isopropanol 
DNA solutions were precipitated by the addition of 1/50 
volume of SM NaCI and 2 volumes of cold ethanol or an equal 
volume of isopropanol. After mixing, the DNA was pelleted by 
centrifugation (27000g, 4°C for volumes of 7.5-20rcm1 or 12000g, 15 
minutes, 4°C for small volumes in microfuge tubes). The pellet was 
washed in 70%(v/v) ethanol and dried briefly in a vacuum 
desiccator or in an open tube on the bench. 
2.3.5 Digestion of DNA with restriction 
endonucleases 
Digestion of DNA was performed usually in a total volume of 
20pl containing 0.25-1. Opg of DNA and 1-10 units of restriction 
endonuclease pg-1 DNA in the appropriate buffer (provided by BRL 
and Promega, the main enzyme suppliers). For the digestion of 
larger amounts of DNA, the volumes were scaled up accordingly. 
The reactions were allowed to proceed for 1-2 hours at the 
appropriate temperature. Reactions were stopped either by the 
addition of gel loading buffer or by rapid heating to 700C for 5 
minutes, followed by cooling on ice. 
2.3.6 Ligation of DNA fragments 
The ligation of DNA fragments was carried out usually at a 
DNA concentration of 20pg. ml-1. The molar ratio of insert fragment 
to vector was 2: 1, when the vector could not ligate itself, but only 
with the insert fragment. A molar ratio of 10: 1 was used when the 
ends of the vector could ligate to each other. Ligations were 
performed usually in 20ul of IX BRL /Promega ligation buffer, 
containing 1U of T4 ligase. The reactions were incubated for 4 hours 
at room temperature or overnight at 160C. 
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2.3.7 Removal of 5' phosphate from linear DNA 
lOX CiP Buffer: 200mM Tris. HCI (pH 8.0). 10mNI \1gCl2, 
10mM ZnC12 and 5mg. ml-1 Bovine Serum Albumin. 
Procedure: Calf Alkaline Phosphate (CIP) was used to remove 
the 5' phosphate from DNA. Around 5p moles of 5'-terminal 
phosphorylated DNA with 5' protruding ends (approximately 1 ug of 
a 5kb molecule) were incubated in 1X CIP buffer, containing 0.1 U of 
CIP at 3700 for 30 minutes. The reaction was terminated by heating 
to 65°C in 1X gel loading buffer for 10 minutes. The 5'-terminal 
dephosphorylated DNA was recovered from an agarose gel after 
electrophoresis. 
2.3.8 Filling recessed 3'-Termini 
Reagents: Restriction endonucleases appropriate for the DNA 
fragment of interest, T4 DNA polymerase and dNTP solutions. 
Procedure: In a 20/ßl reaction, 0.2-5pg of DNA was digested 
with the appropriate restriction enzyme. When the digestion was 
complete, 1 pl of a solution containing each of the desired 
nucleotides at a concentration of 2mM was added. 1-2 units of 
bacteriophage T4 polymerase for each microgram of DNA was added 
to the reaction, and the reaction was incubated at 120C for 15 
minutes. The T4 polymerase 
reaction at 75°C for 10 minutes. 
was inactivated by heating the 
The DNA was extracted with an 
equal volume of phenol/chloroform, ethanol precipitated and 
resuspended in dH2O or T. E. buffer. 
2.3.9 Addition of DNA linkers to blunt-ended DNA 
Reagents: Phosphorylated linkers (available from various 
companies), 5mM ATP, lOX Blunt-end ligation buffer: 0.66mM 
Tris(pH7.5), 50mM MgC12,50mM dithiothreitol, l mg/ml-1 Bovine 
serum albumin, 10mM hexaminecobalt chloride, and 5mM 
seer-midine HC1. 
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Procedure: 0.1-O. Spg of blunt-ended DNA(in a volume of 7pl 
or less) was mixed with 1-2pg phosphorylated linkers (in a volume 
of 8pl or less), dH2O to 15p1,2i1 Blunt end ligation buffer, 2pl of 
5mM ATP, and 1-2 units of T4 DNA ligase. The reaction was 
incubated at 16°C for 6-16 hours. At the end of the incubation the 
ligase was inactivated by heating at 65°C for 15 minutes. The 
reaction mixture was cooled and lOX the appropriate restriction 
buffer and restriction enzyme was added. The reaction was digested 
for 4 hours at the appropriate restriction temperature. EDTA (pH 
8.0) to a final concentration of 0.01mM was added and the DNA was 
extracted with an equal volume of phenol/chloroform. The 
fragments of linkers were removed by electrophoresis through an 
agarose gel followed by DNA extraction from the gel and ethanol 
precipitation. 
2.3.10 Removal of protein from nucleic acid 
solutions using organic solvents 
Reagents: Phenol; All phenol used in the purification of 
DNA or RNA was redistilled, buffered against 500mM Tris. HCI (pH 
8.0) and contained 0.1% (w/v) 8-hydroxyquinoline. 
Phenol/Chloroform; 50 parts phenol, 49 parts chloroform, I part 
iso-amyl alcohol. 
Procedure: Proteins were removed from nucleic acid 
solutions by extracting first with phenol/chloroform and then 
chloroform. 112 volumes of the solvents were added to the nucleic 
acid solution, mixed using a vortex mixer and the phases separated 
by centrifugation (1200g for 3 minutes). Proteins were then retained 
in the organic phase. Subsequently, DNA was precipitated with 
isopropanol or ethanol to purify it. 
2.3.11 Preparation of radiolabelled probes 
2.3.1 1.1 Random primed labelling method 
Labelling of DNA fragments with 32P followed the procedure 
of Feinberg and Vogelstein (1983 and 1984) using a Boehringer 
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Mannheim MultiprimeTM kit. The labelling reaction was set up in the 
following way: 
25-50ng of denatured DNA fragment in a volume less than 
IOpi (denatured by heating for 10 minutes at 95°C with subsequent 
cooling on ice). 
I pl of each unlabelled dNTP, from 0.5mM stocks. 
2pl of reaction mixture (containing hexanucleotide mix and 
] OX concentrated reaction buffer). 
Spl (5OpCi) of [ -32P] dCTP (3000Ci. mmol-1) 
1 pl (2U) of klenow enzyme. 
Made up to 201ßl total volume with dH2O. 
The reaction mixture was incubated at 370C for 30 minutes, 
and stopped by heating to 65°C for 10 minutes. The labelled DNA 
fragments (and template DNA) were purified from the 
unincorporated dNTP's by Sephadex-G50 column chromatography. 
2.3.11.2 5'-End labelling of oligonucleotides 
Oligonucleotide probes were labelled at their 5' terminal ends 
using T4 polynucleotide kinase and [ -32P] ATP. 
Reagents: lOX Kinase Buffer; 500mM Tris-HCl (pH 7.5), 
100mM MgCl2,50mM dithiothreitol, 1 mM spermidine, 1 mM EDTA. 
Stored at -20°C. 
Reaction mixture: 
Volume (ul) 
IOX Kinase buffer 1 
50ng of oligonucleotide 3 
50uCi of [- 32P] ATP (3000Ci. mmol-1) 5 
T4 Polynucleotide kinase (IOU) 1 
The reaction was incubated at 370C for 30 minutes. The 
unincorporated ATP was removed by Sephadex G50 column 
chromatography. 
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2.3.11.3 Sephadex G50 column chromatography 
After labelling had been completed, 5pl of dextran blue 
(50mg. ml-1) and 5pi of phenol red (50mg. ml-1) were added to the 
reaction mixture. The samples were then loaded onto Sephadex-G50 
(5ml sterile plastic syringe), which had been pre-equilibrated with 
column buffer (100mM NaCl, 10mM Tris. HC1 (pH 7.5), 1 mM EDTA). 
Fractions of approximately 500pl were collected. The dextran blue 
coeluted with the DNA fragments and all other aliquots were 
discarded. The labelled DNA sample was boiled for 5 minutes prior 
to use. 
2.3.12 Agarose gel electrophoresis 
Both DNA and RNA were visualised on horizontal neutral 
agarose gels. Although 0.8% (w/v) gels were most commonly used, 
1-2% (w/v) gels were occasionally used to separate fragments of < 
1.5kb. Gels were routinely prepared and run in TBE buffer, however, 
TAE buffer was used when DNA fragments were to be isolated from 
gels. ( see section 2.3.14). 
Buffers: lOX TBE Buffer(pH 8.3); 109g Tris, 55g Boric 
acid, 9.3g Na2EDTA. 2H20 made up to 1 litre in distilled water, pH 
should be ca. 8.3 lOX TAE Buffer pH 8.2; 48.4g Tris, 16.4g Na 
acetate, 3.6g Na2EDTA. 2H20, made up to Ilitre in distilled water, 
pH adjusted to 8.2 with glacial acetic acid. SX Agarose gel 
loading (AGL) buffer (pH 7.4); 0.025% (w/v) bromophenol 
blue, 0.025% xylene cyanol, 25% (w/v) ficoll, 0.5% (w/v) SDS, 50mM 
EDTA. 
2.3.12.1 Mini gels 
BRL model H6 gel kits were used for the rapid analysis of DNA 
after digestion with restriction enzymes or precipitation steps. 0.16g 
agarose was added to 20ml of 1X TBE (TAE), boiled then cooled to 
600C. EtBr was added to 200ng. ml-1 and the molten agarose poured 
into a 7.6cm \ 5.1 cm gel caster with an 8 well slot former (4. I X 
0.8mm wells). After the gel had set, the slot former was removed 
and the gel placed in the tank with 500ml of TBE (TAE). Depending 
on the time available and the level of resolution required the DNA 
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was separated by electrophoresis for 30-45 minutes with an applied 
voltage of 2-1 OV. cm 1. The separated DNA molecules were visualised 
on a 302nm UV transilluminator. 
2.3.12.2 Large gels 
200m1 gels were also used to ensure good separation of DNA 
fragments for accurate sizing and/or southern analysis. They were 
made by pouring 100ml of molten agar containing 100/ßg EtBr, into 
16.5 X 23cm gel former with a 20 space slot former. The gels were 
run overnight at 20V in 1X TBE buffer in gel tanks with a capacity of 
I litre. DNA samples were mixed with 1/5 volume of AGL buffer, 
heated to 70°C for 2 minutes and cooled on ice before loading onto 
the gel. 
2.3.12.3 Photography of resolved nucleic acids 
Gels stained with ethidium bromide were viewed on a 302nm 
UV transilluminator and photographed using a Polaroid type 667 
land film or using. The camera was fitted with a Kodak Wratten 
filter (No. 23A). 
2.3.13 Denaturing polyacrylamide gel 
electrophoresis A BRL sequencing unit (Model S2) was used for 
high voltage polyacrylamide gel electrophoresis. 
Reagents: SX Sequencing gel loading buffer (pH 8.2); 
0.1% (w/v) bromophenol blue, 0.1% (w/v) xylene cyanol, 10mM 
Na2EDTA, 95% (v/v) formamide (de-ionised with a mixed bed 
resin). 40% Acrylamide stock; Supplied already mixed by Severn- 
Biotech Ltd, Kidderminster. Urea; Supplied by Sigma. 
Preparation of polyacrylamide gels: 6% (w/v) 
denaturing polyacrylamide gels were used for sequencing and 
transcript analysis. The gels were prepared from the following stock 
solutions: 
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40%/ (w/v) acrylamide stock 1 Sm! 
urea 55g 
I OX TBE lOml 
dH2O 35m1 
ca. 100m 1 
The urea was dissolved by heating the mix to 37°C and then 
cooled to room temperature. The sequencing gel solution could be 
stored at 4°C for several weeks without loss of resolution. Before 
pouring the gel, 300pl of freshly prepared 10% (w,,, /v) ammonium 
persulphate and 50pl of TEMED were added to S0ml of the stock 
solution. 
Preparation of glass plates and pouring the gel: The 
plates (40cm X 33cm) were cleaned thoroughly with alcohol and 
water and assembled using three spacers (0.4mm thick) along the 
vertical sides and the bottom of the gel. The entire assembly was 
held in place by clamps. The gel solution was poured from a syringe 
down one edge of the plates while tilting the plates at an angle of 
about 300C. The plates were then laid down at an angle of 5°C and 
the sharks tooth combs inserted. The gel polymerised usually within 
30 minutes at room temperature. 
Electrophoresis of sequencing gels: The gel was pre- 
electrophorised for 30 minutes at a constant power of 60W. Prior to 
loading, the samples containing the sequencing loading buffer were 
heated to 95°C for 5 minutes , placed on 
ice and loaded onto the 
gel. 6% (w/v) gels were run 1.75-2hrs to read the first 150 
nucleotides and for 4.5-5hrs to read up to 400 nucleotides. 
2.3.14 Recovery of DNA from agarose gels 
DNA fragments were recovered from TAE agarose gels using 
GenecleanTM and Co-star® spin-xTM. tubes. The GenecleanTM kit 
(purchased from Stratech Scientific Ltd) was used for recovering 
DNA in the size range 1-7kb. Smaller fragments were not recovered 
efficiently from the glass beads and were isolated, therefore, by Co- 
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Star® spin-xTM tubes (purchased from Co-star®, Massachusetts, USA) . 
TBE gels were avoided as the borate ion significantly reduces the 
amount of DNA recovered using GenecleanTM / Co-star® spin-xTS' 
tubes and can influence some enzyme reactions such as ligation. 
2.3.14.1 GENECLEANTM 
The TAE agarose gel was placed on a 302nm transilluminator 
and the DNA band of interest was excised with a clean scapel. The 
agarose block was fragmented and 2.5 volumes of Nal solution were 
added. The suspension was incubated at 55°C for 5 minutes or until 
the agarose had dissolved completely. 5pl of "glassmilk" was added 
to the solution, which was mixed rapidly on a vortex mixer and 
placed on ice for 5 minutes. The glass beads with the DNA bound 
were pelleted by centrifugation (5 seconds in a microfuge) and the 
supernatant discarded. The glass beads were washed three times in 
ice-cold NEW solution (500pl), each time agitating the suspension 
using a vortex mixer and recovering the beads by centrifugation. 
After the final wash, care was taken to remove all traces of NEW 
solution. The DNA was recovered from the glass beads by adding 
20p1 of dH2O and incubating at 55°C for 5 minutes. The glass beads 
were pelleted by centrifugation (12000g for 30s in a microfuge) and 
the supernatant retained. This final step was repeated using another 
20pl of dH20 and the DNA solutions combined. The exact 
composition of the Nal, Glassmilk and NEW solutions were not 
disclosed by the manufacturers. 
2.3.14.2 Co-Star® Spin-XTM tubes 
The TAE agarose gel was placed on a 302nm UV 
transilluminator and a small block (<0.2cm3) of agarose containing 
the DNA fragments of interest excised using a scalpel. The agarose 
block was then placed within the spin-xTM tube and incubated at 
-20°C for 15 minutes. After this the spin-xTM tube was incubated at 
370C for 5 minutes before being centrifuged (12000g for 10 
minutes in a microfuge). The DNA solution was contained in the 
microfuge tube, while the agarose was retained in the top filter. The 
DNA solution could then be used directly in subsequent reactions, 
including ligations, or ethanol precipitated to concentrate the DNA 
if necessary. 
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2.3-15 Southern analysis 
Southern analysis was carried out by a method adapted from 
Southern (1975), and described in "Blotting and hybridisation 
protocols for Hybond-NT 1 membranes" published by Amershanm 
International plc. 
2.3.15.1 Capillary transfer 
After electrophoresis and photography, the resolved DNA 
TM fragments were transferred under alkali conditions to Hybond-N 
Reagents: Denaturing solution; l. SM NaCI, O. SM NaOH. 
Alkali transfer buffer; 0.25M NaOH, I. SM NaCl. 20X SSC; 3M1 
NaCl, 0.3 M tri-sodium citrate. 
Proceedure: The gel was rinsed in distilled water, placed in 
enough denaturing solution to immerse it completely and left for 30 
minutes. The gel was removed, excess liquid removed by blotting 
and equilibrated for 10-15 minutes in alkaline transfer buffer, by 
capillary action (disposable nappies proved a particularly useful 
absorbent material for driving the transfer process). After blotting 
for at least 4 hours (but usually overnight), the membrane was 
washed briefly in 2X SSC to remove any adhering agarose. 
2.3.15.2 Aqueous prehybridisation and hybridisation 
The procedures which follow were suitable for DNA 
immobilised on filters from Southern transfer. 
2.3.15.3 (a) Hybridisation using random probes 
Reagents: 6X SSC, 0.5% (w/v) SDS (Sigma Molecular Biology 
Grade), 0.05% (w/v) sodium pyrophosphate and 200pg. m1-1 
Heparin (Sigma, Gradel). The solution was made up to the required 
volume with distilled water. 
Prehybridisation and hybridisation conditions: The 
pre-hybridisation and hybridisation solutions used in this work 
contained OX SSC, 0.5% (w/v) SDS (Sigma Molecular Biology Grade), 
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0.05% (w/v) sodium pyrophosphate and 200pg. ml-1 Heparin 
(Sigma, Gradel). The solution was made up to the required volume 
with distilled water . The volume of the hybridisation solutions 
depended on the size of the filters; 200pl were added for every cm2 
of membrane. The hybridisation fluid also contained random 
primed probe (50ng, ca. IX 109 cpm. pg-1). The prehybridisation and 
hybridisation reactions were incubated at 65°C for 4 and 16 hours 
respectively . 
Washing of the membranes after hybridisation: The 
nylon membrane was washed twice in 200ml of IX SSC, 0.5% (w/v) 
SDS at 65°C for 20 minutes each. Excess fluid was removed by 
blotting, the filter sealed in a plastic bag and subjected to 
auto radiography. The probe could be stripped from the filter 
(provided the filter was kept moist after hybridisation ) by washing 
in 0.4M NaOH at 45°C for 30 minutes. The filter was then washed in 
OA X SSC, 0.2M Tris. HCl (pH 7.4) and 0.1% (w/v) SDS for 15 minutes 
and stored in a sealed plastic bag until required. 
2.3.15.3 (b) Conditions for aqueous hybridisation 
with oIigonucleotides. 
This procedure was used for probing homologous DNA, which 
was immobilised on Hybond-NTM membranes, with radioactively- 
labelled oligonucleotides of 20 bases. 
Prehybridisation and hybridisation conditions: The 
surface area of the filter was measured and 200pl of 
prehybridisation and hybridisation used for every cm2. The 
pre hybridisation solution contained 6X SSC, 0.05% (w/v) SDS (Sigma 
Molecular Biology Grade), 0.05% (w/v) sodium pyrophosphate and 
200pg. ml-1 Heparin (Sigma, Gradel). The prehybridisation solution 
was heated to 65°C before the required amount of heparin was 
dissolved. The solution was then added to the filter and incubated at 
05°C for 4 hours. The hybridisation solution was the same as the 
prehybridisation solution, except that it contained 0.5%(w/v) SDS 
and 50ng of probe(ca. IX 109 cpm. pg-1). The hybridisation solution 
was heated to 65°C before the heparin and 50ng of oligonucleotide 
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probe was added (see section 2.3.11.2). The filter was incubated 
with the hybridisation solution at 65°C for 90 minutes. 
Washing of the membrane: The membrane was washed in 
150m] of 5X SSC, 0.05% SDS (w/v) for 15 minutes at room 
temperature and then twice in 1 S0rnl of the same wash solution at 
60°C. 
2.3.16 Preparation of single-stranded DNA template 
The single-stranded M13 templates were prepared as 
described in the "M 13 Cloning/Dideoxy sequencing instruction 
manual" published by Bethesda Research Laboratories. 
Minipreparations: A single M13 plaque was used to infect 
1.5m1 of 2X YT broth containing 1511 of an overnight culture of E. 
coli TG 1. This was grown at 370C for 5-6 hours with vigorous 
shaking, then transferred to a microfuge tube and harvested by 
centrifugation at room temperature for 5 minutes. The supernatant, 
containing the phage particles, was recovered and respun. The 
supernatant (1 ml) that remained was mixed with 200pl of a solution 
of 20% (w/v) PEG (6000)/2.5M NaCl and left to stand at room 
temperature for 15 minutes to precipitate the phage particles. 
These were recovered by centrifugation at room temperature in a 
microfuge for 15 minutes. The supernatant was discarded, the pellet 
respun and all traces of supernatant removed. The pellet was then 
resuspended in 100/1 of dH2O and extracted twice with 
phenol/chloroform and twice with chloroform. The DNA was then 
ethanol precipitated from the aqueous phase and recovered by 
centrifugation in a microfuge. The ssDNA was then washed with 7101/16 
(v/v) ethanol, dried in vacuo and redissolved in 20pl dH2O. 
Maxipreparations: The same overall proceedure was 
followed as for the "minipreparations", except that all the volumes 
were scaled up 20-fold. The cells from a 30ml culture were spun out 
(14000g for 2 minutes), the supernatant recovered and respun as 
before. The supernatant (20ml) that remained was then precipitated 
with 5ml of 20% (wow/v) PEG/2.5M NaCl for 10 minutes at room 
temperature and then the phage harvested by centrifugation 
(14000g at 20°C for 15 minutes). The phage pellet was resuspended 
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in I ml of dH2O, then reprecipitated and processed as for the 
mini preparations with the volumes scaled up accordingly. 
2.3.17 DNA sequencing 
Dideoxy sequencing (Sanger et al., 1975) was carried out on 
single-stranded M13 templates using a Sequenase" kit supplied h\ 
United States Biochemical Corporation (USB). 
Annealing template and primer: In a 1.5ml microfuge 
tube, 1 pg of single-stranded template, Ipl of sequencing primer (0.5 
pmols) and 2pl of reaction buffer were combined and the volume 
made up to 10p1 with dH20. After denaturing at 65°C for 2 minutes, 
the primer was annealed to the template by allowing the mix to cool 
to 30°C. After annealing was complete, the tube was placed on ice 
and used within ca. two hours. 
Labelling reaction: To the annealed template-primer, the 
following were added; 
Volume (ul) 
7-deaza-dGTP labelling mix 2 
5pCi of [ 35S] (ca. 1000Ci. mmol-1) 0.5 
Cloned T7 DNA polymerase (2 units) 2 
The above were mixed and incubated at 370C for 5 minutes. 
To read sequences close to the primer annealing site a 1: 5 dilution 
of the labelling mixture was used. 
Termination reactions: Immediately after the labelling 
reaction was complete, 4{ßl aliquots were dispensed into four 
microfuge tubes containing one of the four 7-deaza-dGTP 
termination mixtures; ddATP, ddCTP, ddGTP and ddTTP, 
respectively. The contents were mixed as quickly as possible and 
incubated at 42°C for 5 minutes. After the reactions were complete, 
4pl of Stop loading buffer \N-as added and they were stored on ice 
until the sequencing gel was ready to load. The samples were 
heated 
to 7.5°C for 5 minutes, cooled rapidly on ice and loaded 
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immediately onto the gel. The composition of the buffers and 
nucleotide mixes were not disclosed by the manufacturers (USB). 
2.3.18 Primer extension mapping of 5' transcript 
ends 
The protocol described was communicated by Lewis \Vray 
(Boston University, USA). 
Reagents: 5X Annealing buffer; 1. OM KC1,0.1' 1 Tris. HCl 
(pH 8.3). 5X Elongation buffer; 0.9M Tris. HCI (pH 8.3), 0.1 N1 
MgC12. 
Proceedure: 5'-labelled oligonucleotide (ca. 0.5-1. Ong) and 
Streptomyces RNA were co-precipitated, washed with 70% (v/v ) 
ethanol and resuspended in 20M1 IX Annealing buffer. The sample 
was incubated at 80°C for 5 minutes to denature and then 
incubated at 42°C for 3 hours. After the RNA-oligonucleotide 
annealing reaction was completed and the following were added: 
Volume (pul) 
5X Elongation buffer 2 
Actinomycin D (1 mg-ml-1) 1 
ZmM dATP, dCTP, dGTP, dTTP solution I 
RNA-Guard Ribonuclease inhibitor 
(Phamacia, 37U. p1-1) 1 
Avian Myeoblastosis Virus (AMV) 
reverse transcriptase (Pharmacia) 1(25 units) 
100mM dithiothreitol 2 
Distilled water Z 
The elongation reaction was incubated at 420C for 30 minutes 
and then terminated by the addition of 10pl Sequencing Stop 
loading buffer (USB, SequenaseTM kit). Immediately prior to loading, 
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the extension products were heated to 85°C. 3-5pi of the sample was 
then loaded onto the sequencing gel. 
2.3.19 Autoradiography 
Autoradiography was performed in metal cassettes (medical 
chest X-ray type) using Kodak X-OMATS film. Enhancement in the 
intensity of the autoradiographic images were obtained when the 
film was exposed at low temperature (-70°C) in close contact with a 
du Pont Cronex Lightening Plus intensifying screen. The X-ray films 
were developed using a Compact X-OMAT automatic processor, 
model X-2. 
2.4 Protein isolation and manipulation 
2.4.1 Preparation of crude extracts 
a) Cell breakage 
Reagents: 100mM KPO extraction buffer p. H. 7.0 
Cell pellets were resuspended in ice-cold extraction buffer 
(1 ml buffer/ 4g wet weight of cells) and broken by three passages 
through an automatic French pressure cell at 98 mpa(14300 psi 
internal pressure). The cell was pre-cooled on ice before use (cat. no. 
4-3398A, American Instruments Company, Maryland, USA. ). 
b) Removal of cell debris 
The suspension obtained from the above was subjected to 
centrifugation at I0,000g for 1 hour at 40C and was stored at -200C 
until required. 
2.4.2 Denaturing polyacrylamide gel electrop»oresis 
of proteins 
Reagents: 10% Resolving gels : 40% Acrylamide, 1.5mM 
Tris (p. H. 8.8), 10% S. D. S, 10% Ammonium persulphate, TEMED and 
distilled water. 5% Stacking ', 01: 40% Acrylamide solution, 1M 
Tris p. H. 6.8,10% Ammonium persulphate, 10% S. D. S., TEMED and 
distilled water. 5X Running buffer: 15.1g Tris, 94g glycine made 
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up to 750mis with distilled water then p. H adjusted to 8.3 and made 
up to 1 litre with distilled water. 
Procedure: Gels were made as above and run by 
electrophoresis in 1X buffer as per the method of Laemmli (1970). 
An equal volume of the sample buffer (2X) was added to the protein 
sample and was boiled for 2 minutes. 15pl of the sample/buffer mix 
was then applied to each well in the gel, one well was used to run 
standard protein markers. The gel was run at 150v for 1 hour. 
Protein staining: Protein was localised on gels by staining 
with coomassie reagent (0.1% Coomassie brilliant blue G250 in 10% 
(w/v) glacial acetic acid 50% (w/v methanol) ) for 1 hour at 40°C. 
The gel was then destained in 10% acetic acid, 10% methanol at 
40°C overnight. Gels were then dried down for storage or 
photography. 
Drying down of destained polyacrylamide protein 
gels: Slab gels were dried down for easy storage or photography. 
Destained gels were placed on top of two pieces of Whatman 
no. 3MM chromatography paper cut to size. Heat proof SaranWrapTM 
was placed over the top of this and the sandwich dried down for 30- 
60 minutes on a Biorad slab gel dryer model 1125. 
2.4.3 Immunoblotting of proteins (Western blotting) 
Reagents: lOX P. B. S: For 1 litre: 80g of sodium chloride, 2g 
of potassium chloride, 11.5g of sodium dihydrogen orthophosphate 
7 hydrate and 2g of potassium hydrophosphate. 1% COC12: 10rnls 
distilled water and 100mg of cobalt chloride. Blocking buffer: 
100ml of 1X P. B. S. and lg of instant non-fat milk (Marvel). 
Electroblotting buffer: for 6 litres: 14.5g of Tris base and 67g 
Glycine made up in 4 litres of distilled water and p. H to 8.0 add 2 
litres of methanol and distilled water to a total volume of 6 litres. 
Diaminobenzidine Substrate solution (DAB): 50mg 3`3- 
diaminobenzidine, 2mls I% COC12 in distilled water, 98mls PBS add 
30% hydrogen peroxide prior to use. 
Procedure: After samples have been electrophoresed on an 
SDS-PAGE gel as described in 2.4.2, remove the gel from the plates 
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and soak in electroblotting buffer for about 30 minutes. The precut 
nitrocellulose filter should also be soaked at this time. The 
electroblot sandwich should be assembled in the following manner 
a. spacer 
b. teflon pad 
c. whatmann 3MM paper 
d. gel (with location of well 1) 
e. nitrocellulose filter 
f. whatmann 3MM paper 
g. teflon pad 
h. spacer 
The entire assembly process was carried out submerged in a 
shallow filled tub of electroblotting buffer. The sandwich was placed 
into the transfer unit with the nitrocellulose filter on the anode side. 
The transfer unit was run at 1.1 amps for 45 minutes to transfer one 
gel. After this time the nitrocellulose filter was removed and rinsed 
briefly with IX PBS. The filter was placed in an shallow tray with 
100mis of blocking buffer and incubated on a rotating platform for 
about 20 minutes. The blocking buffer was drained. The desired 
dilution of antibody was made in 100mis of blocking buffer and 
incubated with the filter for an additional 25 minutes on the rotator. 
The filter was rinsed two times for 10 minutes each time with 1X 
PBS. Horse radish peroxidase anti-IgG was diluted in 100mis 
blocking buffer and incubated with the filter for 25 minutes. The 
filter was rinsed two times each with IX PBS, drained of PBS and the 
DAB substate was added as the developing solution. The reaction 
occured quickly. The filter was rinsed well with distilled water to 
stop staining. The filter was placed in the dark while drying. 
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Chapter 3 The otrB gene 
3.1 Introduction 
Bacterial resistance mechanisms can be classified into four 
main categories, as already discussed (section 1.7). Initial cloning of 
the oxytetracycline-related genes of Streptomyces rimosus revealed 
that the oxytetracycline biosynthetic cluster contained two 
resistance genes, otrA and otrB, with different mechanisms (Rhodes 
et aL, 1984). 
The otr'A gene product shows substantial similarity to the tetM 
and tetO resistance gene products of Streptococcus and 
Campylobacter, (Doyle et al., 1991), suggesting that the otrA gene 
product confers resistance to tetracycline by means of a non- 
covalent modification of the ribosome (Ohnuki et al., 1985; 
Manavanten et al., 1990). The otrA gene product also shows 
similarity to the translational elongation factors, EF-G and EF-Tu. It 
may be more likely to function as an alternative EF-G as its deduced 
size is more similar to this than EF-Tu. However, futher biochemical 
evidence is required to substantiate this hypothesis (Doyle et a1., 
1991). 
At the onset of this project, the otrB gene product had been 
cloned on three separate occasions (Friend et a1., 1984; Ohnuki et 
al., 1985 and Reynes et al., 1988). The function of the otrB gene 
product had been demonstrated on two separate occasions (Ohnuki 
et al., 1985 and Butler at al., 1989). Ohnuki et al., showed that a 
tetracycline-sensitive Streptomyces griseus strain containing a 
plasmid-borne otrB gene exhibited reduced uptake of [3H] 
tetracycline, compared with a tetracycline-sensitive control. 
Reduced uptake of tetracycline is equivalent to enhanced output of 
tetracycline. These results were confirmed and extended (Butler et 
a1., 1989: unpublished results). Therefore, the otrB gene product 
was thought to be involved in the transport of the produced 
antibiotic from the bacterial cell. 
Reynes er a1. cloned and sequenced the otrB gene which they 
named (tet347). Sequencing revealed that the tet 
341 gene product 
was 347 amino acids in length with a deduced 
Mr of 35,818. 
Ii 
Chapter 3 The otrB gene 
Overexpression studies confirmed that the protein was indeed 
membrane-associated, supporting the hypothesis that the otrB gene 
product was involved in transport of the antibiotic into and frone 
the cell. Amino acid comparisons of the tet34 7 protein sequence 
against other known transporter genes, in both Gram-positive and 
Gram-negative organisms, indicated that the tet347 protein was 
more closely related to the Gram-negative family (tet A, tetB and 
tetC) than the Gram-positive family (pTHT15 and pT81). The 
location of the otrB gene in Streptornyces rimosus M15883 (this 
study), has been identified by a combination of experiments carried 
out before this current project was undertaken. A Pfizer plasmid 
pPFZ57 was known to contain the otrB resistance gene (Butler et al., 
1989). Futher subcloning experiments located the otrB gene to 
within a 3.7 kilobase SacII PstI (pPFZ 12 3) fragment on the genome 
(Figure 3.1). Supplementary evidence for the location of the otrB 
gene was provided by two Honours project students. Project 1 
showed that transcription did not occur past the BamHI in pPFZ 123, 
confirming data which indicated that preceding this site there 
appeared to be a large terminator structure at the end of the tet347 
gene (K. Mitchell, Honours Project, 1987; Reynes et a1., 1988). Project 
2 confirmed that a 2.3 kilobase Sacl/BamHI DNA fragment showed 
promoter activity when cloned into p1J487 (Lynda Woodward, 
Honours Project, 1988). 
3.1.2 Aims of the project 
The initial aims were to confirm otrB sequence data and 
provide transcriptional analysis of the gene in the Streptomyces 
rimosus strain M15883. The immediate aims of the experiments 
discussed in this chapter were as follows: 
(i) To identify transcriptional and translational start points 
for the otrB gene product. 
(ii) To confirm the sequence data of the otrB gene and 
upstream region and analyse these data with respect to other 
known 
tetracycline resistance genes. 
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(iii) To identify and analyse promoters responsible for the 
transcription of the otrB resistance gene and compare their 
sequence(s) with the consensus for known classes of promoters. 
__ 
(e) 
(d) 
ý. lý1 ! ff'iii; r,:. ': ''"; `:, ý,.. >.:::: r.... 
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SHH Bi p 
pPFZ123 
1 kb 
Figure 3.1: Restriction map of the "right hand" end of the 
oxytetracycline cluster. (a) Denotes fragment cloned into pIJ487 which 
shows promoter activity. (b) Denotes M13 mp18 and M13 mp19 
subclones constructed and sequenced during this work (clones 
annotated smhl and smh2 respectively). (c) Denotes M 13mp 18 and 
M 13mp 19 subclones constructed and sequenced during this work 
(subclones annotated smbl and smb2 respectively). (d) Denotes extent 
of published ter 341 sequence data Reynes et al ., (1988) . 
(e) Denotes 
the complete fragment of the orc cluster subcloned to obtain pPFZ123. 
This construct complemented OTC sensitive mutants (Butler et al., 
1989). Abbreviations: S, Sact, B, BamHI; H, Hincll; P, Pstl. 
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3.2 Computer-assisted analysis 
DNA sequence data was analysed using the "Sequence analysis 
software package, version 7", from the Genetics Computer Group at the 
University of Wisconsin (GCG 7) (Devereux et al., 1984). GCG 7 
comprises of a series of programs compiled specifically for molecular 
geneticists who require to analyse and compare sequence data rapidly 
and accurately. Access to the three main databases; EMBL, NBRF and 
Genbank is also possible through this system. A summary of the main 
programmes used and their functions follows: 
BESTFIT: makes an optimal alignment of the best segment of 
similarity between two sequences. Optimal alignments are found by 
inserting gaps to maximise the number of matches using the local 
homology algorithim of Smith and Waterman. 
TRANSLATE: translates a nucleotide sequence into peptide 
sequences for each reading frame, or a specified reading frame. 
PILEUP: creates a multiple sequence alignment from a group of 
related sequences using progressive, pairwise alignments. It can also 
plot a tree and show the clustering relationships to create the 
alignment. 
CODONPREFERENCE: indicates the potential open reading frames 
(ORFs) using a statistical analysis of codon bias. 
COMPARE: compares two protein sequences for regions of 
similarity. The COMPARE programme finds the points of similarity 
using a "window"/"stringency" match criteria. The sequences are 
compared in all possible permutations and where the quality of the 
matches within a "window" of amino acids is greater than or equal to a 
value specified by the "stringency", the point is written to a file. 
Matches are determined using the Dayhoff matrix which contains a 
numerical value representing the evolutionary distance for every 
possible amino acid comparison (Devereux et al., 1984). Using these 
match criteria it is possible to determine imperfect homologies and 
show evolutionary relationships. COMPARE puts only one point in the 
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file at the middle position of the window whenever the stringency is 
met. 
DOTPLOT: displays graphically the points of similarity found by 
compare. 
STEMLOOP: finds inverted repeats within a sequence which could 
form secondary structure. 
TFASTA: does a Pearson and Lipman search for similarity between 
a query peptide and any group of nucleotide sequences (EMBL and 
GENBANK). 
FASTA: does a Pearson and Lipman search for similarity between a 
query sequence and any group of sequences in a specified database 
(EMBL and GENBANK). 
3.2.1 Analysis of open reading frames 
Streptomycete DNA typically has a base composition of 73% mol 
G+C, although it can fluctuate between 69-78% mol, as analysed by 
thermal denaturing and buoyant density analysis (Enquist and Bradley, 
1971; Goodfellow et al., 1984). The identification of protein-coding DNA 
sequences in Streptomyces is complicated by the presence of extensive 
putative open reading frames (ORFs) in several of the possible six 
frames ie there is no observed translational stop. This property is 
attributed to the scarcity of A and T residues and the subsequent rare 
occurrence of out of frame translational stop codons (TAA, TAG and 
TGA). 
The sequence programs FRAME and CODONPREFERENCE (Bibb et 
al., 1984 and Devereux et al., 1984 respectively), have been developed 
to analyse the relationship between the overall G+C content of a coding 
sequence and the base composition of each of the three positions within 
codons. Bibb et al. (1984), considered codon degeneracy in relation to 
base composition in each of the three codon positions. The occurrence 
of G+C at the third codon position predominated at a frequency of 
greater than 90% compared with those at the first and second position, 
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of around 70% and 50% respectively. They concluded that high G+C 
content reflected base composition with most of the variation being 
expressed in the third codon position. These observations led to the 
deduction of the medium, low, high (M/L/H) G+C codon bias on which 
the FRAME program is based. Identification of a region of MH L'H G+C 
codon bias within a DNA sequence determines the potential protein 
coding sequence and ORF. When analysing Streptomyces sequences in 
this way, the definition between the coding open reading frame and 
"out of frame" alternatives is enhanced by using a codon usage table 
based on genes of G+C content similar to the sequence being analysed 
e. g. a codon usage table derived from all streptomycete genes on the 
EMBL database (Wright and Bibb, 1992). 
Both the FRAME and CODONPREFERENCE programs analyse the 
DNA sequence in a window of 25-50 codons. The window proceeds 
along the sequence until a graphical representation of the codon bias 
within the entire DNA sequence can be plotted. The analysis in this 
particular case was based on CODONPREFERENCE incorporating the 
recent codon usage profile of Wright and Bibb. Additionally, the 
CODONPREFERENCE program identifies rare codons within the DNA 
sequence, indicating further the DNA sequence which is non-coding or 
regions of the sequence which may be "out of frame". 
Analysis of the completed DNA sequence of the 2.09kb 
HincII11 Ba1nHI fragment using the CODONPREFERENCE programme 
revealed two possible open reading frames (Figure 3-3). The 
predominant open reading frame is located between nucleotides (nt) 
294 and 1878nt and a futher small incomplete ORF is located 
upstream. 
3.2.2 Sequencing strategy for the otrB gene. 
A summary of the sequencing strategy is shown in Figure 3.2. 
From previous analysis (section 3.1), it was known that a 2.3kb 
Sacl/BamHI fragment of pPFZ123 should contain the entire otrB gene. 
Another enzyme HincII was known to cut within the 2.3kb fragment and 
was considered a suitable restriction enzyme to carry out subcloning of 
the otrB gene and upstream region. 
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On digestion of the Sacl/BamHI fragment with the restriction 
enzyme Hincl7, three manageable DNA fragments of approximately 0.3, 
1.0 and 1.1 kilobases were produced. One Hincll restriction site could be 
located within the published tet347 sequence. Therefore it was assumed 
(and confirmed by further restriction digests), that the other HincII 
restriction site lay out with the published DNA sequence. Therefore, the 
1.0kb Hincll/BamH1 and the 1. lkb HincIl/Hincll DNA fragments were 
subcloned into both M13mp18 and M13mp19 (methodology, section 
2.2.10) as summarised in Figure 3.1. 
Single-stranded DNA template was produced (methodology, 
section 2.3.17), and sequencing of the otrB gene was achieved by using 
the SequenaseTM(USB) sequencing kit as detailed (section 2.3.18). Since 
few convenient restriction sites were available for subcloning, the entire 
otrB gene sequence was obtained by employment of universal primer 
(UP) or synthetic oligonucleotide primers, constructed when sequence 
data from the preceding region was obtained. 
The Hinc11/BamHl DNA fragment was sequenced on one strand 
only, as this confirmed the sequence data of Reynes et a]. in this region. 
Hence futher detailed sequencing was not required. However, 
sequencing of the Hincll/Hincll DNA fragment revealed several 
sequence ambiguities when the data were compared with the published 
tet347 sequence. Therefore, it became necessary to sequence the 
Hincll/H1ncI1 DNA fragment on both strands using a series of 
overlapping oligonucleotide primers. 
The sequence from Hinc IIl to BamHI comprised 2,094 base pairs 
and has a base composition of 70 mol %G+C, as deduced by 
CODONPREFERENCE. The otrB DNA sequence comprised 1,584 base 
pairs and has a base composition of 72 mol %G+C. The annotated 
sequence, including the amino acid sequence of the otrB gene product, 
and the locations of restriction sites referred to are shown in Figure 3.3. 
The sequence data generated were read and sequenced several 
times by eye to eliminate error and entered into computer files using 
the assembler/editor programme SEQED in GCG (Devereux et al., 1984). 
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Comparison of the completed sequence with that of Reynes et 
al., (1988) revealed that some significant differences. A comparison 
between our sequence data and that of Reynes et al., generated by 
BESTFIT is shown in Figure 3.5 
otrB 
(a) 
(b) 
(a) 
SH H2 
(a) (a) 
t (e} 
(f) (g) 0.5kb 
Figure 3.2: Summary of sequencing strategy for the otrB gene 
and upstream region. (a) Denotes universal primer. (b) Denotes 
smhloligo2. (c) Denotes smhl oligo3. (d) Denotes smhl oligo4. (e) 
Denotes smh 2 oligo2. (f) Denotes smh 2 oligo4. (g) Denotes smh 2 
oligo5. (4ý) Indicates the extent of the otrB gene sequence. 
Abbreviations: B, Barffl; H, Hincll, S, Sac1. 
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Hircii 
CCGTTGACCGCGAAGACCTCGGCGGTCACCTCGACAGAGCGGCCAGGTCA 
---------+---------+---------+---------+---------+ 50 
GGCAACTGGCGCTTCTGGAGCCGCCAGTGGAGCTGTCTCGCCGGTCCAGT 
GGGGCTGAGGAATCCATGGCCACAGCGTATGTACTCCCCGGAGAACGACA 
51 ---------+---------+---------+---------+---------+ 100 
CC CC GACTCCTTAGGTACCGGTGTCGCATACATGAGGGGCCTCTfGCTGT 
AGACCTCGTCAAAAGCCGCGGCGGTGAUACGCTCGGCACCCGGCCTCGG 
101 ---------+---------+---------+---------+---------+ 150 
TCTGGAGCAGTTTTCGGCGCCGCCACTAATGCGAGCCGTGGGCCGGAGCC 
TGCCGATGGTGAACAACGTGTGTGTACGGGGCCGGAAGCGCCGGCCAGGA 
151 ---------+---------+---------+---------+---------+ 200 
ACGGCTACCACTTGTTGCACACACATGCCCCGGCCTTCGCGGCCGGTCCT 
GAGTGAGGAACCGTGTCATCCGCAAATCCGGGCCCGGCGGGCACGGCGGA 
201 ---------+---------+---------+---------+---------+ 250 
CTCACTCCTTGGCACAGTAGGCGTTTAGGCCCGGGCCGCCCGTGCCGCCT 
CCAGGCAGGCGGGGCGTTCACGCATCGGCAGATCCTGACGGCC11 TCGG 
251 ---------+---------+---------+---------+---------+ 300 
GGTCCGTCCGCCCCGCAAGTGCGTAGCCGTCTAGGACTGCCGGTACAGCC 
MetSerG 
got smhl OH 902 
GA CTGCTGCTGGCCGTGTTCTCGCGCCTGACAGACGTCATCGCCACGATG 
301 ---------+---------+---------+---------+---------+ 350 
CTGACGACGACCGGCACAAGAGCGCGGACTGTCTGCAGTAGCGGTGCTAC 
lyLeuLeuLeuAlaValPheSerArgLeuT rAsDVallleAlaThrMet lqw 
smh2 o9 i go5 
CGCACCATCGCGGACGACCTCCACGGCCAGACCGAGCAGGCATGGGCGAC 
351 ---------+---------+---------+---------+---------+ 400 
GCGTGGTAGCGCCTGCTGGAGGTGCCGGTCTGGCTCGTCCGTACCCGCTG 
ArgThrIleAlaAspAspLeu'HisGlyGlnThrGluGlnA1aTrpAlOTh 
GACGGGCTACCTCATCGCCTCCGTCCTGGCGATGCCGTTCTACGGCAAGC 
401 ---------+---------+---------+---------+---------+ 450 
CTGCCCGATGGAGTAGCGGAGGCAGGACCGCTACGGCAAGATGCCGTTCG 
rThrGlyTyrLeulleAlaSerValLeuAlaMetProPheTyrGlyLysL 
TGTCCGACATCTACGGGCGTAACCTGTACCTGATCTCCATCGTGGTGTTC 
451 ---------+---------+---------+---------+---------+ 
500 
ACAGGCTGTAGATGCCCGCATTGGACATGGACTAGAGGTAGCACCACAAG 
euSerAspIleTyrGlyArgAsnLeuTyrLeulleSerlleValValPhe 
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ATCGGCGGCTCGGTGCTGTGCGGCACGGCCGGCTCGATGTGGGAGCTGGC 
501 ---------+---------+---------+---------+---------+ 550 
TAGCCGCCGAGCCACGACACGCCGTGCCGGCCGAGCTACACCCTCGACCG 
IleGlyGlySerVal[euCysGlyThrAlaGlySerMetTrpGluLeuA1 
s mh l oI i go3 
CCTCTTCGGCTCAGGGACTGGCGGCGGCGGGCTGATGTCCTGCCCACCGC 
551 ---------+---------+---------+---------+---------+ 600 
GGAGAAGCCGAGTCCCTGACCGCCGCCGCCCGACTACAGGACGGGTGGCG 
aLeuPheGlySerGlyThrGlyGlyGlyGlyLeuMetSerCysProProA 
GGTGGTCGCCGACTCGCCCGGTGCGCGACCGCCGCCGCTACTTCGCCTTC 
601 ---------+---------+---------+---------+---------+ 
CCACCAGCGGCTGAGCGGGCCACGCGCTGGCGGCGGCGATGAAGCGGAAG 
rgTrpSerProThrArgProValArgAspArgArgArgTyrPheAlaPhe 
smh2 oligo 4 
CTCCAGATGGCGTGGGTGGTCGCCAGCGTCGCGGGCCCGCTGGCGGGCGG 
651 ---------+---------+---------+---------+---------+ 
GAGGTCTACCGCACCCACCAGCGGTCGCAGCGCCCGGGCGACCGCCCGCC 
LeuGlnMetAlaTrpValValAlaSerValAlaGlyPro'LeuAlaGlyGi 
CTTCTTCGCGGAGGCGGGCCAGGTCTTCGGTATCGACGGCTGGCGCTGGG 
701 ---------+---------+---------+---------+---------+ 
GAAGAAGCGCCTCCGCCCGGTCCAGAAGCCATAGCTGCCGACCGCGACCC 
yPhePheAlaGluAlaGlyGlnValPheGlyIleAspGlyTrpArgTrpV 
TGTTCCTGCTCAACGTACCGCTGGGCCTGCTGGCCCTGGTCACCGTGCGC 
751 ---------+---------+---------+---------+---------+ 
ACAAGGACGAGTTGCATGGCGACCCGGACGACCGGGACCAGTGGCACGCG 
alPheLeuLeuAsnValProLeuGlyLeuLeuAlaLeuValThrValArg 
s nih l of ig o4 
650 
700 
750 
800 
101- 
AAGGCCCTGAACCTGCCGCACGAACGCGCACACCG AT GACGTACTGGG 
801 ---------+---------+---------+---------+---------+ 850 
TTCCGGGACTTGGACGGCGTGCTTGCGCGTGTGGCGTACCTGCATGACCC 
LysAlaLeuAsnLeu'ProHisGluArgAlaHisArgMetAspValLeuG1 
CG CGGCGGCGCTGGCGCTGTTCCTGGTGCCCCTGCTGATCGTCGCCGAAC 
851 ---------+---------+---------+---------+---------+ 
GCGCCGCCGCGACCGCGACAAGGACCACGGGGACGACTAGCAGCGGCTTG 
yAlaAlaAlaLeuAlaLeuPheLeuValProLeuLeuIleValAlaGluG 
s mh2 of i got 
AGGGCCGGACCTGGGGCTGGGGCTCGCCGGCCGCCCTCGCCCTCTTCGCG 
901 ---------+---------+---------+---------+---------+ 
TCCCGGCCTGGACCCCGACCCCGAGCGGCCGGCGGGAGCGGGAGAAGCGC 
1nGlyArgThrTrpGlyTrpGlySerProAlaAlaLeuAlaLeuPheAla 
900 
950 
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CTCGGCGCGGCCGGGCTGGCGGTCTTCATCCCCGTCGAGCTGCGGCGCGG 
951 ---------+---------+---------+---------+---------+ 1000 
GAGCCGCGCCGGCCCGACCGCCAGAAGTAGGGGCAGCTCGACGCCGCGCC 
LeuGlyAlaAlaGlyLeuAlaVaWPheIleProValGluLeuArgArgGl 
CGACGAGGCCATCCTGCCGCTGGGGCTCTTCCGGCGCGGCAGCATCGCGC 
1001 ---------+---------+---------+---------+---------+ 1050 
GCTGCTCCGGTAGGACGGCGACCCCGAGAAGGCCGCGCCGTCGTAGCGCG 
yAspGluAlaIleLeuProLeuGlyLeuPheArgArgGlySerIleAlaL 
Hi ncll 
TGTCGTCCGCGGTCAACTTCACCATCGGCGTCGGCATCTTCGGCACGGTC 
1051 ---------+---------+---------+---------+---------+ 1100 
ACAGCAGGCGCCAGTTGAAGTGGTAGCCGCAGCCGTAGAAGCCGTGCCAG 
euSerSerAlaValAsnPheThrIleGtyValGlyIlePheGlyThrVal 
ACCACCCTGCCGCTGTTCCTCCAGATGGTGCAGGGGCGGACCCCGACCCA 
1101 ---------+---------+---------+---------+---------+ 1150 
TGGTGGGACGGCGACAAGGAGGTCTACCACGTCCCCGCCTGGGGCTGGGT 
ThrThrLeuProLeuPheLeuGlnMetValGlnGlyArgThrProThrGl 
GGCCGGACTGGTGGTCATCCCGTTCATGCTGGGCACCATCGCCTCGCAGA 
1151 ---------+---------+---------+---------+---------+ 1200 
CCGGCCTGACCACCAGTAGGGCAAGTACGACCCGTGGTAGCGGAGCGTCT 
nAlaGlyLeuValValIleProPheMetLeuGlyThrIleAlaSerGlnM 
TGGTCTCCGGCAAGCTCATCGCGTCCTCGGGCCGGTTCAAGAAACTGGCG 
1201 ---------+---------+---------+---------+---------+ 1250 
ACCAGAGGCCGTTCGAGTAGCGCAGGAGCCCGGCCAAGTTCTTTGACCCC 
etValSerGlyLysLeulleAlaSerSerGlyArgPheLysLysLeuAla 
ATCGTGGGCCTGGGCTCGATGGCCGGGGCGCTGCTGGCCATGGCCACCAC 
1251 ---------+---------+---------+---------+---------+ 1300 
TAGCACCCGGACCCGAGCTACCGGCCCCGCGACGACCGGTACCGGTGGTG 
IleValGlyLeuGlySerMetAlaGlyAlaLeuLeuAlaMetAlaThrTh 
CGGCGCGACGACCCCGATGTGGGGCATCGTCCTGATCGTCCTCTGGCTCG 
1301 ---------+---------+---------+---------+---------+ 1350 
GCCGCGCTGCTGGGGCTACACCCCGTAGCAGGACTAGCAGGAGACCGAGC 
rGlyAlaThrThrProMetTrpGtyIleValLeulleValLeuTr, pLeuG 
GCGTCGGCATCGGCCTGTCCCAGACCGTCATCACCTCGCCCATGCAGAAC 
1351 ---------+---------+---------+---------+---------- 
1400 
CGCAGCCGTAGCCGGACAGGGTCTGGCAGTAGTGGAGCGGGTACGTCTTG 
IyValGtyIleGlyLeuSerGlnThraallleThrSerProMetGlnAsn 
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TCGGCCCCCAAGAGCCAGCTCGGCGTGGCGAACGGCGCCTCGGCCTGTGC 
1401 ---------+---------+---------+---------+---------+ 1450 
AGCCGGGGGTTCTCGGTCGAGCCGCACCGCTTGCCGCGGAGCCGGACACG 
SerAlaProLysSerGlnLeuGlyValAlaAs'nGlyAlaSerAlaCysAl 
CGGGCAGATCGGCGGCTCCACCGGCATCGCGGTTCTGTTCTCCGTGATGT 
1451 ---------+---------+---------+---------+---------+ 1500 
GCCCGTCTAGCCGCCGAGGTGGCCGTAGCGCCAAGACAAGAGGCACTACA 
aGlyGlnIleGlyGlySerThrGlyIleAlaValLeuPheSerValMetP 
TCGCGGTGGCGCTCGGCCGCCTCGCCGACCTGCTGCACACCCCGCGCTAC 
1501 ---------+---------+---------+---------+---------+ 1550 
AGCGCCACCGCGAGCCGGCGGAGCGGCTGGACGACGTGTGGGGCGCGATG 
heAlaValAla! LeuGlyArgLeuAlaAspLeuLeuHisThrProArgTyr 
GAGCGCCTCCTGACGGACCCGGCGATCACCGGCGACCCCGCCAACCACCG 
1551 ---------+---------+---------+---------+---------+ 1600 
CTCGCGGAGGACTGCCTGGGCCGCTAGTGGCCGCTGGGGCGGTTGGTGGC 
G1 uArgLeuLeuThrAspProAlaIleThrGlyAspProAlaAsnHisAr 
CTTCCTTGACATGGCCGAGTCCGGGCAGGGCGCGGGGATCAACCTTGACG 
1601 ---------+---------+---------+---------+---------+ 1650 
GAAGGAACTGTACCGGCTCAGGCCCGTCCCGCGCCCCTAGTTGGAACTGC 
gPheLeuAspMetAlaGluSerGlyGlnGlyAlaGlyIleAsnLeuAspA 
ACACGTCCCTGCTGAACGGCATCGACGCCCGGCTGATGCAGCCGGTGACG 
1651 ---------+---------+---------+---------+---------+ 1700 
TGTGCAGGGACGACTTGCCGTAGCTGCGGGCCGACTACGTCGGCCACTGC 
spThrSerLeuLeuAsnGlyIleAspAlaArgLeuMetGlnProValThr 
GATTCCTTCGCCCACGGCTTCCACATCATGTTCCTGCCCGGCGGCGTGGT 
1701 ---------+---------+---------+---------+---------+ 1750 
CTAAGGAAGCGGGTGCCGAAGGTGTAGTACAAGGACGGGCCGCCGCACCA 
AspSerPheAlaHisGlyPheHislleMetPheLeuProGlyGlyValVa 
GCTGCTGGCCGGGTTCGTCATGACCTGGTTCCTGCGCGAACTCCAGGAGG 
1751 ---------+---------+---------+---------+---------+ 1800 
CGACGACCGGCCCAAGCAGTACTGGACCAAGGACGCGCTTGAGGTCCTCC 
1LeuLeuAlaGlyPheValMetThrTrpPheLeuArgGluLeuGlnGluG 
AGACCGCGCCGGAGGAGGAGCGGCCGGCCGA'GAGCGGCGCCGGGGCGAAG 
1801 ---------+---------+---------+---------+---------+ 1850 
TCTGGCGCGGCCTCCTCCTCGCCGGCCGGCTCTCGCCGCGGCCCCGCTTC 
luThrAlaProGluGluGluArgProAlaGluSerGlyA1aGlyAlaLys 
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AACGGGCCGCTGCCCGCGTCGGACGCC GTACCGTACGAAGACGGGCTCCG 
1851 ---------+---------+---------+---------+---------+ 1900 
TTGCCCGGCGACGGGCGCAGCCTGCGGACTGGCATGCTTCTGCCCGAGGC 
AsnGlyProLeuProAlaSerAspAtaEnd 
GCACCCGTACGACGCGCTCCGGCGCGGGGAACGTCCGATTCCCCGTGCCG 
1901 ---------+---------+---------+-------------------+ 1950 
CGTGGGCATGCTGCGCGAGGCCGCGCCCCTTGCAGGCTAAGGGGCACGGC 
GAACGCGCGGTTCCCGGCTCCCGGCCGCCGTGCCGGGGTGTTCTGCCACC 
1951 ---------+---------+---------+---------+---------+ 2000 
CTTGCGCGCCAAGGGCCGAGGGCCGGCGGCACGGCCCCACAAGACGGTGG 
AAGGTTGCAGTTTCCCTTCCGGTTTCCGCTGCCGGGCTGCACTTCCGTTG 
2001 ---------+---------+---------+---------+---------+ 2050 
TTCCAACGTCAAAGGGAAGGCCAAAGGCGACGGCCCGACGTGAAGGCAAC 
Bam, Hi 
I 
CCTTTGCTTGGGCCCCCGTTCCGCCGCCATTAGCGTCTGGATCC 
2051 ---------+---------+---------+---------+---- 2094 
GGAAACGAACCCGGGGGCAAGGCGGCGGTAATCGCAGACCTAGG 
Figure 3.3: The complete annotated sequence of the otrB gene. 
The translational start and stop sites are indicated 
by boxes. The 
relevant restriction enzyme sites, relevant oligonucleotides and 
presumptive terminator structures are also 
indicated. 
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Figure 3.4: CODONPREFERENCE indicating the open reading 
frame for the otrB gene from nt 294 to nt 1878. 
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64 CCATGGCCACAGCGTATGTACTCCCCGGAGAACGACAAGACCTCGTCAAA 113 
III11111111111IIIIIIIII VIII HII1111111II 111111 
1 CCATGGCCACAGCGTATGTACTCCCCGGAGAACGACAAGACCTTGTCAAA 50 
114 AGCCGCGGCGGTGATTACGCTCGGCACCCGGCCTCGGTGCCGATGGTGAA 1i, 3 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
51 AGCCGCGGCGGTGATTACGCTCGGCACCCGGCCTCGGTGCCGATGGTGAA 1>ýý 
164 CAACGTGTGTGTACGGGGCCGGAAGCGCCGGCCAGGAGAGTGAGGAACCG 213 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIII 
101 CAACGTGTGTGTACGGGGCCGGAAGCGCCGG. CAGGAGAGTGAGGAA000 149 
214 TGTCATCCGCAAATCCGGGCCCGGCGGGCACGGCGGACCAGGCAGGCGGG 263 
IIIIIH IIIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIII 
150 TGTCATCCGCAAATCCGGGCCCGGCGGCGACGGCGGACCAGGCAGGCGGG 199 
264 GCGTTCACGCATCGGCAGATCCTGACGGCCATGTCGGGACTGCTGCTGGC 313 
II IIII1111111111111111IIIIII111111IIIIIIIIIIIIIIII 
200 GCGTTCACGCATCGGCAGATCCTGACGGCCATGTCGGGACTGCTGCTGGC 249 
314 CGTGTT. CTCGCG........ CCTGACAGACGTCAT000CACGATGCGCA 354 
111111 111111 11 111 11 11 I II 111111111 
250 CGTGTTCCTCGCGGCCCTGGACCAGACGGTCATCGCCACCGCGATGCGCA 299 
355 CCATCGCGGACGACCTCCACGGCCAGACCGAGCAGGCATGGGCGACGACG 404 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
300 CCATCGCGGACGACCTCCACGGCCAGACCGAGCAGGCATGGGCGACGACG 349 
405 GGCTACCTCATCGCCTCCGTCCTGGCGATGCCGTTCTACGGCAAGCTGTC 454 
III III III IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
3S0 GGCTACCTCATCGCCTCCGTCCTGGCGATGCCGTTCTACGGCAAGCTGTC 399 
455 CGACATCTACGGGCGTAA ... CCTGTACCTGATCTCCATCGTGGTGTTCA 
501 
IIIIIIIIIIIIIiI II I IIIIIIIIIIIIIIIIIIIIIIIIIII 
400 CGACATCTACGGGCGCAAGCCCATGTACCTGATCTCCATCGTGGTGTTCA 449 
502 TCGGCGGCTCGGTGCTGTGCGGCACGGCCGGCTCGATGTGGGAGCTGGCC 551 
III1IIIIIIIIIIIIIIIIIIII1IIIIIIIIIIIIIIIIIIIII III 
450 TCGGCGGCTCGGTGCTGTGCGGCACGGCCGGCTCGATGTGGGAGCT. GCC 498 
552 CTCTT..... CGGCTCAGGGACTGGCGGCGGCGGGCTGATGT. CCT000C 59S 
IIIII II IIIIIIIIII II 111111111 1111111 
499 CTCTTCCGGGCCGTCCAGGGACTGGGCGGCGGCGGCTGATGTCCCTGCCC 548 
596 ACCGCGGTGGTCGCCGA. CTCG. 000GGTGCG. CGACCGCCGCCGCTACT 642 
11111111111111111 IIII 111111111 111 Ill 111111111 
549 ACCGCGGTGGTCGCCGACCTCGCCCCGGTGCGCCGAGCGCGGCCGCTACT 598 
643 TCGCCTTCCTCCAGATGGCGTGGGTGGTCGCCAGCGTCGCGGGCCCGCTG 692 
II1IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
599 TCGCCTTCCTCCAGATGGCGTGGGTGGTCGCCAGCGTCGCGGGCCCGCTG 648 
I 
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693 GCGGGCGGCTTCTTCGCGGAGGCGGGCCAGGTCTTCGGTATCGACGGCTG 742 
III1 I IIIIIIIIIIIIIIIIIIIIIIIII11111 111'11111111 
649 GCGGCGGCCTTCTTCGCGGAGGCGGGCCAGGTCTTCGGCATCGACGGCTG 698 
743 GCGCTGGGTGTTCCTGCTCAACGTACCGCTGGGCCTGCTGGCCCTGGTCA 792 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII11111 IIIIIIII 
699 GCGCTGGGTGTTCCTGCTCAACGTACCGCTGGGCCTGCTGG. CCTGGTCA 747 
793 CCGTGCGCAAGGCCCTGAACCTGCCGCACGAA... CGCGCACACCG TG 839 
IIIIII11111II$1H IIIIH I)III)))) Ill) IIIIIIIII 
748 CCGTGCGCAAGGCCCTGAACCTGCCGCACGAACGGCGCGAGCACCG TG 797 
840 GACGTACTGGGCGCGGCGGCGCTGGCGCTGTTCCTGGTGCCCCTGCTGAT 889 
(I11119111Vlllllllil11111! lIIVVIIlH H HIH H IIII 
798 GACGTACTGGGCGCGGCGGCGCTGGCGCTGTTCCTGGTGCCCCTGCTGAT 847 
890 CGTCGCCGAACAGGGCCGGACCTGGGGCTGGGGCTCGCCGGCCGCCCTCG 939 
1111111IIIIII1(11111111(111111111111IIIIIIIIIIIIII 
848 CGTCGCCGAACAGGGCCGGACCTGGGGCTGGGGCTCGCCGGCCGCCCTCG 897 
940 CCCTCTTCGCGCTCGGCGCGGCCGGGCTGGCGGTCTTCATCCCCGTCGAG 989 
IIIIIIilllli1IIIIIIIIIIIIIIIIIII1111111111II111111 
898 CCCTCTTCGCGCTCGGCGCGGCCGGGCTGGCGGTCTTCATCCCCGTCGAG 947 
990 CTGCGGCGCGGCGACGAGGCCATCCTGCCGCTGGGGCTCTTCCGGCGCGG 1039 
IIIIIIIIIIIIIIIIIIIII{IIIIIIIIIIIII11 1IIIIIIIIIII 
948 CTGCGGCGCGGCGACGAGGCCATCCTGCCGCTGGGGCTCTTCCGGCGCGG 997 
1040 CAGCATCGCGCTGTCGTCCGCGGTCAACTTCACCATCGGCGTCGGCATCT 1089 
IIIIIIIIIIIIII IIIIIIIIilllll{IIIIIIIIIIIIilllHI 
998 CAGCATCGCGCTGTGCTCCGCGGTCAACTTCACCATCGGCGTCGGCATCT 1047 
1090 TCGGCACGGTCACCACCCTGCCGCTGTTCCTCCAGATGGTGCAGGGGCGG 1139 
llillllillllllHHIJIHII lllllllllllllHIHIHHI 
1048 TCGGCACGGTCACCACCCTGCCGCTGTTCCTCCAGATGGTGCAGGGGCGG 1097 
1140 ACCCCGACCCAGGCCGGACTGGTGGTCATCCCGTTCATGCTGGGCACCAT 1189 
1098 ACCCCGACCCAGGCCGGACTGGTGGTCATCCCGTTCATGCTGGGCACCAT 1147 
1190 CGCCTCGCAGATGGTCTCCGGCAAGCTCATCGCGTCCTCGGGCCGGTTCA 1239 
III1IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII'III 
1148 CGCCTCGCAGATGGTCTCCGGCAAGCTCATCGCGTCCTCGGGCCGGTTCA 1197 
1240 AGAAACTGGCGATCGTGGGCCTGGGCTCGATGGCCGGGGCGCTGCTGGCC 1289 
III II III IIIIIIIIIIIIIIIIIIIIIIIIIIIIII(IIIIIIIIIII 
1198 AGAAACTGGCGATCGTGGGCCTGGGCTCGATGGCCGGGGCGCTGCTGGCC 1247 
1290 ATGGCCACCACCGGCGCGACGACCCCGATGTGGGGCATCGTCCTGATCGT 1339 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1248 ATGGCCACCACCGGCGCGACGACCCCGATGTGGGGCATCGTCCTGATCGT 1297 
92 
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1340 CCTCTGGCýýý. GCGTCGGCATCGGCCTGTCCCAGACCGTCATCACCTCGC 1389 
IIIIIIIIIIIIIIIIIIIIIIIIIIIII(IIIIIIIIIIIIIIIIIIII 
1298 CCTCTGGCTCGGCGTCGGCATCGGCCTGTCCCAGACCGTCATCACCTCGC 1347 
1390 CCATGCAGAACTCGGCCCCCAAGAGCCAGCTCGGCGTGGCGAACGGCGCC 1439 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1348 CCATGCAGAACTCGGCCCCCAAGAGCCAGCTCGGCGTGGCGAACGGCGCC 1397 
1440 TCGGCCTGTGCCGGGCAGATCGGCGGCTCCACCGGCATCGCGGTTCTGTT 1489 
IIIIIIIIIILIIIIIIIiiIIIIIIIIIIIIIIIIiIIIIIIIIIIIII 
1398 TCGGCCTGTGCCGGGCAGATCGGCGGCTCCACCGGCATCGCGGTTCTGTT 1447 
1490 CTCCGTGATGTTCGCGGTGGCGCTCGGCCGCCTCGCCGACCTGCTGCACA 1539 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1448 CTCCGTGATGTTCGCGGTGGCGCTCGGCCGCCTCGCCGACCTGCTGCACA 1497 
1540 CCCCGCGCTACGAGCGCCTCCTGACGGACCCGGCGATCACCGGCGACCCC 1589 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1498 CCCCGCGCTACGAGCGCCTCCTGACGGACCCGGCGATCACCGGCGACCCC 1547 
1590 GCCAACCACCGCTTCCTTGACATGGCCGAGTCCGGGCAGGGCGCGGGGAT 1639 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1548 GCCAACCACCGCTTCCTTGACATGGCCGAGTCCGGGCAGGGCGCGGGGAT 1597 
1640 CAACCTTGACGACACGTCCCTGCTGAACGGCATCGACGCCCGGCTGATGC 1689 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1598 CAACCTTGACGACACGTCCCTGCTGAACGGCATCGACGCCCGGCTGATGC 1647 
1690 AGCCGGTGACGGATTCCTTCGCCCACGGCTTCCACATCATGTTCCTGCCC 1739 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1648 AGCCGGTGACGGATTCCTTCGCCCACGGCTTCCACATCATGTTCCTGCCC 1697 
1740 GGCGGCGTGGTGCTGCTGGCCGGGTTCGTCATGACCTGGTTCCTGCGCGA 1789 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1698 GGCGGCGTGGTGCTGCTGGCCGGGTTCGTCATGACCTGGTTCCTGCGCGA 1747 
1790 ACTCCAGGAGGAGACCGCGCCGGAGGAGGAGCGGCCGGCCGAGAGCGGCG 1839 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIII III 
1748 ACTCCAGGAGGAGACCGCGCCGGAGGAGGAGCGGCCGGCCGAGAGCGGCG 1797 
1840 CCGGGGCGAAGAACGGGCCGCTGCCCGCGTCGGACGCCTGACCGTACGAA 1889 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1798 CCGGGGCGAAGAACGGGCCGCTGCCCGCGTCGGACGCCTGACCGTACGAA 1847 
1890 GACGGGCTCCGGCACCCGTACGACGCGCTCCGGCGCGGGGAACGTCCGAT 1939 
IIIIIIIIIIII1III1IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1848 GACGGGCTCCGGCACCCGTACGACGCGCTCCGGCGCGGGGAACGTCCGAT 1897 
1940 TCCCCGTGCCGGAACGCGCGGTTCCCGGCTCCCGGCCGCCGTGCCGGGGT 1989 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1898 TCCCCGTGCCGGAACGCGCGGTTCCCGGCTCCCGGCCGCCGTGCCGGGGT 1947 
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1990 GTTCTGCCACCAAGGTTGCAGTTTCCCTTCCGGTTTCCGCTGCCGGGCTG 2039 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1948 GTTCTGCCACCAAGGTTGCAGTTTCCCTTCCGGTTTCCGCTGCCGGGCTG 1997 
2040 CACTTCCGTTGCCTTTGCTTGGGCCCCCGTTCCGCCGCCATTAGCGTCTG 2089 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 
1998 CACTTCCGTTGCCTTTGCTTGGGCCCCCGTTCCGCCGCCATTAGCGTCTG 2047 
2090 GATCC 2094 
IIIII 
2048 GATCC 2052 
Figure 3.5: BESTFIT analysis of the otrB gene sequence in this 
work (top sequence) compared to the tet347 sequence (bottom 
sequence) of Reynes et al., 1989). 
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3.2.3 Translational start and stop codons 
Analysis of the larger ORF revealed three possible translational 
start sites: a GTG at nt 203, a GTG at nt 213, and an ATG at nt 294. GTG 
translational start sites are common in Streptomyces as well as ATG 
translational start sites due to the high G+C content of the DNA. From 
the CODONPREFERENCE analysis it appeared that the ATG at nt 294 was 
the most likely translational start site for the otrB gene product. Two 
possible translational stop sites were identified at nt 1760 at nt 1878- 
The TGA at nt 1760 was not "in frame" with the presumtive 
translational start site at nt 294 as identified by CODONPREFERENCE 
and a large terminator structure downstream the second TGA at nt 18 78 
suggested that this is the probable stop codon. 
3.2.4 Amino acid comparison of the otrB gene product 
Using TFASTA, comparison of the deduced amino acid sequence 
of OtrB to DNA sequences in- the EMBL and GENBANK data bases 
revealed that the gene product of tcmA had the highest sequence 
similarity to OtrB (57% at the amino acid level). Significant similarities 
were also observed to the actll-ORF2 gene product and the actva-ORF 
gene product from Streptomyces coelicolor. 
Tetracycline-resistance genes from E. coli RP1 and Tn10 also 
showed similarity to the otrB gene product over selected regions as did 
the qacA gene product from Staphylococcus aureus and the pHT15 
resistance gene product from Bacillus subtiles. 
The tcrA gene product, from the tetracenomycin C-producer, 
Streptomyces glaucensens encodes a large open reading frame that is 
thought to encode a protein that acts as a membrane export pump 
powered by a transmembrane electrochemical gradient (Guilfoile and 
Hutchinson, 1992). The putative tcmA protein is a large (538 amino 
acid) hydrophobic protein that contains multiple potential 
transmembrane domains. The tcmA protein was found to be 
homologous with one family of the antibiotic resistance proteins that 
encoded the tet347 product sequenced by Reynes et al., 
(1988) and the 
Act[[-ORF2 export protein from Streptomyces coelicolor. 
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Figure 3.6: DOTPLOTS of the comparisons between OtrB tcmA, 
ActII-orf2 and actva-orfl. Indicates common protein regions shared by 
the otrB protein and related Streptomyces electrochemical 
transmembrane transporters. For all DOTPLOTS "window" =40 and the 
"stringency"=20. 
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Figure 3.7: Primer extension analysis to map the 5' 
transcriptional start point of the otrB gene in Streptomyces rimosus. The 
transcriptional start point for the otrB gene product is indicated by an 
asterix. Lanes 6-9 indicate the dideoxynucleotide sequence using the 
oligonucleotide smh2 oligo5 (A, C, G, T respectively). Lanes 1-3 indicate 
RNA from the S. rimosus oxytetracycline production strain from Pfizer 
at 48,64 and 87 hrs respectively (production of otc is at 1570,3840 
and 5000 pg/g for these samples). Lanes 4 and 5 indicate RNA from the 
ex-Pfizer production strain at 48 and 64 hours respectively. All RNA 
samples were used at a concentration of 20pg per reaction. 
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The comparison between otrB and tcmA protein sequences reveal 
several large regions of similarity. This similarity is more conserved at 
the amino terminus as this region (the 2-3 loop region) within the 
export families is thought that this region is important for the 
electrochemical gradient function of the protein and appears to be 
conserved in certain regions across the family. (This is discussed 
extensively in Chapter 4). In the ActII-ORF2 and Actva-ORF1 dotplot 
comparisons, a large degree of conservation is observed across the 
central protein region especially at the C-terminus (Figure 3.6). This 
region is thought to be involved in substrate recognition. The central 
region may seem conserved due to two additional membrane loop in the 
otrB protein which are also observed in the quacA protein. (This is 
discussed in Chapter 4). 
3.2.5 Transcriptional analysis of the otrB gene 
To establish if the transcription of otrB originated from a 
promoter located close to the predicted translational initiation codon 
(ATG 294), primer extension analysis was utilised to map the 5' end of 
the otrB gene and establish the transcriptional start site (Methodology 
section 2.3.20). The oligonucleotide smh2oligo5 (Figure 3.2) was used to 
create an RNA/DNA probe as it hybridised 30nts upstream of the ATG at 
nt 294. For primer extension to work the oligonucleotide must bind 
within 50-150nt of the 5' terminus of the mRNA as in experiments with 
oligonucleotides that are further away secondary structure may 
interfere with the result. Hybridisation of RNA to an excess of the 
synthetic oligonucleotide smh2 oligo5 which was radioactively-labelled 
at the 5' end was used for first strand DNA synthesis (reverse 
transcribed from the Streptomyces rimosus RNA). The produced DNA 
"runoff' fragment formed in this manner corresponds to the distance 
between the smh2 oligo5 oligonucleotide and the transcriptional start 
point of the otrB gene. The "runoff" fragment was then run against a 
sequence ladder from smh2 oligo5 to deduce the exact transcriptional 
start site. 
Smh2 oligo5 was hybridised to a selection of RNA samples isolated 
from a Streptomyces rimosus production strain currently used at Pfizer 
and an ex-Pfizer production strain available within the laboratory. 
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Therefore, the experiment utilised two different and independent 
Streptomyces fermentations. A single transcriptional start point ýv as 
observed in all cases, which co-migrated with aG -base in the sequence 
ladder, 13 bases upstream of the ATG 294 presumptive translationlil 
start site. The results are shown in Figure 3.7. 
The ATG at nt 294 is preceded by reasonable -10 and -35 
hexamers ACGCAT AND CGGACC, respectively. These hexamers 
correspond to the consensus sequences as determined from 139 
streptomycete upstream regions as identified by Stroh], 1992 (Figure 
1.10). The spacer between the two hexamers in the otrB gene region is 
17nts, the most common spacer in streptomycetes, implying that the 
otrB promoter is strong (spacing is critical for promoter strength). The 
transcriptional and translational start sites and the regions are 
indicated in Figure 3.8. 
3.3 Discussion 
Antibiotic resistance is believed to occur by four main 
mechanisms (as discussed in Chapter 1.7). Export of produced antibiotic 
from streptomycete species occurs by two types of transport systems : 
a) Energised by transmembrane electrochemical gradients. 
b) Transport of the antibiotic energised by ATP-mediated 
hydrolysis (ABC transporters-discussed in chapter 1.7.5). 
Export of the antibiotic from the streptomycete cell is doubly 
advantageous: the toxic hazard is removed from the cell and the 
antibiotic is placed within the external environment of the cell, where it 
may confer a selective advantage for the streptomycete. For tetracycline 
antibiotics one of the main characterised export mechanisms is an 
energy -dependent drug efflux mediated 
by resistance proteins that are 
inserted into the bacterial cytoplasmic membrane (Chopra, 1986 and 
Salyers et al., 1990). The efflux mechanism is driven by an electrically- 
neutral proton/tetracycline antiport system with exchange of a 
monocationic magnesium-tetracycline chelate complex 
for a proton 
(Keneko et al., 1985) (discussed extensively in Chapter 4). 
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Sequence analysis of the otrB oxytetracycline resistance gene from 
Streptomyces rimosus identified one large open reading frame. The 
deduced product of otrB has high sequence similarity to the tcniA gene 
product, implying that the otrB gene product acts as a metabolic export 
pump powered by a transmembrane electrochemical gradient. Auch 
debate exists about the regulation and regulatory roles of resistance 
genes relative to antibiotic production genes and only limited 
information exists about the relationship between the expression of 
antibiotic production genes and resistance genes in streptom, cete 
species. The upstream ORF is presumed to be a repressor gene as this is 
a common feature of all the electrochemical genes isolated frone 
streptomycete and Gram-negative families so far (this region is 
discussed extensively in Chapter 5). 
Sheridan and Chopra, (1991) proposed that the tetracycline 
export proteins could be divided into evolutionary families. The 
sequence data of tet347 produced by Reynes et al. allowed a 
conclusion to be drawn that the Streptomyces rimosus export protein 
was similar to the Streptomyces coelicolor rnnrA gene from 
methylenomycin but had evolved slightly differently. The tet347 gene 
product showed similarity to the export families but the protein was 
smaller and did not appear to have an associated repressor gene 
upstream of the tet347 gene. Therefore, the tet347 gene was allocated 
its own separate branch of the evolutionary tree. The data obtained for 
this thesis suggests that an error may have been made and that the 
Streptomyces rimosus export protein does in fact conform to known 
Gram-positive families of tetracycline export proteins and also shows 
substantial similarity to other isolated streptomycete antibiotic export 
genes. 
In conclusion, the evidence presented here identifies the otrB 
gene product as a member of the tetracycline 
family of export genes. 
Evidence also suggests that it has a clear association with other 
streptomycete H+/ antiport genes. The otrB gene protein structure and 
its relationship with other antiporters will 
be discussed extensively in 
Chapter 4. 
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3.4 Future work. 
Further work that can be carried out to extend the analysis of the 
otrB gene product. 
a) Analysis of the otrB transcript at the early stages of S. rimosus 
fermentation. Can a "switch on" of the otrB gene product be observed. 
b) Futher confirmation of the transcriptional data should be made 
using Si analysis. This was not used as no suitable restriction sites were 
available. However, as the whole sequence is now known it should be 
possible to attempt this experiment. 
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Chapter 4 The otrB protein 
4.1 Introduction 
Sequencing of the Hincll/HincII and Hinc11/BamH1 regions of 
the "right" hand end of the otc gene cluster revealed a large open 
reading frame (ORF) (Figure 3.4 j. The sequence comprised 2094 nts 
with an ATG start site at nt 294 and a TGA stop at nt 1878. 
The deduced gene product of otrB, a protein of 528 amino 
acids, showed a high degree of similarity to the deduced tcm: a 
protein, the deduced actll-ORFII protein and various other 
tetracycline resistance proteins. These characterised antibiotic 
resistance proteins in both E. coli and Streptomyces species are part 
of a growing family of proton motive force-dependent drug efflux 
proteins. 
Active efflux as a mechanism for bacterial resistance to 
tetracycline antibiotics is mediated by several related proton- 
dependent inner membrane transporters. These and several other 
seemingly similar transporters involving sugar transport, antibiotic 
transport and antiseptic and disinfectant transporters have related 
amino-acid sequences, similar predicted secondary structures and 
share highly-conserved sequence motifs. 
The above results suggested that the possible function of the 
OtrB protein was as a proton motive force-dependent drug efflux 
protein. Using available information about similar integral 
membrane proteins, especially those of the E. co1i tetracycline 
resistance proteins, a comparison of the OtrB protein with known 
antibiotic transporters has been attempted. 
The aims of these comparisons were: 
i) To compare the known proton motive force-dependent drug 
efflux proteins with the OtrB protein to attempt to establish its 
structure/function relationship. 
ii) To deduce its function by the characterisation of conserved 
motifs within the protein that confer its function. 
iii) To develop an hypothesis on the relationship between all 
of these known transporters. 
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________________________________________________ () 
(b) 
(a) 
SHH Bi P 
pPFZ123 
I kb 
Figure 4.1: Restriction map of the "right hand" end of the 
oxytetracycline cluster. (a) Denotes fragment cloned into pIJ487 which 
shows promoter activity. (b) Denotes M13 mp l8 and M13 nip 19 
subclones constructed and sequenced during this work (clones 
annotated smhl and smh2 respectively). (c) Denotes Ml3mp 18 and 
Ml3mpl9 subclones constructed and sequenced during this work 
(subclones annotated smbl and smb2 respectively). (d) Denotes extent 
of published tet 347 sequence data Reynes eta]. (1988). (e) Denotes the 
complete fragment of the otc cluster subcloned to obtain pPFZ123, this 
construct complemented otc sensitive mutants (Butler et al., 1989). 
Abbreviations: S, Sac]; B, BarHI; H, Hincil; P, Pst]. (From Chapter , 
Figure 3.1). 
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4.2 Results 
4.2.1 Amino acid sequence for otrB 
Translation of the otrB sequence data from the ATG codon at 
nt 294 to the TGA codon at nt 1878 was achieved using the program 
TRANSLATE which is part of the GCG package (described extensively 
in chapter 3). The complete nucleic acid sequence and amino acid 
sequence is shown in figure 3.3. 
4.2.2 Hydropathy profiles. 
Hydropathy profiles predict the trans-membrane topology of a 
protein. The prediction is made possible using a series of 
observations made by von Heijne (1986). Von Heijne observed that 
there was a bias in the distribution of certain amino acids with 
respect to the general topology of membrane proteins. 
Hydrophobic residues ( Phe, Ile, Leu, Val and Met) show a two- 
fold enrichment in membrane-spanning domains. Intra and extra- 
cytosolic membrane loops may be assigned, because there is a 
considerable bias in the distribution of positively-charged, but not 
negatively-charged amino acids, in these loop regions. The 
asymmetry of the charges results in conservation of the basic amino 
acids in the cytosolic loops rather than in the periplasmic loops. 
There are also fewer negatively charged residues in the periplasmic 
loops than in the cytosolic loops. These statistical considerations 
allow a plot of the transmembrane protein showing cytosolic, 
periplasmic and "within the membrane" locations in a graphical 
format (The positive -insider rule). 
The hydropathy profile (Kyte-Doolitle profile) obtained from 
otrB showed the presence of 14 strongly hydrophobic segments, 
likely to form transmembrane alpha-helical domains given their 
length and structural organisation. A comparison of the hydropathy 
profile of OtrB was made with those of TcmA from S. glaucesens , 
Actll-ORF2 from S. coelicolor, Mmr from the methylenomycin SCPI 
plasmid of S. coelicolor and the ActV-Orfl region of S. coelicolor. 
This comparison showed remarkable conservation of 14 
transmembrane domains (Figure 4.2). 
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Figure 4.2: Hydropathy plots of a) the OtrB protein b) the 
TcmA protein (Guilfoile and Hutchinson, 1992a) c) the Actll-ORFII 
protein (Cabellero et al., 1991) and d) the. ActV-ORF1 protein 
(Cabellero et al., 1992). (Kyte and Doolittle, 1982). 
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4.2.3 Comparison to other transport proteins. 
There is a relationship between the various efflux mediated 
resistance determinants in Streptomyces and other determinants 
such as quacA from S. aureus. These resistance determinants show 
some conservation with the sugar transport proteins, in particular 
the arabinose/H+ symport, AraE (Griffith et al., 1992), which has 
led to the suggestion that they share a common ancestry. 
The most definitive way to explore this relationship is to 
analyse the conservation of functional motifs within the proteins. 
Using the GCG package program PILEUP, the similarity of very 
divergent members of this family could be assessed (Figure 4.4). 
Certain other members of this family have been found to contain 12 
transmembrane segments and it has previously been assumed that 
there is significant similarity within only the N-terminal halves of 
these proteins. OtrB having being identified as a cytoplasmic 
membrane protein which is similar to a distinct family of repressor- 
controlled, transport proteins, may be further dissected into specific 
functional domains. The OtrB protein and other members of the 
family have been demonstrated to be proton-dependent, energised 
by the transmembrane electrochemical gradient. The proteins of this 
family are believed to contain two functionally-distinct domains 
(Rouch et al., 1990). The N-terminal domain, being responsible for 
proton transport, shows a degree of amino acid sequence 
conservation. The C-terminal domain is responsible for specific 
substrate transport. Therefore, less similarity should be expected at 
this region. 
When the similar transmembrane domains are identified in 
the PILEUP, it becomes evident that several members of resistance 
proteins have an extra two transmembrane domains. These extra 
helices correspond to the region between transmembrane helix 6 
and 7 for the TetA tetracycline resistance determinant. 
Most of the mutational analysis into the functional 
significance of specific residues has been carried out using the 
tetracycline efflux protein sub-family and so some experimental 
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Figure 4.3 PILEUP of amino acid sequences of the 
transmembrane electrochemical transporters. Genes defined actVA 
gene from S. coelicolor (Cabellero et al., 1991), quacA gene from 
S. aureus (Griffith et al., 1992), tcmA gene from S. glaucesens 
(Guilfoile and Hutchinson, 1992), mmyA gene from S. coelicolor 
(Neal and Chater, 1991), ActII-orfll gene from S. coelicolor (Cabellero 
et al., 1991), tht15 gene from B. subtilis (Griffith et al., 1992), and 
the otrB gene from S. rimosus (this work). 
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TMH 1 TMH 2 
1 MSGLLLAVFS RLTDVIATMR TIADDLHGQT EQÄWATTGYL IASVLAMPFti 
TM H3 TM H4 
51 GKLSDIYGRN LYLISIVVFI GGSVLCGTAG SMWELALFGS GTGGGGLMSC 
TM H5 
101 PPRWSPTRPV RDRRRYFAFL QMAWVVASVA GPLAGGFFAE AGQVFGIDGIV 
TMH 6 TMH7 
151 RWVFLLNVPL GLLALVTVRK ALNLPHERAH RMDVLGAAAL ALFLVPLLIV 
TMH8 TMH9 
201 AEQGRTWGWG SPAALALFAL GAAGLAVFIP VELRRGDEAI LPLGLFRRGS 
251 IALSSAVNFT IGVGIFGTVT 
TMH 10 
TLPLFLQMVQ GRTPTQAGLV VIPFMLGTIA 
TMH 11 
- ----------- - ---- - -------- 301 SQMVSGKLIA SSGRFKKLAI VGLGSMAGAL LAMATTGATT PMWGIVLIVL 
TM H 12 
351 WLGVGIGLSQ TVITSPMQNS AP'KSQLGVAN GASACAGQIG GSTGIAVLFS 
TMH 13 
401 VMFAVALGRL ADLLHTPRYE RLLTDPAITG DPANHRFLDM AESGQGAGIN 
TMH14 
451 LDDTSLLNGI DARLMQPVTD SFAHGFHIMF LPGGVVLLAG FVMTWFLREL 
501 QEETAPEEER PAESGAGAKN GPLPASDAt 
Figure 4.4: OtrB protein complete amino acid sequence 
showing Transmembrane domains as deduced by hydopathy profiles 
and conserved motifs as discussed in section 4.2. S. (T 43\. xjLr-n ýýrus 
ý vW i, 0. }q- (. O v'Sty vt ok ýo 
t% ý). 
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evidence for particular conservation of residues can be 
demonstrated. The comparison of OtrB with other tetracycline 
members has revealed strong conservation of certain structural and 
functional residues in the N-terminal but not the C-terminal domain 
(due to the two additional transmembrane domains in the OtrB 
protein) (Figure 4.5). 
4.2.4 Residue conservation. 
Henderson and Maiden (1990) reported that across six 
different sugar transporters (D-xylose, L-arabinose, D-glucose, D- 
galactose, L-rhamannose and L--fructose), 45 residues were absolutely 
conserved. For some of these transporters the most commonly 
conserved residues were glycine, proline, arginine and glutamate. 
Glycine is a small flexible amino acid which may often occupy 
structurally-important positions constrained by size or requiring 
specific angles. Proline has a rigid, restricted conformation and 
usually has a main structural -role. Conservation of amino acids 
arginine and glutamate (which are only charged at neutral pH) are 
indicative, within transmembrane regions, of charge transfer. The 
tetracycline transporters also show conservation of histidine 
residues, important for a charge relay system in proteins of this 
family (Yamaguchi et al., 1991). 
In OtrB there is a predominance of glycine, proline, arginine 
and glutamate residues. In fact, 133 of the 528 amino acid residues 
are one of these four amino acids. As discussed in this section many 
of these four conserved motifs are found within identified functional 
motifs, important for the function of the export protein. 
4.2.5 Identification of motifs for proton transport. 
The work of Yamaguchi et al. has characterised many 
functional motifs involved in the tetracycline transporters of E. coli 
in the same way as the work of Henderson and Maiden has 
characterised the sugar transporters. 
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1 
TetA. con ... M... L.. 
TetAcon. frg .. KmN. pli. 
OtrB. frg ... MSGLLLA 
1- -4 50 
..... D... ....... jL. v .......... .......... L... LDA.. GIGL. MP1%LP:. LLR. lv. sg d. a. HyG. LL 
VFSRLTDVIA TMRTIADDLH'.......... 
. GQTEQAWAT 1_ 1 
51 
----- _-1 100 TetA. con .. Y....... . P.. 1G. LSD. . GR. 
1.. 'L^.. ..... ............ TetAcon. frg ALYAlmQ. i. APvLG. 1SDr fGRRPvILL. S L. GAsvth. l At. pvLWmL 
OtrB. frg TGYLIASVLA MPFYG'KLSDI YGR'1LYLISI VVFIGG9VLC GTAGSMWELA 
101 150 
TetA. con .. G.... G ............ .......... . A........ ... 
ý AGP 
TetAcon. frg YLGRi.. GIT GAT. GAVA. a . iADiTdgs. Rak. FGymsA . FG! G. iAGP OtrB. frg LFGSGTGGGG LMSCPPRWSP TRPVRDRRRY FAFLQMAWVV ... 
ýASVAGP 
-151t 200 TetA. con .. Gh...... .. F ....... ....... L.. .......... .......... TetAcon. frg . iGGGeiSpH PFf. AAaLN . I. flF. l. r e.. k. e.. p. . k........ OtrB. frg LAGJFFAEAG QVFGIDGWRW VFLLNVPLGL LALVTVRKAL NLPHERAHRM 
201 250 
TetA. con .......... .......... .......... .......... .......... TetAcon. frg 
.......... .......... .......... ..... nplss . rwo.. m. 
io 
OtrB. frg DVLGAAALAL VPLLIVAEQG RTWGWGSPAA LALFALGAAG LAVFIPVELR 
251 300 
TetA. con .......... L... G..... .. V. FT.... ..... T .... .......... TetAcon. frg aLl. vfFs. Q L... GQ.. PAt 1WV1FtEdRF gW.. atiGiS LAg. GilHal 
OtrB. frg RGDEAILPLG LFRRGSIALS SAVNFTIGVG IFGTVTTLPL FLQMVQGRTP 
301 350 
TetA. con . QA.. V .... .......... . G...... G. . K.. A.. G.. .. A.. 
LLA. A 
TetAcon. frg fQA.. v .... .......... . G. fakrfgE . kt. a. 
iG. i ADa. itlafa 
OtrB. frg TQAGLVVIPF MLGTIASQMV SGKLIASSGR FKKLAIVGLG SMAGALLAMA 
351 400 
TetA. con T. G ....... .......... .. G....... .. Q..... 
SQ .......... 
TetAcon. frg t. GWmf.... ..... p.. iL LAGGI. mPAL .. 
Qm.... Sq .. gerQG. LQ 
OtrB. frg TTGATTPMWG IVLIVLWLGV GIGLSQTVIT SMQNSAPKSQ LGVANGASAC 
401 450 
TetA. con .......... .......... ....... 
L.. .......... .......... 
TetAcon. frg G......... ... *. L.. LTs 1T. viGPL. 
f . aI... as.. .......... 
OtrB. frg AGQIGGSTGI AVLFSVMFAV ALGRLADLLH TPRYERLLTD PAITGDPANH 
" 451 500 
TetA. con .......... .......... .......... .......... .......... 
TetAcon. frg .......... .......... .......... .......... .......... 
OtrB. frg RFLDMAESGQ GAGINLDDTS LLNGIDARLM QPVTDSFAHG FHIMFLPGGV 
501 544 
TetA. con .......... .......... .......... ... 
K...... .. A* 
TetAcon. frg .. i. tw. Gwa 
WiiG. AIY.. . 1... rrgaw ... 
k.. t.. E TSA* 
OtrB. frg VLLAGFVMTW FLRELQEETA PEEERPAESG AGAKNGPLPA SDA* 
Figure 4.5: A comparison between the TetA consensus 
protein sequence (Varela and Griffith, 1993) and the 
OtrB protein 
sequence (the oveall concensus sequence 
between TetA and OtrB is 
shown on the top line of the lineup). Conserved 
functional motifs 
within the N-terminal domain are indicated( ný, Q d43ý, ca 
b° X) - As t. 
0+%16 prc+Ot; , Cc vOVU 
1-ßa° 114 t-a.,... s r.. cýº,. wý... ý dýsw. c, º. ý, laps av4- 
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The work of Griffith et al., 1992, has classified the proton- 
motive force transporters into four main groups, the OtrB protein 
seems to show most similarity to the class III members of these 
groups although all of these groups show a degree of 
interelatedness. 
Class I- Sugar transporters such as AraE and Qa-Y are included 
in this diverse group. 
Class II- Contains the TetA, B andC transporters as classified by 
Yamaguchi et al., 1981. This group also contains the NorA quinolone 
resistance protein and Bmr the multi-drug resistance protein. 
Class III- Contains the TetL and TetK tetracycline transporters 
and QuacA. It also contains Mmr the methylenomycin resistance 
protein, ActII-orf2 and actVA-orfl all from S. coelicolor. 
Class IV- Contains transporters for citrate and proline 
transport. 
Therefore analysis of functional motifs of the OtrB protein was 
based on the assumption from other analyses that it was most 
closely related to the members of the Class III family. The motifs 
discussed here are shown on the amino acid sequence of otrB as 
ckot+ 4 regions in Figure 44- 
Motif 1 
L-P 
This is found at the external end of transmennbrane segment 
1, and corresponds to a conserved motif within the functionally 
identified proton-dependent transporters, Tet AraA and QuacA. In 
OtrB only the L residue is conserved. 
Motif 2 
G-X -X -S- D- R/K -X-G-R/E- R/ K 
12 3 4 5 6 789 10 
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This is a highly polycationic motif that was identified by 
Rouch et al. (1990). It begins in the last residue of the 
transmembrane segment 2 and continues through the cytosolic loop 
into the transmembrane segment 3 and has been postulated to act 
as the substrate entrance gate (Yamaguchi et al., 1990). The motif is 
conserved in all four families of transporters, from sugar to 
antibiotics, and is predicted to form a ß-turn structure. 
This is the most highly conserved motif in the N-terminus 
and its residues have been the subject of intense study especially in 
the tetracycline transporters. The two glycine residues at positions 1 
and 8 are essential for the function of the whole motif. They have 
been postulated to fufil a gating function and are important for the 
structure of the polypeptide backbone by maintaining the ß-turn 
structure of this loop. In tetracycline transporters the S-D motif of 
serine 65 and aspartate 66 shows strong conservation. The aspartate 
66 is absolutely conserved in tetracycline export in all Gram-positive 
and Gram-negative organisms (Chopra, 1986), and replacement of 
this residue with another amino acid results in no antibiotic 
transport. This residue is believed to be involved in the recognition 
of substrate. 
The R/K residue at position 10 in the case of antibiotic 
transporters is always an R residue as this is essential for drug 
efflux. The R-X-G-R-R motif was previously identified in the sugar 
transporters (Henderson and Maiden, 1990), and is postulated to be 
involved in the formation of the ß-turn. In ActII-orf2 and Tht15 the 
R/K has been replaced by an R or aQ motif and in OtrB this residue 
has been replaced by an N. 
The OtrB protein has retained total conservation of this loop 
as per the tetracycline transporters ( G-K-L-S-D-I-Y-G-R-N). This is 
strong evidence to suggest that the OtrB protein in S. rimosus 
is 
likely to act as an H+ pump. 
This translocation channel motif can be extended to 
encompass LXXGXXFXXXS (Yamaguchi et a]. 1993). In 
family III 
members a conserved glycine, phenylalanine and serine are 
found 
separated by a turn of the helix (shown in Figure 4.4). 
In OtrB, 
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conservation of the phenylalanine and serine residues, but not of 
the glycine residue, is observed. 
MOTIF 2 IN GENE DUPLICATION 
G-X-X-X-X-R/K-X-G-R/E-R/K 
This conserved motif is the duplicated homologue of not if 2. 
It is found between loops 8-9 in the E. coli tetracycline transporter, 
(12 transmembrane domains) and within the 10-11 loop region of 
streptomycete members of this family (14 transmembrane domains). 
This region is believed to have occurred by an ancestral tandem 
gene duplication event, as it is essentially similar to that in the 2-3 
inter loop region and maintains a similar position in the second set 
of transmembrane domains within the proteins. 
In the OtrB protein this motif is conserved as G-K-L-I-A-S-S-G - 
R-F-K. The location of this motif in the loop 10-11 interloop region is 
believed to occur to form a symmetrical pair with the loop 2-3 
region to form part of the substate translocation pathway, although 
there is a lack of direct evidence to confirm this (Yamaguchi et al., 
1993). In the mutational analysis of tetA(C) by McNicholas at a1., 
(1992) on the duplicated motif, the only mutation which resulted in 
a functional protein was of the first glycine residue. The mutation 
strategy was aimed at the production of stable membrane proteins, 
which showed altered tetracycline efflux activity but left potassium 
transport unaffected. Considering the lack of mutations in the 
duplicated motif, apart from the glycine, which is presumably 
responsible for a similar ß-turn structural role to that in loop 2-3, it 
seems unlikely that the loop has much involvement in the proton 
translocation. The aspartate residue at position 5 which is negatively 
charged has been suggested to form part of an inter-loop salt-bridge 
in the Tn 10/H+ antiporter. 
MOTIF 3 
G -X-X-X-G - P-X-X-G 
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This motif was first identified by Rouch et a] (1990). This 
motif is found in the C-terminal half of the 5th membrane spanning 
region and is 80-100% conserved in all the transporters of classes II 
and III which all direct substrate export. Most of the streptomycete 
members show conservation of this motif. In the OtrB protein the 
first G is substituted by A, but otherwise the motif is conserved as . A- S-V-A-G-P-L-A-G. In mutational analysis on the TetA(C) and TetA(D) 
efflux proteins (McNicholas, 1992) substitution of the final G with a 
charged amino acid was shown to abolish efflux. It is speculated that 
this motif may influence the orientation of the unoccupied 
substrate-binding site which presumably faces inwards for proteins 
that direct efflux, and outward for proteins that direct uptake 
(Griffith et al., 1992). 
MOTIF 4 
W-X-X-V -X-X Y -X-X-X- F/ L 
This motif is found in the transmembrane two region of the 
class III family. Residue I of this motif in class III is a tryptophan 
residue, compared to the observed histidine residue in the Tet 
transporters. ýý5 e %+%) 
The tyrosine residue at position 6 is conserved in class III and 
is also observed in Tn 10 TetA. In TetA this residue is part of a 
conserved and duplicated quartet of residues in transmembrane 
domains 2 and 3 and transmembrane domains 8 and 9 of the 
protein (Yamaguchi et al., 1993). The precise function of this 
residue has not been established, and it is believed to be important 
but not essential for tetracycline transport, as mutation of this 
residue causes a decrease in tetracycline transport but does not 
abolish transport completely (Yamaguchi et al., 1993). 
In OtrB this motif is seen as WATTGYLIAS and lines up with 
the other members of class III transporters. In the class III members 
of the family only QuacA shows a degree of conservation of a similar 
motif (WlqvVeelspfk) where the W and V residues are in the correct 
position preceeding the duplicated motif in the 10-11 loop region. 
However all of the other class III members, except Thtl 5 contain a 
glutamate residue at a similar position and within what should be 
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this duplicated motif. Yamaguchi et al. (1993), identified a similar 
glutamate preceeding the loop 8-9 region. However, in the class III 
family if this is a duplicated motif it appears to lie further away 
from the 10-11 loop motif than the comparable one in the 
preceeding region to loop 8-9 of TetA. 
4.2.6 Dotplot analysis. 
Dotplot analysis of the OtrB protein with members of the class 
III family of transporters is shown in Figure 3.6. A further dotplot 
analysis with two other members of family III the QuacA protein 
from S. aureus and Tht15 from Bacillus subtilis, is shown in Figure 
4.6. 
It is observed that the similarity between the OtrB protein and 
QuacA appears to extend only over regions of the functional motif: s 
that, as discussed previously, are common to class III family' 
members. The same observation can be made for Oti-B in 
comparison with Thtl5 (conserved regions are indicated in PILEUP, 
Figure 4.4). 
4.3 The Antiport system. 
The resistance mechanism is based on the active efflux of the 
antibiotic out of the cells driven by a proton gradient ((ýc,,,,, e. ho .) 
1985). The efflux is electrochemically neutral indicating the 
presence of a 1: 1 stiochiometrical exchange of a metal-tetracycline 
complex and a proton. However, no direct evidence has been 
obtained that tetracycline transporters can carry protons. 
A substrate/H+ antiporter principally requires at least three 
features: 
i) A substrate binding site(s), which fluctuates between high 
and low affinity states. 
ii) At least two gating sites, one on the cytoplasmic and one on 
the periplasn-iic side of the protein. These should open and close 
together with the affinity change of the binding states. 
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Figure 4.6: Dotplots of OtrB efflux protein against the QuacA 
efflux protein from S. aureus and the Thtl 5 gene from B. subtilis. 
"Window" at 40 and 'stringency" at 20. 
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iii) A H+ transfer site(s) where protonation and de- 
protonation will affect the affinity of the binding site(s) and maybe 
even the opening and closing of the gates. 
4.3.1 Conservation of transmembrane charged 
residues 
Three transmembrane aspartyl residues Asp 15, Asp84 and 
Asp285, were found in the tet/H+ antiporter protein of Tn 10 
(Yamaguchi et al., 1992a). It has been suggested that Asp15 and 
Asp84 form a substrate-binding pocket, where the substrate enters 
the gate at loop2-3, passes up helix-3 and enters the pocket. 
Furthermore Asp285, a likely candidate as the duplicate to Asp84, in 
the C-terminal half of the protein, could possibly form an ion pair 
with the sterically-close His257 (Yamaguchi et al., 1992a). 
This pattern is not retained even among some of the 
tetracycline efflux proteins and certainly not across the transport 
protein super-family. Only the transmembrane 1 aspartyl residue, 
corresponding to Aspl5 has been well conserved (Henderson, 1990). 
In general the location of this aspartyl residue within the helix 
appears to vary between transporters. In the OtrB protein the 
residue is in a reasonably conserved location, occurring at position 
14 of the proposed protein sequence. With regard to the tandem 
duplication theory an equivalent residue to Asp15 is not found in 
transmembrane domain 9. 
His257 of the TnlO antiporter, was proposed to form an ion 
pair with the aspartate in transmembrane region 9 (Yamaguchi et 
al., 1992a). This histidine is not conserved among the class 11 and 
class III efflux proteins, as various substitution mutants have been 
shown not to retain tetracycline export activity indicating that it is 
not essential for function. It has been suggested that the aspartate of 
the transmembrane region 9 in the TnlO antiporter might be a 
common binding site for both the substrate and proton, the 
competition for which at each gate, enables the antiport activity 
(Yamaguchi et al., 1992a). 
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4.4 Membrane topology 
In considering the topology of the OtrB protein in the 
membrane, the work of Eckert and Beck (1989) on the topology of 
the Tn10 tetA protein would suggest that both the N and C-termini 
are on the cytoplasmic side of the membrane. Using 35S-methionine, 
TetA was shown to have an unprocessed N-terminus in the 
cytoplasm. The C-terminus was located in the cytoplasm through 
carboxypeptidase A digestion. Although proteolytic digestion was 
used to determine loop positions, periplasmic loops were not 
susceptible to digestion. This finding led to two possibilities, either 
that the hydrophilic domains entering the periplasm are not large 
enough to be recognised by the proteases, or that they are somehow 
shielded by their conformation. 
Given that the N-terminus of the OtrB protein is not much 
longer than the TetA protein, and that there is no run of 
hydrophobic residues preceding the homologous transmembrane 
region 1, it can be assumed that both the N and C termini will be 
located in the cytoplasm. The model proposed for the Class III family 
of transporters is characterised by the Mmr methlenomycin efflux 
protein from the S. coellcolor plasmid SCP1 and can be assumed to 
be representative of what the OtrB protein topology would look like 
as it shows the conservation in many of the important residues 
(Figure 4.7). 
fti 
tlfm t'l I Lir 
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Figure 4.7: Membrane topology of the mmr export protein 
from the SCPI plasm id of S. coelicolor (From Griffith et al., 1992). 
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4.5 Discussion 
Until recently there was scarce information about the amino 
acid sequences of integral membrane proteins that transport small 
molecules such as sugars, antibiotics and ions across the cell 
membrane. The advent of cloning and sequencing technology for ýI 
multitude of genes coding for these proteins, has resulted in the 
amino acid sequences being determined, and has allowed 
relationships between these proteins to be characterised. 
A statistical comparison between many membrane transport 
proteins obtained was generated from the SWISSPROT database and 
compiled by Griffith et al., (1992) using the ALIGN programme fron 
GCG. This has allowed a classification of these membrane transport 
proteins into four main classes as discussed in the results section. A 
proposed tree of the evolutionary relationships between the proteins 
is shown in Figure 4.8. 
Comparison between the amino and carboxy terminal halves 
of the antibiotic transporters showed a significant pattern. The 
amino-terminal halves of the proteins contain a significant degree of 
conservation, whereas the carboxy terminal halves show very little 
conservation. Therefore, the N-terminal half of the protein is 
predicted to be involved in the antiport/H+ mechanism, whereas the 
carboxy terminus of the protein is predicted to be involved in 
substrate recognition. Numerous studies have shown that the 
transport of antibiotics via a transmembrane efflux protein is very 
specific in each bacterial species. The Tet transmembrane efflux 
proteins exhibit a complex recognition system and will only 
transport the antibiotic(s) that they produce and not closely related 
derivatives (Hunter, personal communication). The mechanism for 
this specificity has yet to be elucidated. However, it can be 
speculated, from the work of Yamaguchi and colleagues, that 
mutational studies on the carboxy terminal half of a particular 
export protein could provide an indication of particular residues 
that may be involved in substrate recognition. These observations 
are strengthened because the amino and carboxy termini of 
transporters that transport structurally-similar substrates are highly 
conserved within families of proteins. 
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Figure 4.8: The evolutionary "tree" of the four classes of 
electrochemical transporters. (From Griffith et al., 1992). 
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Although the four families of membrane transport proteins 
may seem totally dissimilar, it is believed that they descended from 
a common ancestor as shown in Figure 4.8 (Chopra, 1985). The OtrB 
protein is most similar to the Mmr protein and has been indicated as 
such in Figure 4.8. The evidence for the common ancestor is based 
on several pieces of evidence (Griffith et aL 1992). 
i) They have a similar structure of 12,13, and 1-4 
transmembrane domains, and can be aligned using their N -terminal 
regions. 
ii) There is a high degree of conservation within the classes of 
transporters and also between the classes of transporters. 
iii) As discussed in the results section, there is an observed 
conservation of particular motifs. Certain motifs are conserved 
across all classes of the membrane transporter. 
iv) There is an observed motif duplication between the N and 
C-terminal of nearly all of the super-family (the 2-3 and 8-9/ 10-11 
inter domain regions). 
The occurrence of the duplicated sequence motifs in the 
super-family at topologically similar locations, is highly conserved. 
The presence of such motifs indicates that the proteins probably 
evolved, via an internal gene duplication event, from an ancestral 6 
helix transporter and then arranged as two bundles of 6 (or 6+2+6) 
in the case of those in class III. Little is known about the tertiary 
and quaternary structures of these proteins. However, in the related 
lactose transporter, electron microscopy has revealed that the two 
domains are separated by a cleft (Ki and Tooth, 1987). 
Two hypotheses exist about the arrangement of the six 
transmembrane helices. The helixes are arranged as two bundles of 
6 helices and located about a two-fold axis of symmetry. The C- 
terminal domain forms a separate substrate-binding cleft or channel 
with the transmembrane domains arranged so that those joined by 
adjacent short extraneous loops are adjacent. There is no inter- 
domain relationship (Baldwin, 1991). The charged residues from 
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both domains form symmetrically about a central translocation 
channel. A duplicated quartet of residues have been identified which 
would appear to act functionally as pairs between the two domains 
(Yamaguchi et al., 1992 and 1993). However, there is little 
conservation of these quartets among members of the super-farn i lvv 
making this hypothesis not globally true. The in ik-o assembly of 
the N and C terminal halves of the Tn 10-encoded tetA protein 
expressed separately in E. coli, proved that the N and C terminal 
halves of the protein could insert into the membrane independently 
supporting the above hypothesis. (Yamaguchi et al., 1993a). 
The OtrB protein is clearly a member of the super-fancily of 
electrochemical membrane transporters. It shows extensive 
similarity with the members of the class III family (Figure 3.6). in 
dotplot comparisons with the otrB gene product and members of the 
class III family of transporters. Also the conservation of particular 
functional motifs within the OtrB protein both at the inter class level 
and also at the super-family level, as discussed in the results section, 
indicates its place as a member of the super-family of drug-efflux 
transporters. 
Several main questions still remain unanswered about this 
super family of transporters. The specific residues involved in 
substrate recognition are still to be characterised. Yamaguchi er ail. 
(1992a) made an attempt at addressing this question for the Teti\ 
transporter. Unfortunately their observations do not apply to all of 
the families. However, similar experiments can be used as a basis for 
similar studies with other transporters. The exact H+/antiport 
mechanism for each transporter and the residues involved need to 
be characterised. The mechanism by which drug transporters 
recognise only one antibiotic and not closely-related structural 
isomers, needs to be explored. Finally the question of the differences 
in membrane-spanning regions needs to be addressed. 
The question of the evolution of membrane spanning regi, )ns 
is an interesting one. Hydropathy analysis and alignment of 
conserved motifs revealed that both eukaryotic and prokaryotic 
membrane proteins can be divided into two separate families with 
either 12 or 14 transmembrane segments. Conserved motifs 
have 
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been identified which are either characteristic of each 12 or 14 
transmembrane family or conserved in both families. The 
conservation of these motifs suggests that they may be essential or 
necessary for the function of the proteins. Phylogenetic and 
structural analysis revealed that the two families may have evolved 
from a common ancestor with 6 transmembrane domains (Chopra et 
a1., 1992 ). The phylogenetic tree in Figure 4.7 as deduced by Griffith 
et a] (1992), suggests that the sugar and antibiotic transporters 
evolved in parallel from a common 6 transmennbrane ancestor. 
Therefore the addition of two extra transmembrane domain in some 
of the transport proteins remains to be investigated fully. 
4.6 Future work. 
For the further analysis of the OtrB protein several questions 
should be studied: 
i) Does the OtrB protein exhibit specific substrate transport? 
ii) If the OtrB protein is placed in an E. coli cell does it still 
transport oxytetracycline or tetracycline, will the 14 transmembrane 
domain be assembled in the membrane or will the cell favour 12 
transmembrane domains? 
iii) Mutagenesis studies to determine the functional motifs of 
the OtrB protein and to elucidate the H+ /antiport mechanism. 
iv) Membrane topology studies to determine the cytosolic 
loops of the protein and its orientation within the cell membrane. 
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Chapter 5 The otrR gene 
5.1 Introduction 
Tetracycline efflux resistance genes are widespread among 
Gram-negative bacteria. Sequence analysis of these genes kind 
surrounding regions has revealed the existence of two genes 
involved in the export of the antibiotic product; tetA (resistance) 
and tetR (repressor) ( Klock et al., 1985). Resistance of Gram- 
negative bacteria against tetracyclines is triggered by drug 
recognition of the Tet repressor. This causes dissociation of t the 
repressor-operator DNA complex and enables expression of the 
resistance protein TetA, which is responsible for active efflux of 
tetracycline (Hinrichs et al., 1994). 
In each case, among four different classes of resistance 
determinants (A, B, C and D), these genes have divergent polarities 
and overlapping promoters located within the intercistronic region. 
The plasmid or transposon encoded tet genes are characterised into 
defined groups based on the absence of DNA homology measured by 
DNA-DNA hybridisation, together with some differences in 
resistance levels to tetracycline and some of its analogues. Since 
1991, it has been recognised that antibiotic efflux resistance genes 
in Streptomyces sp. may also possess a similar genetic organisation, 
consisting of a resistance and repressor gene with divergent 
polarities and overlapping promoters (Neal and Chater, 1991, 
Cabellero et a1., 1991 and Guilfoile and Hutchinson, 1992). 
From sequence analysis of the otrB resistance gene and 
upstream region (Chapter 3), it became apparent that Streptoni -ces 
rimosus might share a similar organisation of efflux/ repressor gene 
organisation. The upstream region of the otrB gene appeared to 
contain several putative divergent translational start sites. 
CODONPREFERENCE indicated the presence of a small upstream 
reading frame. The similarity between the tcmA gene and the otrB 
gene suggested that, if the architectures of the regions were similar, 
the gene upstream of otrB might be a repressor. 
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5.1.2 Aims of the project 
a) To complete the sequence of the otrR gene. 
b) To characterise the otrB/otrR intergenic region. 
c) To analyse transcription of the otrR gene. 
orf 1 
44 otrR 
otrB - ýmjolo- 
CSHH Ba 
-dm 
(a) 
* (b) 
-: (c) 
4___ (e) lKb 
Figure 5.1: Restriction map of the "right" end of the 
oxytetracycline cluster. The location of the otrR gene is shown in 
relation to the location of the otrB and the probable location of or! ] 
(not confirmed by transcriptional data as yet, sequence date 
provided by Kim et al., 1994). (a) denotes sequence obtained by 
using the smh 5 oligonucleotide. (b), (c), (d) and (e) denotes 
sequence obtained by using universal primer to sequence \113 
subclones in the indicated regions. For simplification only the 
restriction sites that are relevant to the position of the otrR gene are 
shown. B, Bg1I; S, Sacl; H, Hincil; Ba, BamHI, N, Norl. 
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5.2 Computer assisted analysis of the otrR gene 
Analysis of the otrR gene sequence was carried out using 
various programs from the Sequence analysis software packag; tý, 
version 7, compiled by the Genetics Computer Group at the 
University of Wisconsin (GCG 7) (Devereux er al., 1984). These 
programs and their basis of analysis are described extensively in 
Chapter 3. 
5.2.1 Frame analysis of the otrR gene (potential 
protein coding regions) 
Potential protein coding regions were identified in the 54 
base pair fragment using the CODONPREFERENCE program. This 
revealed one major coding region within the 543 base pair region of 
DNA sequence. 
Three potential start codons, a GTG at nt 43, a ATG at nt 47 
and a GTG at nt 87 were identified for the coding region. 
The otrR sequence data were analysed by the 
CODONPREFERENCE programme on GCG7 (Figure 5.2). This analysis 
indicated that the sequence data consisted of one continuous open 
reading frame, with the predicted translational start site identified 
as the GTG at nt 87. The presumed translational stop site was 
identified as a TGA at nt 537. 
5.2.2 Sequencing strategy for the otrR gene 
A summary of the sequencing strategy for the otrR gene and 
its position relative to other genes within the right end of 
oxytetracycline production cluster are detailed in Figure 5.1. 
The Hincll/Hincll and HinclI/Sacl DNA fragments were subcloned 
into both M 13mp 18 and M 13mp 19 (methodology, section 2.2.10) as 
summarised in Figure 3.1. 
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Figure 5.2: CODONPREFERENCE analysis of the otrR gene 
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Single-stranded DNA template was produced (methodology, 
section 2.3.17), and sequencing was performed by using the 
SequenaseTM(USB) sequencing kit as detailed, (section 2.3.18). The 
smh2 oligo5 oligonucleotide, which was originally designed to 
identify the transcriptional start point for the otrB gene was used to 
sequence over the HincIl restriction site and into the Hinc II Sac I 
region. The localisation of otrR, identification of the otrR 
transcriptional start site and the construction of oligonucleotides for 
DNA sequencing and transcriptional mapping were carried out 
within this work. The region upstream of orfl was analysed in 
collaboration with Dr. K. J. Linton, a postdoctoral researcher within 
the laboratory who was sequencing the PKS of Streptomyces rimosus 
including the orfl. Figure 5.2 shows the completed otrR DNA 
sequence, including relevant restriction sites and oligonucleotides. 
The sequence from 111 base pairs upstream of the HinclI/ 
Sacl fragment to the end of the otrR gene is comprised of 543 base 
pairs and has a base composition of 72.5% G+C. The otrR gene is 
comprised of 453 base pairs and has a G+C content of 76%. The 
annotated sequence including the amino acid sequences of the 
potential protein coding regions and the location of restriction sites 
is shown in Figure 5.3. 
The sequence data generated were read and sequenced 
several times to eliminate error and entered into computer files 
using the assembler/editor program SEQED (Devereux et al., 1984). 
5.2.3 Data base analysis of the otrR gene product 
The otrR gene product is an amino acid of 151 amino acids. 
Using BLAST, comparison of the predicted amino acid sequence of 
otrR to protein sequences held in the NCBI Protein database 
revealed that the greatest similarity was to the tcmR gene product 
from the tetracenomycin producer Streptomyces glaucescens (47% 
amino acid similarit\'). This similarity is not unexpected as the otrB 
gene product shows substantial similarity with the tcmA gene 
product and the divergently transcribed tcrR product is located in 
the region upstream of tcmA (discussed extensively in Chapter 3). 
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- 
smhl of i go5 (see Figure 3.3 for exact sequence) 
TTTTGACGAGGTCTTGTCGTTCTCCGGGGAGTAACATACGCTGTGGCCATGGATTCCTCA 
---------+---------+---------+---------+---------+---------+ 60 
AAAACTGCTCCAGAACAGCAAGAGGCCCCTCATTGTATGCGACACCGGTACCTAAGGAGT 
Hi ncl ! 
GCCCCTGACCTGGCCGCTCTGATCGA GT CCGCCGAGGTCTTCGCGGTCAACGGCCGC 
61 ---------+---------+---------+---------+---------+---------+ 120 
CGGGGACTGGACCGGCGAGACTAGCTCCACTGGCGGCTCCAGAAGCGCCAGTTGCCGGCG 
ValThrAlaGluValPheAlaValAsnGlyArg 
CTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAG 
121 ---------+---------+---------+---------+---------+---------+ 180 
GACGAGGCGCT-TCCGCTGTCGGAGTGGCGGGTGCGCCCCGACTGGAGCCGCGCGACCGTC 
LeuLeuArgGluGlyAspSerLeuThrAlaHisAlaGlyLeuThrSerAlaArgTrpGln 
GTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGG 
181 ---------+---------+---------+---------+---------+---------+ 240 
CACCGGCCTGACGACGACTCGCCGGGGAGCTGCCAGCGGGCGGACCGGGCGCTCGCCCCC 
Val Ala GlyLeu Leu Leu SerGlyPro SerThrVal AloArg Leu AIaArg GluArg Gly 
CTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACG 
241 ---------+---------+---------+---------+---------+---------+ 300 
GACGCCGCCGTCCGCCAGGTCGTCTGGCAGCTCGCCGACTTCCGGCTCCCGCAGCAGTGC 
LeuA rgA rgGlnAlaValGlnGlnThrValGluArgLeuLysAlaGluGlyValValThr 
Sad 
I 
ACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGG 
301 ---------+---------+---------+---------+---------+---------+ 36,0 
TGGGCCGGGTTGGGCGTCCTGGTCGCGTCGGGGGACCAGCTCGAGTGGCGTGCGCCGGCC 
ThrArg Pro AsnPro GlnAsp GlnArg SerPro Leu Val GluLeu ThrAIaArg GlyArg 
CAGGGGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGAC 
361 ---------+---------+---------+---------+---------+---------+ 420 
GTCCCCGACCTGCTGGACGCAGGGGACCTTGCCGCCACCGACCTCATAGACCGGCTCCTG 
G1nGlyLeuAspAspLeuArgProLeuGluArgArgTrpLeuGluTyrLeuAlaGluAsp 
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ATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTG 
421 ---------+---------+---------+---------+---------+---------+ 480 
TAAGGCCAGCTCCTGTACGCGCACCGCTAGCGCCACGACTCGGCGGACGCCCTCTTCGAC 
IleProValGluAsp'MetArgValAlaileAlavalLeuSerArgLeuArgGlu'LysLeu 
GACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCC'GA 
481 ---------+---------+---------+---------+---------+---------+ 540 
CTGCGGGCAGGCCGCTGCCTCAAGCCCTGGCCCCGGCCCAGGCCCGCCGTCAGGCGGACT 
Asp Ala Arg Pro Ala ThrGluPheGlyThrGlyAla GlySerGlyArg GlnSerAla End 
Not I 
GCG 
541 --- 543 
CGC 
Figure 5.3: The annotated sequence of the otrR 
gene and 
upstream region. Relevant restriction 
sites and the translational 
start and stop sites are indicated. 
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The deduced gene product of the tcmR resembles repressor 
proteins encoded by the tetR regulatory genes from E. coli and the 
actll-orfl gene from S. coelicolor (Guilfoile and Hutchinson, 1992). 
However, the deduced tcmR protein contains 226 amino acids, 
whereas the otrR gene product appears to be slightly smaller at 1-1 
amino acids. 
The tcmR protein is similar to several tet resistance repressors 
including the Tn10 protein, particularly in the N-terminal region 
that has a potential helix-turn-helix motif. The tcmR gene product, 
as shown by gel retardation studies, binds to the tcmA-tcmR 
intergenic region in vitro and inhibits transcription of the tcmR and 
tcmA genes. The binding of tcmR to the intergenic region is 
inhibited by tetracenomycin C, supporting the model that the tcniR 
protein acts as a repressor in inhibiting transcription of the tcn7A 
and tcmR genes. 
The next most similar gene product to the otrR gene was the 
Ecoli multiple antibiotic locus (mar locus) showing 46% similarity 
at the amino acid level- only slightly less than that of tcmR. On 
further analysis this similarity of otrR to the mar gene locus was 
defined as similarity to the marR gene product. The marR gene 
product is 145 amino acids long and is of similar length to the 
predicted otrR gene product (151 amino acids). The marR gene 
product is thought to act as a repressor of the marO gene product 
in E. coli (Cohen et al., 1993). Introduction of extra copies of marR 
already containing the mar locus led to increased susceptibility of 
the E. coli cells to tetracycline, chloramphenicol and norfloxacin 
when assayed by gradient plate analysis. High copy number 
plasmids containing the marO gene product, when introduced into 
wild-type Ecoli cells, led to an observed increase in the resistance of 
the cells to the three afore-mentioned antibiotics. This evidence 
suggests that the marR gene product represses expression of the 
marO gene, increasing the susceptibility of E. coli cells to attack 
h\ 
tetracycline antibiotics. The marA phenotype is induced 
by 
tetracycline. 
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Figure 5.4: DOTPLOT analysis of the otrR protein against 
the a) actII-orfl protein, b) the marR protein and c) the tcmR 
protein. "Window" =30 and "stringency"= 15. 
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5.2.4 Dotplot analysis of the otrR gene. 
Dotplot analysis of the otrR gene product was compared with 
similar efflux-associated repressors. The otrR gene product when 
compared with other Streptomyces repressors did not appear to 
show substantial similarity in Dotplot analysis. The comparison 
between the actll-orfl gene product and the otrR gene product is 
shown in Figure 5.4. The dotplot indicates conserved regions over 
the whole of the proteins with no directly defined region. A greater 
similarity was observed when the otrR gene product was compared 
with the marR gene product. The similartity between marR and otrR 
can be observed in Figure 5.4. The region of similarity between 
these two gene products is defined between amino acids 65-95. The 
region between 50-100 amino acids in the tetA repressor from Tnl0 
has been defined as part of the tetracycline binding pocket 
(Hinrichs et al., 1994). It could hypothesised be that the region of 
similarity between the otrR gene product and the marR gene 
product reflects a similarity in this region. 
5.3 Transcriptional analysis of the otrR gene 
Primer extension was carried out using an oligonucleotide 
primer, smh 1 oligo 1 (Figure 3.2), 3Ont upstream of the three 
presumptive translational start sites for the otrR gene product. From 
CODONPREFERENCE analysis, it was assumed that the most probable 
translational start site was the GTG at nt87 and, by using 
oligonucleotide smhl oligol the transcriptional start point for the 
otrR gene could be detected and confirmed. RNA was isolated fron 
an oxytetracycline-producing strain of Streptomyces rimosus at 
various timepoints during oxytetracycline production as detailed, 
Chapter 2 section 2.3.2. Different oxytetracycline timepoints were 
used to establish whether differences in otrR expression could 
be 
observed at various stages of antibiotic production. The results are 
shown in Figure S. S. 
From the transcriptional analysis an increase in the 
transcriptional signal from the otrR gene product can be observed. 
Similar observations have been made for the P2 promoter of tcmR 
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(Guilfoile and Hutchinson, 1992), the ActII-orfl repressor gene t 
Streptomyces coelicolor (Cabellero et al., 1991) and the ninir 
repressor gene on the Streptomyces coelicolor plasniid SCP1 
(Chater and Bruton, 1985). The tcmR gene product has t \\ 
promoters PI and P2, similar to the tetracycline repressor/opei-ator 
regions. PI is inducible and translation of Tcm R from mR\A 
initiated at PI inhibits expression of tcmA (export protein) in the 
presence of tetracenomycin production. The expression of P2 is 
constitutive in the absence of tetracenomycin allowing repressi0>n of 
the tcmR gene product and expression of the tcm, A gene product to 
produce a membrane protein for export of the produced antibiotic. 
For the Actll-orfl repressor and the mmr repressor only one 
promoter is observed whose expression is inducible analogous to the 
tcrnR P2 in the presence of the produced antibiotic. 
Although the primer extension analysis for the otrR gene 
product is faint, it is observed to be induced over the course of 
oxytetracycline production. This poor primer extension analysis 
may be explained as follows: 
a) The RNA used (20pg- i. e. the same for primer extension 
analysis of the otrB gene product) was an insufficient amount to 
observe induction of the transcript. Therefore at the chosen 
timepoints, the otrR mRNA was not abundant. 
b) The RNA timepoints used to map the 5' end of the otrk 
transcript were during antibiotic production when the expression of 
the otrR transcript would be repressed. Therfore, much earliei 
timepoints should have been used to detect the otrR gene transcript. 
From the preliminary results presented here it would apj)ý-. Irr 
that the otrR gene is transcribed from only one promoter similar to 
that observed in transcription of the actll-orfl repressor and ninir, 
repressor, although this requires futher experimenidi irýtiýsti atiý>n 
to confirm this. 
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5.4: Characteristics of the otrR gene and upstream 
region 
Proteins involved in transcriptional regulation recognise 
specific DNA sequences through the properties of discrete DNA 
binding domains. These domains are, in general, relatively small. 
Several structures have been studies. The most extensive work has 
been centred on the helix-turn-helix motif (H-T-H). The otrR protein 
product is similar to several tetracycline resistance gene repressors, 
and the tcmR protein, particularly in the N-terminal region. Guilfoile 
and Hutchinson (1992) identified that the tcmR gene product had a 
putative helix-turn-helix DNA binding motif, as did the Tn 10 tetR 
repressor and the Actil-orfl repressor. It has been shown 
experimentally that the H-T-H motif can recognise particular DNA 
sequences by studies involving the lac and lambda repressors. These 
repressors are characterised by containing H-T-H motifs and being 
preceded by specific operator sites on the DNA that can be 
recognised by the H-T-H motifs (Harrison and Aggarwal, 1990). 
An H-T-H motif is usually a twenty residue segment 
corresponding to particular residues. Residues 4,8,10,16 and 18 are 
usually hydrophobic as they define the interior of the two-helix 
elbow. Residue 5 is likely to be a glycine or an alanine residue as 
longer side chains disturb the geometry of the second helix. Residue 
9 is frequently a glycine and no prolines should be found at the 
internal positions of the two helixes. A comparison between the oti R 
protein sequence with tcmR, Actil-orfl and the Tn 10-tetR protein 
sequences reveals the occurrence of a putative R-T-H domain 
(Figure 5.6). The putative otrR H-T-H motif shows several of the 
conserved features: residues 4,8,10 and 15 are hydrophobic, aind 
it 
does not contain any proline residues. 
The otrR putative repressor H-T-H motif lies near the 
beginning of the protein. This may suggest that it may not 
be a true 
H-T-H motif. This would need to be investigated further. 
It has been 
suggested that not all Streptomyces repressors need 
H-T-H motifs to 
function. Therefore, it might be expected that a true H-T-H motif 
may not exist in the otrR gene. In the marR gene product 
no 
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obvious region has similarity with H-T-H motifs. Since the otrR gene 
is similar in length and shows high similarity to the marR gene 
product, it might function in a similar manner. 
Another main characteristic of these H-T-H repressors is the 
presence of upstream operator sequences as identified for the 
tetracycline resistance/repressor systems. Operator sequences in the 
four classes of tetracycline resistance/repressor gene clusters, have 
been shown to be palindromic sequences recognised by four 
repressor subunits per control sequence but with different affinities 
(Klock et al., 1985). There are two duplicated operator sequences in 
the tetracycline effl ux/ repressor region of each of the four classes of 
tetracycline exporters. The only observed difference between them 
is their positioning relative to the transcriptional start sites for the 
resistance and the repressor genes (Figure 5.8). 
The crystal structure of the homodimeric Tet repressor 
complexed with tetracycline-Magnesium reveals detailed drug 
recognition. The orientation of the operator-binding helix-turn-helix 
motif of the repressor is inverted in comparison with the other DNA 
binding proteins. The repressor-drug complex is unable to interact 
with the DNA because of the separation of the DNA binding motifs 
which is 5 angstroms wider than usually observed. This results in 
the repressor being unable to interact with the Tet efflux DNA 
transcriptional region, thereby allowing transcription of the Tel 
efflux gene (Hinrichs et al., 1994). TetA couples the efflux of 
tetracycline in a complex with a divalent metal ion with the uptake 
of a proton (Kaneko et al., 1990). The Tet repressor regulates the 
expression of this antiporter at the level of transcription. 
In the absence of tetracycline, tetR binds to two tandem 
operators of nearly identical palindromic sequences, thereby 
preventing expression of tetR and tetA (Hillen et a], 1983). In the 
presence of tetracycline, as the affinity of the Mg-Tc complex 
for 
tetR is stronger than that for the ribosome, the expression of the 
resistance protein is initiated and tetracycline is removed from the 
cell before inhibition of protein synthesis occurs. 
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Figure 5.5: Primer extension analysis of the otrR gene to 
locate the 5'end of the transcript. Lanes 1-3 contain RNA from an 
Pfizer oxytetracycline production strain fermentation at 48hrs, 
64hrs and 72 hrs respectively. Lanes 4-7 indicate the 
dideoxynucleotide sequence A, C, G, T. The presumptive 
transcriptional start site is indicated by an asterix. 
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OtrR. frg .......... ....... 
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Figure 5.6: A comparison of presumptive electrochemical 
membrane protein repressor regions indicating a presumptive 
HELIX-TURN-HELIX motif. (shaded region). tetr=Tn10 TetR protein 
(Postle et al., 1984). actii-orfl= ActII-orfI protein from S. coelicolor 
(Calbellero et a1., 1991), tcmr= TcmR protein from S. glaucesens 
(Guilfoile and Hutchinson, 1992). and otrR= otrR protein from 
S. rimosus (this work). 
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On analysis of similar resistance/ repressor intergenic regions 
in Streptomyces antibiotic producers, it was observed that several 
clusters contained palindromic sequences that could be presumptive 
operator sites. Repressor/operator sites for H-T-H containing 
proteins could be assumed to show a consensus homology as certain 
nucleotides will allow strong binding between the repressor protein 
and the DNA. For the bacteriophage 434 like repressors the operator 
sequence has a consensus of 5' AACAXXXXXXTTGT 3. Variations in 
the AACA 5' region strongly diminish repressor binding. 
In the intergenic region of the otrB/otrR, tcmA- tcrnR and 
ActII-orf2/ActII-orfl resistance/repressor gene clusters, the 
bacteriophage 434 operator sequence is highly conserved near thou 
-35 region of the repressor sequence. Therefore it could be 
hypothesised that intergenic regions in these Streptomyces 
exporter/ repressors contain operator sequences that function in a 
similar manner to the H-T-H motif recognition of bacteriophage 434 
operator sites. The sequence of the otrR exporter/ repressor 
intergenic region with highlighted putative operator regions is 
shown in Figure 5. -- and the relationship of the tcmR and Actil-orfI 
bacteriophage 434 operator sequence and -35 box is shown in 
Figure 5. IS- Many of the presumptive operator sequences form part 
of inverted repeat structures. In the case of the tcmA/tcmR region 
these inverted repeat regions with operator sequence upstream bind 
the repressor (as shown by footprint analysis; Guilfoile and 
Hutchinson, 1992b). 
The Tet repressor structure has recently been defined by 
Hinrichs et a1., (1994). The asymmetric unit of the crystal structure 
of the repressor protein contains the Tet R monomer with one 
tetracycline molecule and one magnesium ion bound. The 
polypeptide then folds into 10 alpha helices with interconnecting 
loops and turns. Two monomers are related by a twofold axis of 
symmetry (as defined by crystallographic studies), to form a 
dinier 
which is observed to be divided into the protein core and the two 
DNA binding domains. The protein core is responsible for the 
stability of the dimer and is the regulatory domain of the tet 
repressor, as it contains the tetracycline binding pocket. 
The 
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CCGTTGACCGCGAAGACCTCGGCGGTCACCTCGACAGAGCGGCCAGGTCA 
1 --------------------------------------------------50 
GGCAACTGGCGCTTCTGGAGCCGCC TG GCTGTCTCGCCGGTCCAGT 
GGGGCTGAGGAATCCATGGCCACAGCGTATGTACTCCCCGGAGAACGACA 
51 ---------------------------------------+----------100 
CCCCGACTCCTTAGGTACCGGTGTCGCATACATGAGGGGCCTCTT CTGT 
-35 
AGACCTCGTCAAAAGCCGCGGCGGTGATTACGCTCGGCACCCGGCCTCGG 
101-----------------------------+-------------------+ 150 
OrCTGGAGCAGTTTTCGGCGCCGCCACTAATGCGAGCCGTGGGCCGGAGCC 
TGCCGATGGTGAACAACGTGTGTGTACGGGGCCGGAAGCGCCGGCCAGGA 
151 --------------------------------------------------200 
ACGGCTACCACTTGTTGCACACACATGCCCCGGCCTTCGCGGCCGGTCCT 
-35 
GAGTGAGGAACCGTGTCATCCGCAAATCCGGGCCCGGCGGGCACGG GGA 
201 --------------------------------------------------f 250 
CTCACTCCTTGGCACAGTAGGCGTTTAGGCCCGGGCCGCCCGTGCCGCCT 
I CC GGCAGGCGGGGCGTTCACGCATCGGCAGATCCTGACGGCC TG CGG 
251-------------------+---------+-------------------+ 300 
GGTCCGTCCGCCCCGCAAGTGCGTAGCCGTCTAGGACTGCCGGTACAGCC 
Figure 5.7: The otrB' otrR intergenic region. -35 regions of 
the otrB and otrR genes are indicated. (Calculated according to 
Strohl., 1992). Presumptive operator sites for the otrR protein are 
also indicated by bold lines. Translational start sites are indicated 
by bold boxes. 
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CACCCGCCAACCCTATCTTGCGCCACCTGGTGACACCTGCATGCG GTC TGTGAC 
-----rte ------------------------------ 
---------_f"__ -___-- 
VV [: aGGCGGTTGGGATAGAACGCGGTGGACCACTGT-- 
ACGT GCTAACAGTTTACACTG 
35 
TGCTGTTAGCTTCGGGGCCATGTTCTCCTCGTCACACACGCGTCCGTCCTGCCGGAAATC 
61 ---------------------------------------------w-------------- 
1 20 
ACGACAATCGAAGCCCCGGTACAAGAGGAGCAGTGTGTGCGCAGGCAGGACGGCCTTTAG 
GTTAGGGGGACGCTGAtEE]AGCACGGAAACGCACGACGA 
121 ------------------- . --------------------- 160 
CAATCCCCCTGCGACTTTACTCGTGCCTTTGCGTGCTGCT 
CACGTGCTCCTCATCGTATGGCATGAACGGCCACCGTTTCTTGACGCGACCACCGTTCCA 
1 --------r-----------------r-a-tea---------4- ----------------- 60 
GT CA GAGGA TAGCATACCGTACTTGCCGGTGGCAAAG AACTGCGCTGGTGGCAAGGT 
-35 
TTGTAGAACGGTGGTCGTTCGTGGACCAATAGTCGAGGACCC GGGGA GCC TG 
61 --------- ----______.., _____- ----____--__-_-r____.. --. _- 115 
AACATCTTGCCACCAGCAAGCACCTGGTTATCAGCTCCTGGGCCCCCTGCGGTAC 
Figure 5.8: The presumptive bacteriophage 434 
sites and the -35 regions of the tcmR 
(top) and the 
(bottom) nucleotide sequences. 
operator 
Actll -orfl 
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tetracycline binding pocket is essential for the function of the 
tet repressor and it appears to be this region that may sho\ti the 
greatest similarity between the otrR gene product and the m, -irR 
gene product. 
5.5 Discussion. 
Antibiotic resistance mechanisms can be classed into four 
main groups as discussed in Chapter 1. Antibiotic efflux mediated 
by electrochemical gradients is one of the two export methods of 
antibiotic resistance. This type of resistance is characterised as 
having a resistance/repressor gene organisation. The regulation of 
these genes is mediated by two main types of control (1) induction: 
of transcription of genes by the presence of antibiotic and (2) 
complex repressor-operator interactions. 
Homologous and heterologous repressor-operator interactions 
have been extensively characterised among the four classes of 
tetracycline-resistant (A, B, C and D) determinants in E. coli. The 
similarities in the arrangement, sequence homologies and repressor- 
operator interactions among these four classes demonstrate that the 
tet resistance/repressor genes of all classes possess similar 
methods of transcriptional regulation by related control elements 
(Klock et al., 1985). 
In Streptomyces several regions of the resistance /repressor 
genes are beginning to be characterised. It is predicted that the otrR 
gene product is a putative repressor belonging to this family. 
Comparison of the deduced amino acid sequence of the otrR 
repressor with that of TcmR , ActII-orf 
1 and Tn 10 TetR has revealed 
the presence of a putative helix-turn-helix motif that is 
characteristic of repressor/operator type systems. This observation 
coupled with the analysis of the otrB/otrR intergenic region which 
reveals the presence of putative operator sites leads to a conclusion 
that the otrR gene product is most likely a repressor. 
In S. coelicolor, the ActII-orfl/orf2 operator/ promoter 
arrangement and regulatory connection of an antibiotic 
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export/ repressor gene pair is observed. In the intergenic region, 
two similar palindromic sequences of 15 and 16 base pairs are 
apparent. A longer 31 base pair punctuated palindrome is also seen 
covering the whole region between the -35 regions of Actli-orfl and 
ActII-orf2. These repeats may be involved in the mechanism of 
regulation by serving as recognition sequences for the orf1 putative 
repressor protein. (Cabellero et al., 1991). In the analysis presented 
here it could be concluded that the 1S and 16 base pair palindromic 
repeat sequences are putative repressor/operator sites, whereas the 
larger punctuated palindrome may be involved in another method 
of regulation that involves the actll-orf3 gene as well. 
In the case of the tetracenomycin producer, S. glaucscens, the 
repressor/operator region between the tcmA /tcmR genes has been 
the most extensively characterised in Streptomyces species. DNAase 
footprinting studies have determined that the repressor protein 
binds to the -10 and -35 promoter regions containing sets of 
inverted repeats that allow two adjacent operators to control the 
expression to regulate the tcmA and tcmR pl promoters (Guilfoile 
and Hutchinson, 1992). 
A similar series of inverted and direct repeats have been 
found in divergent promoter regions of mmR/ orfJ12, Quac \ 
(resistance gene from S. aureus), cmlRlcmlA (resistance gene and 
repressor from S. ambofaciens) and now in otrB%otrR - the resistance 
and putative repressor from S. rimosus. The complex nature of 
transcriptional regulation in these systems may indicate that the 
linkage of antibiotic resistance and antibiotic production genes 
ensures that the resistance export mechanism is always 
functional 
when the organism produces or is exposed to antibiotics. 
Stringent 
regulation of these systems, especially the membrane/export protein 
is especially important as the overexpression of this product may 
be 
lethal to the cell by creating too many membrane channels 
(Eckert 
and Beck, 1989). 
All of the characterised streptomycete resistance/repressor 
gene systems have apparent operator sequences that resemble those 
of bacteriophage 434 and some of the other systems, 
for example 
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those associated with QuacA resemble the Cro/lambda operators. 
These operators in bacteriophages control the switch between lyric 
and non-lytic growth, a process which again must be exactly 
regulated for the survival of the phage. These similarities may 
suggest the importance of these operator sites that has allowed their 
strong evolutionary conservation among many different bacterial 
and bacteriophage species. 
Conservation of these complex regulatory regions for the 
resistance and repressor genes is essential, which is not suprising 
considering that under or over regulation of these systems can be 
fatal to the bacterial cell. The high degree of conservation of the 
regulatory mechanisms among bacteria may also suggest: 
a) Antibiotic resistance exerts a global benefit on bacterial 
species allowing this mechanism to be conserved over many 
bacterial species. 
b) The repressor/resistance gene regions are efficient at self- 
regulation. 
c) Mechanisms of the resistance/repressor system between 
bacterial species are very similar, suggesting a common origin. 
The similarity between the repressors at the amino acid level 
is not particularly high. This may be explained because bacterial 
survival will dictate that each step in evolution will result in 
structures which are slightly different from competitors. This point 
may explain why the otrR protein shows significant similarity with 
the marR putative repressor. However the region around the marR 
gene does not appear to be of similar organisation to some of the 
other systems discussed, as it comprises a complex regulon of orfs 
that may characterise its phenotype of multi-antibiotic resistance. 
5.6 Future work 
Future work on the otrB/otrR genomic regions should be in 
several areas: 
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a) Futher transcriptional analysis of the otrR promoter. Is 
there only one promoter as in S. coelicoior systems or are there two 
promoters like in the S. glaucesens system ? 
b) DNAase footprinting of the intergenic region to 
characterise the repressor binding. How many operator sites are 
there? 
c) Crystallographic studies of the otrR and other 
streptomycete repressors need to be initiated and compared with 
those of TetA. 
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Chapter 6 Physiological Investigation 
6.1 Introduction 
At the onset and at stages during this work several 
physiological investigations into the control of antibiotic production 
were explored. The relationship of regulation by phosphate on 
oxytetracycline production and its effect on gene expression at 
different parts of the oxytetracycline gene cluster were investigated. 
Mutagenesis studies were undertaken to produce "knock-out" 
mutants in the oxytetracycline cluster. An investigation of the effect 
of introduction of a plasmid encoding haemoglobin on 
oxytetracycline production strains of S. rimosus was undertaken. 
Antibiotic production, as discussed in chapter 1 is influenced 
not only by internal gene regulation but also by external 
environmental factors. In 1989 a new vector, pIJ2843, was 
constructed that could be used not only to quantitatively monitor 
the expression of regulated promoters in Streptomyces species, but 
also to identifying mutations or factors that altered the expression 
levels of specific promoters of interest (Ingram et al., 1989). The 
promoterless xyIE gene, when placed under control of a promoter 
containing a segment of Streptomyces DNA, allowed detection of 
the promoter contained in colonies through the production of an 
intense yellow colour when the transformant colonies were sprayed 
with a solution of catechol. This allowed clones containing promoter 
sequences to be identified. 
Transposon mutagenesis has also been identified in many 
studies in E. coli as a powerful mechanism for the study of genetic 
regulation, by disrupting targeted genes leading to the identification 
of gene function. In Streptomyces, the Tn3-like transposon Tn4556 
had been isolated and linked to a temperature-sensitive vector 
pMT660 and was expected to produce mutated streptomycete genes 
(Chung, 1987). The 6.8 Kilobase Tn4556, marked with a viomycin 
resistance gene, was shown to be able to transpose from plasmids to 
random locations in the S. 1ividans chromosome and from plasmid 
to plasmid. The applications of this transposon were thought to be 
three-fold. Firstly, transposon mutagenesis could be a valuable 
technique to randomly "knock-out" chromosomal streptomycete 
genes thereby allowing new null mutants to be produced and 
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investigated. Secondly, they are attractive for investigating antibiotic 
synthesis genes in Streptomyces strains, because the enzVmes are 
often difficult to characterise and the genes for a complete pathway 
usually lie within a single cluster (Malpartida and Hopwood, 1984). 
Finally, bifunctional transposon reporter systems could be 
constructed to monitor the expression of primary metabolic genes in 
the vegetative mycelium of Streptomyces species. This would 
facilitate gene transfer between Streptomyces spp. and F. coli and 
help to characterise the molecular genetics of Streptomyces (Neeson 
et al., 1989). 
In industrial antibiotic production one of the main problems 
encountered is to provide an adequate supply of oxygen to 
fermentations. The problem is mainly due to the low solubility of 
oxygen, and also because of the highly viscous properties of 
Streptomyces cultures. For example avermectin production is 
considerably reduced when the dissolved oxygen falls below 20% of 
air saturation (Hughes, personnal communication). As the 
fermentation proceeds large bacterial pellets form whose centres 
have poor access to oxygen. New designs of fermentation vessels 
have improved mixing and gas-liquid dispersion, although this often 
involves the use of high agitation rates which may shear the pellets 
too much, producing an overall reduction in yields. 
The characteristics of the fermentation medium can also be 
altered by adding perflourocarbons to increase oxygen solubility 
within the medium. However this is impractical in large scale 
fermentations. A genetic approach to the problem is to improve the 
cell's oxygen utilisation by introducing genes capable of producing 
proteins which can modify cell metabolism to utilise the oxygen 
more efficiently. A bacterial haemoglobin gene (VHb) from 
Vitreoscilla, an obligate aerobe which lives in oxygen-poor 
environments, has been cloned. 
The expression of VHb in E. coli resulted in an enhancement 
of growth properties and protein synthesis (Hughes and Galazzo, 
1992). Although the mechanisms by which VHb is affecting the cell 
metabolism are not completely understood, there is some evidence 
that ATP production is enhanced by expression of VHb. The \'Hb 
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gene was cloned into high copy pIJ486 and low copt SCP2* plasmids 
and introduced into oxytetracycline producing strains to assess 
whether bacterial haemoglobin could help the culture to utilise 
oxygen more efficently and so produce greater yields of 
oxytetracycline. 
6.1.2 Experimental aims 
To investigate the three afore-mentioned systems in relation 
to oxytetracycline production in Streptomyces rlmosus. 
6.2 Results 
6.2.1 The influence of phosphate concentration on 
oxytetracycline production. 
Subclones were constructed of the otrA gene region, the 
orfl/orf2 region downstream of the otrB/otrR gene region, the ACP 
region upstream of the otrB/otrR gene region and the otcC gene 
region into the BamH 1 site of the xylE promoter probe vector, 
pIJ2843 (Chapter 2). To construct the subclones the appropriate 
restriction fragments containing the relevant genes were Klenow- 
filled (Materials and methods section 2.3.9) and BamHI linkers 
added (Materials and Methods section 2.3.10) as the pIJ2843 vector 
contains only a BamHI cloning site. The plasmid pIJ2843 contains 
the xylE gene from pAMB22 and also a thiostrepton-resistance 
marker, making transformants selectable. Subclones showing 
promoter activity were selected by flooding the plate of 
transformants with a 1% catechol solution. Positive colonies, those 
with promoter activity, appeared as yellow colonies and were re- 
streaked on agar plates to make spore suspensions (Materials and 
methods section 2.2.4). The spore suspensions were then titred and 
plated onto Emersons agar containing varying phosphate 
concentrations from 0 to 2.5g 1-1. The plates were then incubated at 
300C over a period of five days. Each day one plate from each 
phosphate concentration and each of the two promoter regions was 
removed and sprayed with a 1% catechol solution. The morphology 
of the streptomycete colonies was also noted. The results are shown 
in Table 6.1. 
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Gene 
region 
DAY 1 
otcC High Phos. - 
Low Phos. - 
otrA High Phos. + 
Low Phos. + 
orfl /orf2 High Phos. 
Low Phos. 
ACP High Phos. 
Low Phos. + 
pIJ2843 High Phos. - 
alone Low Phos. - 
xylE Expression 
DAY 2 DAY 3 DAY 4 
+ + + 
+ + + 
+ +ý- + 
++ ++ 
+++ 
++ ++ ++ 
TABLE 6.1: Results of xylE expression in different gene 
regions of the otc cluster. - indicates no expression, +/- indicates 
slight expression, + indicates good expression and ++ indicates 
intense expression of xylE.. 
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The otcC gene region was affected by phosphate 
concentration. In high phosphate the gene was better expressed and 
was only slightly expressed at low phosphate concentrations. This 
region of the otc cluster was found to contain putative phosphate 
control sequences with 44% similarity to E. coli pho boxes (K. 
McDowall, 1991) (Chapter 1 section 1.5). 
The otrA gene region was not affected in high or low 
phosphate concentrations as expression was constitutive. The 
orfl /orf2 gene region was intensely expressed at low phosphate 
concentrations after Dayl. At high phosphate concentrations on 
Days 2,3 and 4 the reporter gene was well expressed. The ACP gene 
region was intensely expressed after 1 day at low phosphate and not 
as intensely expressed in high phosphate concentration after 2 
days. 
It was noted in all cases that the colony morphology was 
adversely affected in high phosphate concentrations. In low to 
intermediate phosphate concentrations the Streptomyces colonies 
were "nicely domed", whereas in high phosphate concentrations the 
colonies were "volcanic" in appearance and had difficulty in 
attaching to the agar surface (the colonies tended to "float" when 
sprayed with catechol solution). 
From these results conclusions can be drawn that different 
regions of the OTC cluster are differentially affected by phosphate 
concentration. This may indicate that some phosphate regulatory 
mechanism exists within the OTC cluster. 
In a further investigation, the susceptibility of the \\'hole 
oxytetracycline cluster to phosphate was determined. A glucose- 
based minimal medium without phosphate was used to grow a 
current Pfizer oxytetracycline producing strain in different 
phosphate conditions over a period of 7 days. Each day a culture 
from each phosphate concentration was extracted with acid and 
tested for oxytetracycline production. The results are shown in 
Figure 6.1. It was observed that with no phosphate the culture 
started to produce oxytetracycline but only very slowly in relation 
to the other cultures. However, it was suprising to observe that the 
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addition of between 0.15 to 2.0 gl-1 of phosphate (the 
recommended addition of phosphate to minimal media is 0.15g1-1) 
to the S. rimosus fermentations did not have an adverse affect, and 
the production of oxytetracycline was relatively constant in all the 
fermentations. This may suggest that the S. rimosus cells have an 
ability to just utilise the phosphate that they require via some 
mechanism of phosphate control, or more likely that the production 
culture has mutated to become insensitive to phosphate 
concentration. The only problem that they encounter is in 
conditions of no phosphate where they have to slow down antibiotic 
production until they can scavenge or metabolise sufficient 
phosphate to proceed with oxytetracycline biosynthesis. It was not 
observed that under even fairly high phosphate concentrations that 
the antibiotic production was shut down. 
EFFECT OF PHOSPHATE CONCENTRATION ON ANTIBIOTIC 
PRODUCTION 
400 
350 
} 300 
U 
250 
w 
0 200 
150 
100 
50 
0 
TIMEPOINTS 
Figure 6.1: The effect of phosphate concentration on 
oxytetracycline production in a current S. rimosus production 
strain. Timepoints are 1=0 hrs, 2=24hrs, 3=48 hrs, 4 72hrs and 
5=96hrs. The Dgl-1 phosphate concentration is shown by the shaded 
square. The other phosphate concentrations are 0.15: open triangle, 
0.5: open diamond, 1.0: closed diamond, 1.5: open square and 2.0: 
closed diamond all in gl-1. 
i -- 
5 
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To confirm the observations that OTC production in a 
S. rimosus production strain was not adversely affected by 
phosphate, the biomass in Iml of culture was compared at different 
timepoints and phosphate concentrations (Figure 6.2). The best 
biomass yielded was observed at lg/1-1. It was observed that 
oxytetracycline production under different regimes of phosphat(- 
concentration is not proportional to biomass 
Protein extracts were made of the S. rimosus cells at different 
phosphate concentrations and run on an S. D. S. polyacrylamide gel. 
No defined protein bands were observed to increase or decrease in 
abundance at different phosphate concentrations (Results not 
shown). 
In a final experiment, p1J940 containing the entire OTC cluster 
on a plasmid (strain pGLWl01) inTK54, was subjected to different 
phoshate concentrations. Colonies of pGLW 101 were grown on 
Emersons agar containing differing levels of phosphate from 0 g1-1 
to 2.5g1-1 over a period of six days. Each day two plugs of agar 
containing a Streptomyces colony were removed from each 
phosphate plate. The first plug was placed on an plate seeded with 
E. coli MC 1061 to assay OTC production and by the zone of 
inhibition around the plug. The second plug was eluted in acid to 
extract any produced oxytetracycline that could be quantified by 
HPLC analysis at Pfizer. The plugs on the plates seeded with E. coli 
showed no zones of inhibition after 1 day. After 2 days zones of 
inhibition started to appear between phosphate concentrations of 
0.5 and 1.0g1-1. On days 3-6 all the colonies showed zones of 
inhibition (results summarised in Table 6.2). The oxytetracycline 
production from plug eluates confirmed the observations made in 
the inhibition experiments (results shown in Figure 6.2). Therefore, 
a definite link can be established between phosphate regulation and 
oxytetracycline production in Streptomyces rimosus. This will 
be 
further discussed in section 6.3. 
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Observed zone of inhibition 
(g. 1 1) Day l Day2 Day3 Day4 Days Day6 
o --+ ++ 
0.5 -+ ++ 
1.0 -++ +++ 1.5 --+ +++ 
2.0 --+ +++ 
2.5 --+ +++ 
Table 6.2: Observed zones of inhibition of the 
oxytetracycline producing strain, pGLW 1 Ol, plugs on E. coli MC 1061 
seeded plates under different phosphate concentrations. -, no 
observed zone of inhibition and +, observed zone of inhibition. 
Phosphate concentrations 1=0g1-1,2=0.5g1-1,3=1.0g1-1, -4=1. Sgl-1. 
5=2.0gl-1 and 6=2.5gl-1. 
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0.25 
d 0.2 
0.15 
O 
10.1 
°' 0.05 
0 
Figure 6.2: Biomass in Im! of a fermentation of S. rimosus 
4018 at different phosphate concentrations. Timepoints 1=Ohrs, 
2=24hrs, 3=48hrs and 4=72hrs. Shaded box= Ogl-1, shaded 
diamond= 0.5g1-1, open diamond=1.0gl-1, open box, =1.15g1-1, 
shaded triangle =1.5g1-1 and open triangle= 2. Ogl-1: 
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6.2.2 Transposon mutagenesis of the oxytetracycline 
gene cluster 
The transposon that was used in these studies is Tn 4 56». This 
is a derivative of the isolated Tn4556 from Streptonl 
-ý ces 
fradh: w 
that has the viomycin resistance gene inserted near the right hand 
side of the transposon. Tn4560 contains terminal inverted repeats 
(IRS) of 38 bases with a single mismatched pair. The IRS's are 70% 
homologous with the ends Tn3 and the transposition of Tn4560 
generates five base pair direct repeat sequences in the region of 
insertion. The Tn4560 was shown to have a transposition frequeinc\ 
of 1.3x 10-3 per spore (Chung, 1987). The transposon construct 
used in this work had been linked to a temperature-sensitive 
plasmid pMT660 and shown to transpose to random locations 
within the Streptomyces lividans chromosome, identifying the 
system as a useful tool for transposon mutagenesis studies (Figure 
6.3). 
A construct made at Pfizer containing the entire 
oxytetracycline cluster, cloned in pIJ916 was subcloned into p1J940 
(Hunter, personal communication) to give a plasmid, pGLW1'101, 
containing the oxytetracycline gene cluster plus transfer genes, 
thiostrepton and hygromycin resistance markers. This construct was 
identified as being useful for transposon mutagenesis studies. 
The aim of the transposon work was to allow conjugation 
(mating) of pGLW101 with the S. lividans strain containing Tn4560 
:: pMT660 and select for the new transposon-containing strain with 
antibiotic resistance markers thiostrepton, hygromycin, and 
viomycin (Materials and Methods section 2.2.12). Once this had 
been achieved the new transposon-containing strain was mated \\ ith 
TK24, TK54 or TK64 to "mate out" the pGLW 101 plasniid noý% 
containing a site of transposon insertion, hopefully within the otc 
cluster (strategy shown in Figure 6.4). 
This strategy appeared to be successful and produced nOrl 
oxytetracycline non-producing mutants (characterised by 
lack of 
brown pigment production and lack of oxytetracy-cline observed 
in 
acid extracts analysed by HPLC). The scheme also produced mutants 
162 
Chapter 6 Physiological Investigation 
pMT660 
K 
5.8 Kb 
p mel 
Sp 
9 
*Bg 
lsr PUC1214 
Ba 
ga 3na555 Ba 
4 6.8 Kb 
Ligation 
Kp 
Sp 
Bg fsr 
Puc1165 P 
12.6 Kb 
Bg Bg 
Partial Bg 
Ligation 
Sr Sp /ý 
pIJ13 
+Ba 
Ba 
YQý 
Ba 
Sp Sp 
2Kb 
09 Is[ +ßg dsr 
ea 1 pUC1167 _ pUC1169 Sa 
ýI pUC1168 14.6 Kb 
14.6 Kb Kp 
KQ 
89 8g 
- `ý X69 
so sr um 
so sa g, 
Ba Sp Sp Ba 
Figure 6.3: The pUCI 169 transposon construct. ((llung, 
1987). 
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hygR/thioR 
otc gene 
cluster 
pIJ91 6 
tra 
X 
hygR/thioR 
Kb Transfe 
enes 
p{J940 
otc 
otcR 
pGLW 101 
"Mated" with pUC1 169 select for thioR/ 
hygR and vioR. 
Transposoricontaining pGLW 101 
"mated out" with recipient TK24 strR 
or TK64 strR if TK54 was the donor. 
Selected for thioR/hygR/vioR and 
strR or spcR. 
Figure 6.4: A schematic diagram of the pUC 1 1()v) 
mutagenesis strategy for pGLWI01. 
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Tn Mutant Colony Colour Inhibition of Ecoh growth 
101 Brown + 
103 Brown - 
108 White - 
209 White - 
303 Brown - 
408 White - 
501 Brown + 
502 White - 
511 White - 
1014 Brown - 
Table 6.3(a): Colony pigmentation and otc production (as assesed 
by zones of inhibition of L-agar plates seeded with E. coli MC 1061 ) 
of selected pGLW 101:: Tn4560 transposon mutants. 
TRANSPOSON MUTANTS 
Table 6.3 (b) : Cross-feeding 
pGLW 101:: Tn4560 mutants. 
101 
103 
108 
209 
303 
408 
501 
502 
511 
1014 
CROSSS-FED WITH 
103 108 
++ 
+- 
-+ 
studies between selected 
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that were pigmented but did not produce oxytetracycline. \ft(-r 
transposon crosses a selection of brown and white colonies wer,, 
picked after growth on viomycin, hygromycin and thiostrepton 
plates (control strains for each antibiotic resistance %%ere also used 
to check that the antibiotic was selecting for resistance). Single 
selected colonies were placed on an L-agar plate seeded with I . col i MC 1061 to test for oxytetracycline production or another 
bacteriocidal compound chracterised by observed zones of 
inhibition around the plug. The results of pigmentation and 
inhibition of growth of E. coli MC1061 by the selected colonies are 
shown in Table 6.3(a). Cross-feeding studies were investigated 
between the mutants. Mutant 101 could cross-feed with mutants 103 
and 108, mutant 501 could cross-feed with mutant 103 and mutants 
511 and 1014 could cross feed with mutant 108 (Results 
summarised in Table 6.3(b)). It had also been intended that a 
postdoctoral assistant in a collaborative project with the Department 
of Chemistry at Glasgow University would analyse these mutants to 
indicate where the mutants may be blocked in the oxytetracycline 
pathway. However this work was never completed. 
Futher analysis of the transposon mutants was attempted. 
Southern blot analysis, using a randomly primed piece of the 
transposon Tn 4560 as a probe against total DNA from the isolated 
mutants (cut by restriction enzymes) were attempted (Materials and 
Methods sections 2.3.12 and 2.3.16). During the preparation of 
agarose gels for Southern analysis some observations were made 
about the transposon mutagenesis (results shown in Figures 6.5 and 
6.6). 
In Figure 6.5 it was observed that after "mating out" of the 
pGLW101 plasmid containing a presumptive transposon insertion 
into TK24 (pGLW104D), a restriction digest with the enzyme Sstl 
indicated a transposon event. Unfortunately, pGLW 104D appeared 
to have part of the transposon delivery plasmid remaining within 
the pGLW104D mutant. This suggests that incomplete excision of tli«, 
transposon plasmid had occured during its insertion into pGL`W'10. 
Further observations (Figure 6.6), indicated that two of the 
randomly-selected mutants (from a different mutagenesis 
experiment) were the same or that further deletions may 
have 
occured in pGLW 101. 
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Figure 6.5: Restriction digests of 
transposon mutants digested with Sstl. 
KEY 
1. HindIll / Lambda DNA markers. 
2. pGLW 101 /SstI. 
3. pGLW102/SstI. 
4. pGLW103/Sstl. 
5. pGLW104/Sst1. 
6. pUC1126/Sstl. 
7. Transposon mutant pGLW102B/ TK24 
8. Transposon mutant pGLW 103C/ TK24 
9. Transposon mutant pGLW 104D/ TK24 
10. Transposon mutant pGLW101A/ TK24 
11. Transposon mutant pGLW102E/ TK24 
12. Transposon mutant pGLW104F/ TK24 
13. BLANK 
14. HindIll / Lambda DNA markers. 
pGLW 1 Ol :: Tn4560 
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Figure 6.6: Restriction digests of pGLW 101:: Tn4560 
mutants in TK54 digested with Sstl. 
(EY 
_. 
HindIII / Lambda DNA markers. 
pUC1126. 
>. pGLW 101. 
L pGLW101/TK54. 
". pGLW101/TK54/ Transposon mutant. 
º. pGLW 103. 
. pGLW103/TK54 
º. pGLW 103/TK54/ Transposon mutant. 
pGLW 104. 
0. pGLW 104/TK54. 
1. Hind111 / Lambda DNA markers. 
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This could be confirmed by Southern analysis. This indicated 
non-random insertion of the transposon into pGL%%'101 which was 
contrary to reports about the transposon and its random insertion. 
Also, it was observed from Figure 6.5 in relation to Figure 6. (1, 
that the same restriction enzyme digests (Sst[) gave a different 
restriction pattern for the pUC1169 plasmid. This suggested some 
genetic rearrangement had occured or that the DNA had become 
sheared (as many more bands were observed). 
Southern analysis detected the transposon-containing plasmid 
control but failed to detect the prescence of sites of transposon 
integration. Zhou et al., (1988), had proposed that degradation of 
chromosomal DNA occured in Streptomyces lividans in the presence 
of EDTA. Therefore all gels and reagents in this work were made 
without EDTA. However, this work was abandoned due to the 
descrepancies as reported here and after a report from a PhD 
student in G. Muth's laboratory that the temperature-sensitive 
integration of a pMT660 based vector had not only inserted into the 
Streptomyces chromosome but had also induced a deletion event of 
between 30-40 kilobases. 
Since this, work many'transposon systems have been reported 
that insert into the Streptomyces genome and that some of these 
insertions may not be entirely random (Solenberg and Baltz, 1991). 
Ray et a], 1992 discovered that the presence of Tris in 
electrophoresis buffer cleaved large pieces of Streptomyces lividans 
DNA. This may be explain why, in Southern blot analysis, no defined 
transposon insertion sites could be detected as the DNA would have 
been sheared by Tris. This work has been surpassed by a currently- 
available system allowing gene disruption of targets (rather than 
random) gene disruption (see for example replacement of the : MCP 
protein in S. coelicolor with ACP genes from other Streptomyce. s 
species, discussed in Chapter 1, section 1.6-3). 
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6.2.3 Analysis of a haemoglobin gene containing 
plasmid and its influence on oxytetracycline production. 
Two plasmids containing the Vitreoscilla bacterial 
haemoglobin gene (VHb) were obtained from the Exogene 
Corporation in the U. S. A. The Exogene Corporation had studied the 
effects of the haemoglobin gene on actinhorodin and oxytetracvcline 
production in S. coelicolor and S. rimosus 4018 (an OTC production 
strain) respectively and concluded, that oxytetracycline production 
could be enhanced in minimal medium cultures containing the VHb 
gene in minimal medium. 
Since oxytetracycline fermentations in industry occur in a 
complex medium, an investigation of how the VHb plasmid 
containing strains would perform in this medium as opposed to the 
standard was attempted. 
Three strains were constructed for the study using 
transformations of the ex-oxytetracycline production stain of 
S. rimosus 4018 with DNA from various plasmid constructs. Four 
strains were used in the study: 
a) 4018/pDS118- The 4018 ex oxytetracycline production 
strain containing the plasmid pDS1 18. The pDS118 contains the 'Hb 
gene and is under control of the ermE promoter. It is classed as a 
high-copy number plasmid with high expression. 
b) 4018/pDS903- The 4018 ex oxytetracycline production 
strain containing the pDS903 plasmid. The pSD903 plasmid 
contains the VHb gene and is under the control of the native V1 1b 
promoter. It is classed as a low-copy number plasmid sind low 
expression. 
c) pIJ916- A low copy number Streptom ces vector as a 
control with no VHb gene. 
d) 4018-The 4018 ex-ox tetracy cline production strain 
without any plasmids. 
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e) 4018 containg pIJ486 -A high cop}, number Srreprom vices 
vector as a control with no VHb gene was to be utilised as a contr(A. 
Unfortunately it did not survive the journey to Pfizer where this 
work was carried out. 
Starter cultures were prepared of the above strains by making 
a spore suspension (Materials and Methods section 2. '. 4), 
subculturing into inoculum medium and incubating at 30°C for two 
days. 2mls of this culture was then used to inoculate the flasks of 
fermentation media for the experiment. A flask of each construct 
was removed from 30°C incubation at 16,24,40,48,64,72,87,91 
and 94 hrs and analysed for oxytetracycline production by HPLC 
analysis as detailed in the materials and methods section 2.2.7. The 
production of oxytetracycline in 4018,4018/pDS 118,4018 pDS903 
and pIJ916 is shown in Figure 6.7 a), b), c) and d) respectivel\. 
The 4018/pDS1118 and 4018/pDS903 constructs show as 
higher rate of oxytetracycline production than the 4018 strain 
alone. Between the two strains there is very little difference in 
oxytetracycline production suggesting no obvious difference 
between oxytetracycline production and plasmid copy number. 
Additionally the pIJ916 containing S. rimosus strain shows 14% less 
oxytetracycline production' as the two VHb containing strains 
suggesting that the presence of a low copy plasmid has an effect on 
oxytetracycline production without the presence of the k 'Hb gene. 
Protein extracts were also obtained from the 4018/pDS l 18 
and 4018/pDS903 S. rimosus strains during the fermentations. The 
protein extracts were run on denaturing polyacrylamide gels (Figure 
6.8). The protein gel was also blotted onto nitrocellulose (materials 
and methods section 2.4.3) and the filter was probed with antibody 
to the VHb protein. In all the samples several % 'Hb protein bailds 
were detected confirming that it was present in the 4018 cell 
constructs and being expressed (Figure 6.9). 
171 
Chapter- 6 
4018 
300 
250 
200 
r_ 
CJ 
0 
Q 150 
rn 
100 
50 'i 
0 
1 
-U- - -- --- 
2 
TIMEPOINTS 
4018/pDS 118 
2000 
1800 
1600 
a, 1400 
1200 
Q 1000 { 
800 
600 
400 
200 
0' 
1 2 
TIMEPOINTS 
172 
- -- a 
3 
3 
I 
4 
4 
Chapter 6 Physiological Investigation 
1600 
1400 - 
1200 - 
1000 - 
d 
ä 800 
rn 
600 
3 
400 
200 
  0 
1 
1400 
1200 
1000 
c m 800 
0 CL 
vi 600 rn 
400 
200 
I 0 
1 
a 
2 
2 
4018/pDS903 
TIMEPOINTS 
4018/pIJ916 
  
3 
  
3 
TIMEPOINTS 
Figure 6.7: The effect of the VHb gene 
production. a) OTC production in 4018 alone, b) 
4018/ pDS 118, c) OTC production in 4018 ' pI 
production in 4018/ pIJ916. Timepoints are I 
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173 
on oxvtetracycline 
OTC production in 
)S903 and d) OTC 
= 24hrs, 2=4Shr-,,, 
a 
-1 
a 
,1 
Chapter 6 Physiological Investigation 
The detected bands corresponded with those detected by 
Hughes et a]. (1992), in cultures of Acremonium chrn'sogenuni 
containing the VHb gene on a relevant plasmid. 
The results were inconclusive. The VHb protein mad, or may 
not contribute to an increase in oxytetracycline production in 
S. rimosus. It appears that the presence of a low copy-numher 
plasmid pIJ916, may also increase the production of oxytutrac\ c line. 
6.2.4 Comparison of oxytetracycline production to 
isolate RNA for transcriptional studies. 
In order to prepare good quality, abundant RNA for 
transcriptional mapping of the otrB gene, studies were undertaken 
to establish oxytetracycline production from various oxytetrac), cline 
production strains and on various media. 
The ex-oxytetracycline production strain was grown on minimal and 
fermentation media and an assessment was made of oxytetracycline 
produced (Figure 6.10). It is obvious that the 4018 strain produces 
the most oxytetracycline when grown on fermentation medium. The 
current Pfizer production strain was also assessed in shake flask 
culture for oxytetracy, cline production on fermentation medium at 
Pfizer (Figure 6.11). The yield of oxytetracycline in the Pfizer stain 
was substantially higher than 4018. Therefore RNA was chosen to be 
made from this strain at Pfizer and then transported back toi 
Glasgow. 
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Figure 6.8: A protein gel of the 401 8/pDSI 18 and 
4018/pDS903 cell extracts. 4018/pDSI 18 Lanes 1-7 at timepoints 
16hrs, 24hrs, 40hrs, 48hrs, 64hrs, 72hrs, 87hrs, 91 hrs, and 94hrs 
respectively. 4018/pDS903 Lanes 8-13 at the same timepoints as 
previously indicated. Lane 14 contains protein standards. 
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Figure 6.9: A western blot of the protein gel in figure 6.5 
with VHb antibody. Lane 1 contained protein markers that do not 
cross-react with the antibody. 4018/pDS903 Lanes 2-8 at tirepoints 
16hrs, 24hrs, 40hrs, 48hrs, 64hrs, 72hrs, 87hrs, 91 hrs, and 94hrs 
respectively. 4018/pDS118 Lanes 9-14 at the same timepoints as 
previously indicated. 
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4018 comparison between oxytetracycline production on 
minimal and fermentation media. 
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Figure 6.10: The comparison of oxytetracycline production 
in 4018 on minimal (open squares) and production media (shaded 
squares). Timepoints 1=24hrs, 2=40hrs, 3=48hrs, 4=68hrs, and 5= 
72hrs. 
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Figure 6.11: Oxytetracycline production in a Pfizer 
production strain of S. rimosus. Timepoints 
1=24hrs, 2=48hrs, 
3=72hrs and 4=96hrs respectively. 
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6.3 Discussion 
Over the course of this work many small areas of 
streptomycete physiology have been investigated. \lan%- of the 
results presented here are of a preliminary nature that could be 
investigated further. 
Phosphate regulation is apparent in the S. rirnoýsus 
oxytetracycline production strains. Gil er al. (1985) identified that 
transcriptional regulation of the PA: A synthase (p-amino-benzoic 
acid) involved in candicidin biosynthesis is strongly repressed by 
phosphate in S. griseus. Sequencing of the gene revealed the 
presence of PHO boxes (disscussed in chapter 1 section 1.5) that are 
hypothesised to act as the site of transcriptional regulation. PHO 
boxes were detected in Streptomyces rimosus before this work %va, ' 
undertaken, within the otcC/otcX gene region McDowall (1991). It 
should be possible to examine the transcription of various 
oxytetracycline genes at different timepoints and at different 
phosphate concentrations to determine if phosphate regulation is at 
the transcriptional level. The observation that, in the production 
strain of S. rimosus, oxytetracycline production is not severly 
affected by high phosphate concentrations may suggest that the 
intense strain selection process undergone by this industrial strain 
has deselected for the regulation by phosphate within the cell. 
Alternatively, there may be a series of genes as in E. coli that can 
regulate the uptake and utilisation of phosphate by the cell in an 
efficent manner. Therefore, the studies would have to extend to 
wild-type and industrial S. rimosus oxytetracycline production 
strains. It would also be interesting to isolate specific phosphate- 
induced proteins, purify and sequence them to compare them with 
the identified E. coli phosphate proteins. Also, it would be 
interesting to clone these genes and determine the biology behind 
these observations. 
Transposon mutagenesis studies in Streptomyces have also 
progressed significantly since the undertaking of this project. 
A 
report in 1991 indicated that the Tn4560 transposon on a 
temperature sensitive plasmid (the construct on which pt 
ýC 1169 was 
based) when used in S. coelicolor was unable to 
insert into the 
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chromosome and so produce chromosomal insertions. (Schauer et 
al., 1991). The delivery vector was found to persist at high 
temperature and hindered the ability to select for the relatively low 
frequency of transposition. It was observed that selection of the 
transposition event solely with viomycin resistance I not 
temperature sensitivity led to sucessful transposon mutants being 
obtained. This strategy unfortunately still could not be used in 
Streptomyces rimosus as it is already viomv-cin resistant. 
From the work of Ray et al. (1992), it would now be possible 
to return to the transposon mutants and characterise them by using 
Southern analysis without Tris. However, as discussed, the non- 
random of nature transposition by Tn4560 could mean that the 
transposon mutagenesis experiments have not produced a large 
range of novel mutants within the otc cluster. As the sequencing of 
the otc cluster draws to a close and with the recent developments in 
replacement gene targeting, it probably would not be advantageous 
to revive this work. Gene replacement technology provides a greater 
scope for defining gene function in Streptomyces by "knocking out" 
defined antibiotic genes and therby establishing their function. 
The haemoglobin plasmid work has proved interesting. 
Introduction of a low copy number plasmid (pIJ916) appears to 
produce an increase in the amount of otc produced. Futher work 
needs to be carried out to deduce if the haemoglobin gene 
is 
advantageous in production strains on a larger scale or whether the 
introduction plasmids in a production strain could induce the same 
effect. 
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Chapter Future work 
Much of the work presented in this thesis identifies areas of 
future work. Future investigations are discussed in this chapter. 
7.1 The otrB gene and putative membrane protein. 
The otrB gene product would appear to show extensiv cc 
similarity to a family of transmembrane electrochemical 
transporters. Several lines of futher investigation need to be 
established to confirm the function of the otrB protein and the 
function of the otrB gene within the oxytetracycline gene cluster. 
7.1.1 Transcriptional studies. 
A preliminary investigation as reported in Chapter 3 hýý,, 
indicated the putative transcriptional start point for the otrB gene. A 
more detailed study including Si analysis experiments should be 
undertaken to confirm this observation. Different timepoints for- 
isolation of RNA from oxytetracycline fermentations (especially the 
early timepoints before and at low oxytetracycline production) need 
to be investigated to establish "switch on" of the otrB gene in the 
presence of nil and differing amounts of oxytetracycline. It would 
also be interesting to compare the abundance of the otrB gene 
transcript in a wild-type strain of S. rimosus with an oxytetracycline 
production strain. If the wild-type strain is exposed t() 
oxytetracycline does it exhibit a similar response to that of an 
oxytetracycline production strain? 
7.1.2 Studies of the otrB protein. 
The putative structure of the otrB protein needs to be 
investigated. Overexpression of the protein will allow several 
investigations to be carried out. Inverted membrane vesicles can be 
constructed from the overexpressed protein to 
look at the proton- 
motive force utilised by the protein. Inverted membrane vesicles can 
also be utilised to establish cleavage sites (achieved using proteases) 
within the otrB protein. This will allow a model 
for the t\v, () 
dimensional topology of the protein to be established. 
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Expression of the otrB protein should be looked at within an 
E. coli system. It would be useful to establish if the otrB protein (aa 
putative 14 transmembrane domain protein) was functional within 
E. coli-a bacterium that usually carries a 12 transmembrane domain 
protein conferring resistance to tetracycline. 
Mutagenesis studies of Streptomyces transporters have, as yet, 
not been well established. Experiments to determine the functional 
residues involved in substrate recognition and transport need to be 
initiated. The work of various researchers as discussed in Chapter 4, 
has allowed particular amino acid motifs to be identified for other 
systems. These motifs can be utilised for PCR mutagenesis of defined 
DNA sequence of these residues allowing the function of specific 
amino acids to be assigned. 
7.2 The otrR gene product 
In chapter 5, the otrR gene product was identified as a 
putative repressor protein. Further investigations need to be carried 
out to confirm its function. 
7.2.1 Transcriptional studies 
Si protection experiments need to be carried out to confirm 
the transcriptional start point of the otrR gene. These experirilcrnts 
should investigate the RNA produced before oxytetracycline 
production until just slight after oxytetracycline production. It 
would be expected that the otrR transcript is abundant before 
oxytetracycline production, when it is acting as a repressor of the 
otrB gene. The entire otrB/otrR intergenic region also needs to be 
characterised at the transcriptional level to establish that if the otrR 
gene is under control of only one promoter. 
7.2.2 Studies with the putative otrR protein. 
The otrR protein should be overexpressed. This would alloy\' 
protein /DNA complexes to be evaluated using the otrB"otrR 
intergenic region as the DNA target. This experiment %v, ould 
be 
carried out in the presence and absence of oxytetracycline to 
181 
Chapter 7 'Future work 
establish, as for the tet repressor, if the otrR repressor binds to the 
DNA in the presence of oxytetracycline or (as observed in the tet 
repressor) the combination of the repressor with the tetracycline 
makes it unable to bind the intergenic region and so the tetA gene is 
transcribed. In the absence of oxytetracycline the otrR repressor 
should bind to the operator sites in the intergenic region. 
Putative operator sites have been suggested in Chapter >, 
based on comparison with other systems that act in a similar 
manner. Confirmation of the operator sites for the OtrR protein can 
be confirmed by DNAase footprint analysis by indicating that the 
repressor binds in the intergenic DNA region between the otrB 
/otrR genes and the precise region that the OtrR protein binds to. 
7.3 Physiological investigations 
7.3.1 The effect of phosphate on oxytetracycline 
production 
A comparison should be made of the effect of phosphate on a 
production and wild-type oxytetracycline strains of S. rimosus. This 
effect could be monitored by looking at RNA abundance from the 
transcripts of various genes within the oxytetracycline cluster at 
different phosphate concentrations. Further investigations (for 
example 2-D gel electrophoresis) should be made on protein extracts 
extracted from wild-type cells exposed to different phosphate 
concentrations to see if specific proteins involved in phosphate 
regulation can be identified. If phosphate-regulated proteins are 
identified in the wild-type S. rimosus oxytetracycline-producing 
strain, an oxytetracycline strain of S. rimosus used for commercial 
production could be probed to see if intact or remnants of these 
proteins exist in this severely-genetically inbred strain. 
7.3.2 Transposon mutagenesis studies 
Unfortunately this work has been superseded by the ability of 
streptomycete molecular biologists to successfully replace specific 
genes with genetically mutated or homologous counterparts. 
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However, it would now be possible (after the revelations about Tris 
degradation) to return to these mutants and characterise them to 
see if they could be of use in establishing the function of some of the 
genes within the oxytetracycline cluster. 
7.3.3 The VHb gene. 
Results as presented in chapter 6 indicate that the presence of 
a low copy number plasmid may work to increase the production of 
oxytetracycline, but not as successfully as the \-Hb gene. This work 
needs to be investigated more fully on larger scale fermentations. 
Also, the feasibility of using these systems in industry would need to 
be evaluated. 
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